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Abstract
Metacaspases are distant orthologues of mammalian caspases and have been 
proposed to play a role in programmed cell death in yeast and plants, but little  is known 
about their function in parasitic protozoa. In this study, I found that the single tACA 
gene of Leishmania major {LmaJMCA or MCA) is expressed in actively replicating 
amastigotes and promastigotes, whereas expression level is significantly lower in non­
dividing stationary phase promastigotes. In order to determine the role of the 
metacaspase during promastigote division, an analysis of the events of the L. major cell 
cycle was performed. Based on these findings, immunofluorescence experiments 
revealed the presence of LmajMCA in punctate structures throughout the cytoplasm of 
interphase cells and its accumulation in the kinetoplast (mitochondrial DNA) at the time 
of the organelle’s segregation. LmajMCA also translocates to the nucleus during mitosis, 
where it associates with the mitotic spindle. LmajMCA null mutants could not be 
generated using standard gene deletion techniques. When LmajMCA was expressed from 
an episome, the only mutants that were viable were those expressing LmajMCA at 
physiological levels. Over-expression of LmajMCA in promastigotes leads to changes in 
ploidy and a severe growth retardation, associated with defects in kinetoplast 
segregation and nuclear division and an impairment of cytokinesis. Several LmajMCA 
variants lacking their N-terminal and/or C-terminal domains or with active site 
mutation(s) (C201G, C201-C202G, C202G, H147A) were expressed, with or without tags, 
in L. major promastigotes, in Escherichia coli, in the yeast Pichia pastoris^ and using an 
in vitro translation kit. In all the systems used, the expression of most LmajMCA variants 
was barely detectable and was apparently toxic for the host cells. Some encouraging 
results were obtained using P. pastoris, with the expression and secretion in the culture 
medium of N- and C-terminally truncated LmajMCA. Thus, this system may facilitate 
production of sufficient enzyme for the characterisation of the biochemical properties 
of LmajMCA. Insights into the putative function of the different domains of LmajMCA 
were gained when it was observed, that the first 101 N-terminal amino acids of 
LmajMCA worked, in L.major, as a mitochondrion targeting signal. A potential role of 
the LmajMCA proline-, glutamine- and tyrosine-rich C-terminal domain in protein- 
protein interactions was also hypothesized. Together these data suggest that LmajMCA 
is essential for the correct segregation of the nucleus and kinetoplast and cytokinesis 
and that the tight regulation of the amount of LmajMCA within the cell is crucial for the 
development of Leishmania promastigotes.
Trypanosoma brucei possesses five metacaspase genes. Two of the encoded 
proteins, TbMCAl and TbMCA4, possess substitutions at their putative active site 
residues and thus might lack peptidase activity. Therefore functional studies were
performed only on the three other metacaspases. Triple RNAi analysis showed TbMCA2, 
TbMCA3 and TbMCAS to be essential in the bloodstream form, with induced parasites 
showing a delay in kinetoplast segregation and being blocked in pre-cytokinesis. Triple 
null mutants {ATbmcal/3ATbmca5) were found to be initially affected in their 
development, but recovered after several weeks of in vitro adaptation. The initial slow 
growth rate of the ATbmcal/SATbmcaS mutant was associated with a delayed entry in 
cytokinesis. This phenotype was similar, although less extreme, to that produced upon 
triple RNAi of TbMCA2, TbMCAS and TbMCAS. These data suggest that these 
metacaspases are essential for T. brucei bloodstream forms, but they have overlapping 
functions and their progressive loss can be compensated for by activation of alternative 
biochemical pathways. Analysis of ATbmca2/3ATbmca5 revealed no greater or lesser 
susceptibility to stresses reported to initiate programmed cell death, such as treatment 
with prostaglandin 0%. These metacaspases co-localfse with RAB11, a marker for 
recycling endosomes but variant surface glycoprotein (VSG) recycling processes and the 
degradation of internalised anti-VSG antibody were found to occur similarly in v/ild 
type, ATbmca2/3ATbmca5 and triple RNAi-induced parasites. Thus the data provide no 
support for the direct involvement of T. brucei metacaspases in programmed cell death 
and suggest that the proteins have a function associated with RAB11 vesicles that is 
independent of known recycling processes of RAB11-positive endosomes.
As both the L  major and the T. brucei metacaspases appear to play crucial roles 
in cell cycle progression and because metacaspases are absent from the mammalian 
genome, these metacaspases have potential as novel drug targets.
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1.1. Leishmania
1.1.1. Leishmaniasis causative agent
Leishmania are parasitic protozoa belonging to the Kinetoplastidae order and the 
Trypanosomatidae family. They are the causative agent of leishmaniasis. More than 20 
species and subspecies of Leishmania can infect humans. The induced symptoms, which 
are species-specific, range from self-healing skin ulcers to severe life-threatening 
disease. The leishmaniasis can be classified into 4 main clinical forms (figure 1.1):
1. Localised cutaneous leishmaniasis (LCL), the most common form, causes skin 
lesions which usually self-heal within a few months, but which leaves unsightly scars, in 
Asia and Africa, where i t  is mainly due to Leishmania major, this disease is commonly 
termed Baghdad ulcer, Delhi boil or Bouton d'Orient. Leishmania mexicana is mainly 
responsible for New World cutaneous leishmaniasis.
2. Mucocutaneous leishmaniasis (MCL) starts with skin ulcers but rapidly becomes 
a disfiguring affliction, causing massive destruction of the nose and mouth tissues. In 
the New World, it  is due to Leishmonia braziliensis subspecies: mainly L. b. broziliensis, 
but also L. b. ponamensis, L. b. guyonensis and L. b. peruviana.
3. Diffuse cutaneous leishmaniasis (DCL) produces disseminated and chronic skin 
lesions comparable to those of leprosy and is particularly difficult to treat. It is a 
pathology observed with L. amozonensis and L. aethiopica infections, but which can 
also be attributed to L. major, L. b. braziliensis and L. b. guyonensis for 
immunodeficient patients.
4. Visceral leishmaniasis (VL) is the most serious form and is fatal in 90% of cases 
if  left untreated. L. donovani is the primary cause of human visceral leishmaniasis 
(known as Kala azar) in the Indian subcontinent and East Africa. In the Mediterranean 
region and in the New World, L. infantum and L. chagosi, respectively, are responsible 
mainly for canine visceral leishmaniasis but also for some human disease.
Leishmaniasis is a worldwide disease, endemic in 88 countries: 72 of these are 
developing countries and 13 are amongst the least developed. More than 90% of 
cutaneous leishmaniasis cases occur in 7 countries: Afghanistan, Algeria, Brazil, Iran, 
Peru, Saudi Arabia and Syria. More than 90% of visceral leishmaniasis cases occur in 5 
countries: Bangladesh, India, Nepal, Sudan, and Brazil (figure 1.1). Every year 1 to 1.5 
millions cases of cutaneous leishmaniasis and 500 000 cases of visceral leishmaniasis are 
declared. But it  is estimated that 12 million people are infected and 350 million people 
are at risk (www.who.int/tdr).
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Localised cutaneous leishmaniasis
\
L. m. mexicana I I L. major
Visceral leishmaniasis
I I L. donovani and canine leishmaniasis
Mucocutaneous leishmaniasis
L. b. braziliensis 
L. b. panamensis
I I L. b. peruviana 
WÊÊ L. b. guayanensis
Figure 1.1: Causative agents of leishmaniasis around the world.
From World Health Organisation (WHO at www.who.int/tdr)
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1.1.2. Lifecycle
The Leishmania life cycle alternates between mammalian host and phlebotomine 
sandfly host. Humans contract leishmaniasis via the bite of Le/shmania-infected female 
phlebotomine sandfly. As the sandfly feeds, promastigote forms of the Leishmania 
parasite enter the skin of the mammal via the proboscis. It has been reported that only 
-16% of those promastigotes (called metacyclic promastigotes) are infectious and able 
of successfully entering a host macrophage directly or indirectly (Killick-Kendrick, 
1990). Polymorphonuclear neutrophil granulocytes (PMN), the first immune cells present 
at the site of Leishmania infection, are also readily infected by the parasite and are 
used as a means of attracting and entering macrophages "silently" (van Zandbergen et 
al., 2004). This "Trojan horse" strategy employed by the parasite maximises its survival 
and development in its final host cell, the macrophage. Once there, the metacyclic 
promastigote differentiates into a small aflagellated avoid cell called an amastigote. 
These latter forms will multiply inside the newly formed parasitophorous vacuoles until 
the cell eventually bursts, freeing the parasites and allowing them to infect other 
phagocytic cells. Leishmania parasites will remain as amastigote forms for the duration 
of the life cycle in the mammalian host (Handman and Bullen, 2002).
In one sandfly vector, Lutzomyia longipalpis, seven morphologically distinct 
forms of L. amazonensis were identified. The following occurred at different time 
points after infection: the amastigote, and several variations of a long body flagellated 
cell - the procyclic promastigotes, the nectomonad promastigotes, the leptomonad 
promastigotes, the metacyclic promastigotes, the haptomonad promastigotes (rarely 
seen) and paramastigotes (Rogers et al., 2002; Kamhawi, 2006) (figure 1.2). Only the 
procyclic promastigotes, in the sandfly abdominal midgut (bloodmeal phase) and the 
leptomonad promastigotes, in the sandfly thoracic midgut and foregut (sugarmeal 
phase) are replicatively active (Gossage et al., 2003). Based on these finding, a life 
cycle for these Leishmania species is proposed and described in figure 1.2.
1.1.3. Leishmaniasis control
The chemotherapy currently available for leishmaniasis treatment involves 
mainly pentavalent antimonials (Croft and Coombs, 2003). Yet, resistance to these 
drugs is now common in some parts of the world, requiring the use of more toxic drugs, 
such as pentamidine or amphotericin B. Further more, most available drugs are costly, 
demanding long treatment and are becoming less effective, necessitating the discovery 
of new drugs (www.who.int/tdr/diseases/leish).
Currently, strategies piggybacking upon medicines used for anticancer and 
antifungal treatments are among the most successful approaches leading to the
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Figure 1.2: Life cycle of Leishmania species in Lutzomyia iongipalpis.
From Kamhawi, 2006 and Gossage et al., 2003
A) Schematic representation of a Leishmania infected phlebotomine sandfly. The 
diagram shows the time-dependant appearance of distinct morphological forms of 
promastigotes. Oesophagus and stomodeal valve are held open by promastigotes 
secreted gel (PSG). B) Digenetic life cycle of Leishmania. Only three forms of the 
parasites are able to replicate: i) the amastigotes in the parasitophorous vacuole (a type 
of phagolysosomes) of mammalian macrophages, ii) the procyclic promastigotes in the 
sandfly abdominal midgut, and iii) the leptomonad promastigotes in the sandfly thoracic 
midgut. The life cycle is completed by non-dividing stages.
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identification of new candidate drugs against leishmaniasis. Indeed, miltefosine, an 
anticancer drug, has shown its efficiency as an oral treatment of LCL and L. infantum 
and L. chagasi VL and is now registered in India for the use against L  donovani VL (Croft 
et al., 2003). Miltefosine is also a candidate drug for the treatment of canine 
leishmaniasis, a disease for which no drugs are currently potent enough. Effective 
treatment of canine leishmaniasis would not only affect dogs' well-being but also, and 
more importantly, reduce the number of Leishmania animal reservoirs. Current ways of 
controlling this Leishmania repository involve the culling of infected animals and the 
limitation of the size of the insect vector population via large scale spraying of 
insecticides.
Other antileishmanial drugs have been discovered and are at various stages of 
development e.g. sitamaquine (by GlaxoSmithKline) and paromomycin (by Walter Reed 
Army Institute of Research, USA), but problems remain for the future of antileishmanial 
treatment: i) the toxicity of theses drugs is not negligible ii) the modes of 
administration are often unpleasant (e.g. parenteral formulation).
Research for new drugs continues. Fundamental research into Leishmania- 
specific drug targets is one of the most promising fields being explored. Big advances in 
the identification and functional analysis of new virulence factors and other critical 
enzymes have been made thanks in part to the recently available entire genome 
content of several Leishmania species and powerful bioinformatic tools. Inter-strain 
genome comparisons will hopefully contribute to the characterisation of parasite factors 
responsible of tropism and disease pathology (Ivens et al., 2005). As apparently early- 
branching eukaryotes (Coombs et al., 1998), trypanosomatids possess a cellular 
organisation that is considerably different from that of mammalian cells (see 1.1.4.). 
Therefore, many of the parasite's proteins should be sufficiently different from 
anything in the mammalian host to be successfully exploited as drug targets or vaccine 
candidates. Unfortunately, to date there are no effective vaccines against Leishmania. 
Many strategies have been followed using live, killed or attenuated parasites, 
recombinant DNA, peptides or purified parasite antigens (Handman, 2001; 
Selvapandiyan et al., 2006). Recently, advances have been the creation of a promising 
multi-epitope subunit vaccine (Skeiky et a i,  2002) and of an increasing number of 
genetically altered parasites, which could constitute live attenuated vaccines 
(Alexander et al., 1998; Papadopoulou et al., 2002; Uzonna et al., 2004). However, 
their protective efficiency in humans still remains to be determined.
There is a need for funds of the public and private sectors to shift towards 
neglected diseases such as leishmaniasis so that the discoveries made by fundamental 
research could be exploited to beneficit the field problems (Guerin et al., 2002). The 
current situation of the death-threatening visceral leishmaniasis remains, in the 21^ ^
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century, purely unacceptable. Hopefully, the advent of the genomics and proteomics 
era will lead to a better understanding of Leishmania biology and to the development of 
new affordable drugs.
1.1.4. Ultrastructure
1.1.4.1. Leishmania amastigote and promastigote forms
Leishmania ultrastructure differs from that of other kinetoplastids and also 
between different Leishmania species and even, for a given species, between the two 
life stages of the parasite. The different forms of the Leishmania life cycle were 
initially classified by the observation of their overall dimensions, flagellar morphology, 
kinetoplast (mitochondrial DNA) position and basal body to nucleus distance (Clayton et 
al., 1995).
The amastigote form is a small aflagellated ovoid cell of around 5 jim diameter 
occurring within acidic parasitophorous vacuoles of mammalian host macrophages 
(figure 1.3).
The promastigote form is a motile extracellular cell with a long thin body 
(approximately 5 by 20pm) with a flagellum of up to 20 pm, which is present inside the 
alimentary tract of the female sandfly vector (figure 1.4). Cell body and flagellum 
lengths are the main criteria used to distinguish the different forms of promastigotes 
found in the phlebotomine vector (figure 1.2).
1.1.4.2. Specialised organelles in Leishmania
Leishmania possesses many of the organelles found in higher eukaryotes, 
nevertheless they are characterised by a number of peculiarities. A cellular envelope 
called the glycocalyx, which is thin in amastigote forms and thick in infectious 
metacyclic promastigotes, can be observed. This envelope is made of glycolipids: the 
glycoinositol-phospholipid (GPI), its hyperglycosylated form, the lipophosphoglycan 
(LPG) (mainly present in Leishmania promastigotes) and its protein-associated form, the 
proteophosphoglycan (PPG) (McConville et al., 2002). While LPG is essential for the 
infectivity of L. major promastigotes in both the insect and the mammalian host (Sacks 
et al., 2000; Spath et al., 2000), L. mexicana promastigotes lacking this molecule are 
still able to infect mice (llg, 2000; Turco et al., 2001). Leishmania promastigotes also 
synthesize free GPIs which are 10-times more abundant (5x10  ^ copies/cell) than LPG. 
Leishmania amastigotes lack the prominent surface glycocalyx of GPI or other GPI- 
anchored macromolecules. Both Leishmania promastigotes and amastigotes secrete 
large quantities of soluble PPGs. The PPGs, through their ability to form, individually or
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Figure 1.3: Ultrastructure of Leishmania amastigote seen by electron 
microscopy
Lys: lysosomes; fp: flagellar pocket; M: mitochondrion; N: nucleus; arrowheads: 
membrane of the parasitophorous vacuole.Scale bars: 500 nm. From Waller and 
McConville, 2002.
MVB
MVT
?
&■
In Trypanosoma brucei
Figure 1.4: Ultrastructure of Leishmania promastigote.
On the left: schematic representation of Leishmania organelles (not to scale). Adapted 
from Clayton et al., 1995 and Waller and McConville, 2002. F: flagellum; Ax: axonemal
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microtubules; PR: paraflagellar rod; D: desmosome junction; MVB: multivesicular 
bodies; V: vesicules; G: golgi; MVT: multivesicular tubule/lysosome; N: nucleus; LP: 
lipidic inclusion; Ac: acidocalcisome; SPM: sub-pellicular microtubules; Gly: glycosome; 
ER: endoplasmic reticulum; M: mitochondrion; K: kinetoplast; BB: basal bodies. FP: 
flagellar pocket. On the right: electron microscopy images showing the kinetoplast area 
of T. brucei. Adapted from (Ogbadoyi et al., 2003) in an interphase (A) and a dividing 
cell (B). Large bracket: exclusion zone filaments; small bracket and arrow: unilateral 
filaments; arrow: flagellum; arrow head: fibrous lobe
after self-association, very large filamentous structures, mediate parasite aggregation 
and thus participate to the early stages of the invasion process. Leishmania 
promastigotes secrete a PPG-rich gel (PSG) in order to obstruct the digestive tract of 
the infected sandfly (Stierhof et al., 1999; Rogers et al., 2004). The Leishmania 
glycocalyx is also composed of several proteins (e.g. gp63) (McConville et al., 2002). 
The gp63 glycoprotein is a metallo-peptidase, which is anchored into the Leishmania 
promastigote plasma membrane by a GPI molecule.
In the internal side of the plasma membrane, subpellicular microtubules 
(containing tubulin) that spiral around the cell form the cytoskeleton and are involved 
in the maintenance of the cell shape. This arrayed corset of microtubules converge in a 
closed structure at the posterior end of the cell while it  remains open at the anterior 
end of the cell, giving rise to the flagellar pocket. Because the subpellicular 
microtubules block any vesicular exchanges between the extra- and intra cellular 
environments, the flagellar pocket is the privileged location for endo- and exocytosis. 
This specialised invagination of the plasma membrane formed of cortical microtubules 
and desmosome junctions gives Leishmania its apical polarisation.
A flagellum arises from the flagellar pocket and is made of the traditional 
axonemal microtubules, as well as the trypanosomatid-specific paraflagellar rod (PFR). 
While giving to Leishmania promastigotes their motility, the flagellum also mediates 
attachment to the host cell (KiHick-Kendrick et al., 1974a; KiHick-Kendrick et al., 
1974b). In addition the flagellum could act as an environment sensor and function in 
cell signalling (Bastin et al., 2000). Leishmania amastigotes possess a shortened 
flagellum which, as it  does not emerge from the flagellar pocket and is non-motile, can 
not mediate locomotion.
The Leishmania flagellum is anchored to the cell by a basal body, which is 
physically linked to the mitochondrion. Another basal body, which lies perpendicular to 
the major one, will develop during cell division. While, in Trypanosoma brucei, basal 
bodies take part in the kinetoplast division (Robinson and Gull, 1991), it  has been 
reported that in L. donovani amastigotes the duplication and segregation of the 
kinetoplast can still occur in the absence of basal body replication (Selvapandiyan et 
al., 2004).
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The kinetoplast is an encapsulation of the condensed mitochondrial DMA. 
Composed of 10 to 30 maxicircles (20 to 40 Kbp) intertwined with between 1,000 and 
10,000 minicircles (1 Kbp) (Simpson, 1987; Feagin, 2000), the kinetoplast represents 10 
to 20% of the cellular DNA (Simpson, 1986). While the maxicircles have some of the 
functions of the mitochondrial DNA of higher eukaryotes and encode genes for the 
respiratory complexes, the minicircles encode guide RNAs that mediate the maturation 
of the non functional pre-messenger RNAs produced by the maxicircles. This editing 
process, through insertion or deletion of a defined number of uridine residues at 
specific sites within the transcripts, contributes to the formation of start and stop 
codons, frameshifts and open reading frames within the cryptic maxicircle transcripts, 
thus rendering them functional and promoting their translation into proteins (Benne et 
al., 1986). The cytosolic messenger RNAs are matured via polyadenylation and trans- 
splicing (LeBowitz et al., 1993). In T. brucei, the kinetoplast is attached to the 
mitochondrion membrane via unilateral filaments and to the basal bodies through the 
exclusion zone filaments. This structure constitutes the tripartite attachement zone 
(TAG) (Ogbadoyi et al., 2003) and mediate interactions between the cytoskeleton and 
the mitochondrion. The TAG is also likely to be present in Leishmania, although this 
remains to be confirmed.
Leishmania possess a single mitochondrion. While in logarithmic phase 
promastigotes the mitochondrion has a symmetrical circular shape with distension all 
over the cell body, non-dividing promastigotes possess a tubular mitochondrion that 
extends longitudinally within the cell (Simpson and Kretzer, 1997). In the amastigotes of 
L. mexicana, the mitochondrion is in the form of a complex network extending 
throughout the cell (Goombs et al., 1986). The mitochondrion produces part of the 
energy necessary for the cell’s survival. Other energy is synthesized in a specialised 
organelle called the glycosome. Glycosomes are small spherical peroxisome-related 
organelles involved in Leishmania glycolysis. Other structures present are used for lipid 
storage (lipid inclusions), or for polyphosphates, magnesium, calcium and zinc storage 
(acidocalcisomes).
Leishmania also possess a single Golgi apparatus, located between the nucleus 
and the flagellar pocket. Endoplasmic reticulum (ER) and rough endoplasmic reticulum 
(RER) are mainly present around the nucleus. The ER provides part of the membranes 
necessary for the biosynthesis of endosomes and lysosomes. In stationary phase 
promastigotes the lysosomal compartment appears as a tubular structure and is termed 
the multivesicular tubule (MVT)/lysosome (Ghedin et a i,  2001; McConville et al., 2002; 
Waller and McConville, 2002). In Leishmania amastigotes, the lysosomal system is more 
extensively developed and appears as one or several very large vesicles called 
megasomes (Goombs et aL, 1986; Ueda-Nakamura et aL, 2001). Megasomes contain
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abundant highly active cysteine peptidases, but also arylsulfatase, p-glucuronidase, 
DNAse and RNase (Pupkis et al., 1986; Alberio et al., 2004). Cysteine peptidases have 
been shown to play major roles in the differentiation process (Williams et aL, 2006) as 
well as in parasite-host cell interaction and also in the survival of amastigote forms 
(Mottram et al,, 1998). Therefore, cysteine peptidases are considered as a potential 
targets for antiparasite drugs (Barrett et aL, 1999).
1.2. Cysteine peptidases
1.2.1. General
Enzymes that cleave polypeptide chains are named peptidases. When the 
excision site is present within the polypeptide chain, the enzyme is termed an 
endopeptidase, whilst when the cleavage occurs at the polypeptide ends the enzyme is 
called an exopeptidase (with aminopeptidase and carboxypeptidase cleaving N-terminal 
or C-terminal ends, respectively). Depending on the type of catalysis used for the 
peptide bond hydrolysis, peptidases are classified as serine, threonine, cysteine, 
aspartic, glutamic and metallo-peptidases. Peptidases using several catalytic 
mechanisms are termed “ mixed” type peptidases. For their catalysis, most peptidases 
draw upon a nucleophile and a proton donor (very recently identified, glutamic 
peptidases employ a catalytic mechanism that remains obscure (Fujinaga et aL, 2004)). 
In the case of the serine and threonine peptidases, the role of the nucleophile is played 
by a reactive hydroxyl group (belonging to a serine or threonine residue, respectively) 
while in cysteine peptidase this function is undertaken by the sulfhydryl group of the 
active site cysteine. In aspartic and metallo-peptidases, the nucleophile attack of the 
peptide bond does not, like in serine and cysteine peptidases, depend directly on amino 
acid residues but on the activation of a molecule of water. The binding and activation 
of the catalytic water molecule can be mediated by either two aspartate residues or a 
metal ion (mainly zinc, but also cobalt or manganese) held in place by usually three 
amino acids, hence the respective names of the peptidases. The identity of the proton 
donor varies with the type of peptidase. This role is played by a histidine residue in 
cysteine peptidases (http://merops.sanger.ac.uk/about/about 9.htm) (Rawlings et aL, 
2006).
In many cysteine peptidases the catalytic mechanisms by which the substrates 
are being hydrolysed are well understood. Mainly, they reside in the peptidase's ability 
to change the geometry of a substrate peptide bond (from a trigonal plane to a 
tetrahede), at a specific location within the peptide sequence (Stennicke and Salvesen, 
1999). During its interaction with the peptidase, the substrate lies in the binding site of
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the enzyme, with the scissile peptide bond positioned close to the catalytic residues. 
Indeed, while physically distant in the primary amino acid sequence, the active site 
residues are, within the tertiary structure of the peptidase, closely associated and 
together line the substrate binding pocket. Before or during catalysis, a nucleophile 
donates H-bonds to the substrate carbonyl oxygen thus polarizing the carbonyl group of 
the scissile bond and promoting the creation of a thiol ester intermediate with the 
substrate. Hydrolysis of the substrate will then occur by displacement of this ester and 
scission of the peptide bond. While the active site cysteine acts as the aforementioned 
nucleophile, the active site histidine promotes the formation of this nucleophile by 
acting as a base and removing the thiol- proton from the nearby active site cysteine. 
The de-protonation of the active site cysteine will then promote the creation of the 
thiol ester intermediate and the subsequent nucleophilic attack and protonation of the 
a-amino group of the substrate scissile bond, leading ultimately to the peptide bond 
proteolysis (Stennicke and Salvesen, 1999). Thus the active site cysteine is, in itself, 
essential for the catalytic activity of the cysteine peptidases. However, other conserved 
residues are important for the catalytic activity of some cysteine peptidases. A 
glutamine residue might participate to the formation of an oxyanion hole and thus to 
the stabilisation of reaction intermediates. Asparagine or aspartate residues might also 
orientate the imidazole ring of the active site histidine and facilitate the catalytic 
process.
Based on their primary and tertiary structural similarities, cysteine peptidases 
were assigned to families (Barrett and Rawlings, 2001). Families predicted to possess 
common evolutionary origin are grouped in clans. Each clan arose independently in 
evolution and only share its catalytic mechanism with the other clans. In regard of the 
conservation of the catalytic dyad residues, cysteine peptidases have been divided into 
12 clans (http://merops.sanger.ac.uk) : clan CA, CD, CE, CF, CH, CL, CM, CN, C-, PA(C), 
PB(C), and PC(C) (figure 1.5). Initially identified by the presence of the catalytic 
cysteine-histidine dyad, some clans of cysteine peptidases (CA, CE, CF, CH, CM and 
PA(C)) function actually with a catalytic triad. Furthermore, it  has to be noted that the 
tertiary fold around the active site cysteine differ significantly between different clans 
and thus underpins variations in substrate specificity. Clan PA(C) and PB(C) contain 
mixed-type peptidases. Respectively resembling chymotrypsin-like and threonine 
peptidase, they both contain active site mutations which might modify their catalytic 
properties.
Amongst the - 500 types of peptidases currently indexed in the human genome 
(http://merops.sanger.ac.uk). many cysteine peptidases were characterised to play a 
vital function or to be involved in disease processes and are under investigation as drug
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Figure 1.5: Clans of cysteine peptidase and the CD families.
Adapted from Mottram et al., 2003. Each clan (in black) is indicated by a black arrow. 
Important catalytic residues as well as their order in the protein sequence are written in 
green. The phylogenetic relationship between different families (in open circles, red) of 
clan CD peptidases is shown. Abbreviations: C, cysteine; D, aspartic acid; E, glutamic 
acid; GPI, glycosylphosphatidylinositol; H, histidine; N, asparagine; R, arginine; T, 
threonine.
targets (Lecaille et al., 2002). Cysteine peptidases belonging to clans CA and CD are the 
most studied.
Clan CA is defined around the largest subfamily of cysteine peptidases, papain­
like, also known as thiol-dependent cathepsin, and belonging to the Cl family. Papain­
like cysteine peptidases are widely represented in eukaryotic cells, but are also present 
in viruses and bacteria. Papain-like cysteine peptidases were shown, in mammals, to 
mediate extracellular matrix turnover, antigen presentation, and processing events. 
Furthermore, they might constitute potent drugs targets for osteoporosis, arthritis, 
immune-related diseases, atherosclerosis, cancer, but also for numerous parasitic 
infections (Lecaille et al., 2002). Indeed, when compared to the human enzymes, the 
parasite papain-like cysteine peptidases cluster in three major groups: cathepsin B-like, 
cathepsin L-like and cathepsin F-like. In Leishmania, cathepsin B-like (also called CPC) 
and cathepsin L-like (CPA and CPB) cysteine peptidases were found to mediate cell 
growth and differentiation (Mottram et al., 1996b; Williams et al., 2006) but also, 
through their functions in host-parasite interactions, to act as virulence factors 
(Alexander et al., 1998; Lecaille et al., 2002).
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1.2.2. Clan CD cysteine peptidases
The analysis of the amino acid sequences, protein structures and biochemical 
properties of these enzymes clearly demonstrate that they are distinct from those of 
the others clans (Mottram et al., 2003). For example, it  appears that clan CD cysteine 
peptidases are much stricter in their substrate specificity (especially at the 51 sub-site) 
than clan CA cysteine peptidases. Consequently, clan CD cysteine peptidases are not 
inhibited by E-64 (L-trans epoxysuccinyl-leucylamido-(4-guanidino)-butane), the much 
used clan CA cysteine peptidase inhibitor. But, in contrast, various clan CD cysteine 
peptidases are inhibited by aza-epoxides while clan CA enzymes are not (Asgian et al.,
2002). Another interesting feature of the clan CD cysteine peptidases is that whereas 
most of the cysteine peptidases require a catalytic triad for the hydrolysis of peptide 
bonds, they appear to be functional with only a catalytic dyad (Mottram et al., 2003). 
Furthermore, while clan CA cysteine peptidases can either be endo- or exo-peptidases, 
the clan CD enzymes characterised so far are all cleaving within the peptide sequence.
Clan CD peptidases sharing relative amino acid sequences similarities are 
classified in 5 families: C11, C l3, C14, C25 and C50 (figure 1.5) (Chen et al., 1998). 
Nevertheless, some members of the different families possess very different biological 
functions and mechanisms of action.
For example, in the C13 family, the asparaginyl endopeptidase, present in plants 
and animals, has been identified as a lysosomal cysteine peptidase that specially 
cleaves after asparagine residues, playing, in mammals, an important role in antigen 
processing and immune disorders (Li et aL, 2003). Whereas the GPI:protein 
transamidase, a cysteine peptidase that also belongs to the Cl 3 family and is found in 
eukaryotes, adds preformed glycosylphosphatidylinositol (GPI) anchors to polypeptides 
that form in L. mexicana and T. brucei the parasite's surface (Ellis et aL, 2002; Lillico 
et aL, 2003). The C25 family is represented by a Porphyromonas ginsivalis cysteine 
peptidase, known as gingipain. This bacterial pathogen of human mucosal surfaces is 
known to produce two individual cysteine peptidases of this type, Arg-gingipain (R) and 
Lys-gingipain (K), with, respectively, arginine and lysine specificities at the 51 sub-site, 
but both causing tissue damage in periodontal disease (Curtis et aL, 2001). The 
clostripain (Cl 1 family) is also involved in bacterial infection and also has Arg-gingipain 
specificity. Another arginine-specific endopeptidase is found solely in eukaryotes: the 
separase (C50 family). This enzyme was shown to play a major role in mammalian cells 
in chromosome division during mitosis (Nasmyth et aL, 2000; Uhlmann, 2001). Separase 
exercises this precise function via the cleavage of cohesin, a protein tying together, at 
the centromere, the sister chromatids of each chromosome. Separase becomes active
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when the sister chromatids are accurately connected to the mitotic spindle 
microtubules and upon degradation of its complexed inhibitor, securin. While the gene 
coding for an apparent homologue of the separase is present in L  major (Mottram et 
al,, 2003), the genome of the parasite lacks securin, suggesting that separase might be 
involved in alternative mechanisms. The final family, C14, is described in detail in the 
section below.
1.3. Clan CD cysteine peptidases, the C14 famiiy
The C14 family of the clan CD cysteine peptidases is composed of three sub­
families: the caspases, the paracaspases and the metacaspases.
Until recently, metazoa were thought to be the only organisms to possess 
caspases, because no homologous caspase genes were found in the genomes of yeast or 
parasitic protozoa. But in their attempt to characterise sequences with distant but 
statistically significant similarity to caspases, doing database searches, Uren et al. 
managed to distinguish two groups of caspase-like proteins (Uren et al., 2000). 
Paracaspases were identified from their low sequence identity with caspases while 
metacaspases were found through their distant similarity with paracaspases. Within 
eukaryotes, paracaspases are found in metazoa and Dictyostelium discoideum, whereas 
metacaspases are only found in plants, fungi, and protozoa.
The primary sequences as well as the secondary structure of these two families 
share similarity with human caspases but they also possess specific features (figure 
1.6).
1.3.1. Caspases
The caspases. Cysteine ASPartate specific proteASES, are a family of more than 
15 members of which about two-thirds are involved in apoptosis (a form of programmed 
cell death) in mammalian cells (Earnshaw et al., 1999). Caspases are associated with 
inflammatory disorders and neurodegenerative diseases such as stroke, Alzheimer's and 
Parkinson’s (Cohen, 1997; Thornberry and Lazebnik, 1998; Barrett and Rawlings, 2001; 
Dickinson, 2002; Mottram et aL, 2003).
All the caspases contain a conserved QACXG (where X is R, Q or G) active site 
motif which gives them a very strict specificity for aspartate residue at the PI position 
of their targets. Because of their lethality for the cell, caspases are synthesized and 
stored as inactive proenzymes. The zymogens comprise an N-terminal peptide 
(prodomain) along with one large (-20 kDa) and one small (-10 kDa) sub-unit (figure 
1.7A). Some caspases have specific features at their N-terminus e.g. large prodomains 
containing protein-protein interaction modules such as the caspase recruitment domain
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Figure 1.6: Domain structure of caspases, paracaspases, and metacaspases.
From Uren et aL, 2000. Caspases possess a caspase domain (p20, empty box) and in 
some case a prodomain with CARD or DED oligomerization motifs. Paracaspases, 
metacaspases, and several bacterial cysteine peptidases are predicted to possess a 
caspase-like proteolytic domain. The prodomains of the metazoan paracaspases are 
generally composed of a death domain (“ DD” ) and one or two Ig domains. According to 
their sequence and structural similarities, the metacaspases are divided in two groups, 
type I and type II. In plants and fungi, the type I metacaspases have prodomains with 
proline-rich repeat motif (“ Pro” ). A zinc finger motif (“ Zn” ) similar to those of the plant 
hypersensitive response protein lsd-1 can also be observed in the plant type I 
metacaspases. Meanwhile, the plant type II metacaspase, which lacks a prodomain, has 
an insertion of approximately 200 amino-acids close to their C-terminus. Streptomyces 
coelicolor pk3 possess both a caspase-like and a protein kinase domain. All the 
sequences are presented as their unprocessed zymogen forms.
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(CARD) (caspase-1) or death effector domain (DED) (caspase-8). Caspases with large 
prodomains are generally Involved in the initiation phase of apoptosis and are called 
initiator caspases. Caspases with shorter N-terminal domains (caspase-3, -6 and -7) are 
termed effector caspases and are generally activated by initiator caspases. Another 
group of caspases comprise those with a potential involvement in the control of 
inflammation (caspase-4, -5 and -13) (Fuentes-Prior and Salvesen, 2004). Meanwhile, 
caspase-2 and caspase-14 are difficult to classify. More details about the caspase- 
dependant programmed cell death and its regulation in mammals can be found in 
section 1.4.
The crystal structure of caspase-1 and caspase-3 showed that the active enzyme 
is a dimer, containing two small and two large sub-units. The activation of the caspase 
zymogens is mediated by at least two cleavages, one removing the N-terminal domain, 
the other separating the large and small subunit. Cleavages occur after specific D-X 
bonds, with the removal of the inter-sub-unit linker apparently preceding the one of the 
N-terminus. The catalytically active dimer results from either proteolytic 
autoprocessing or cleavage by other caspases, followed by self-association and 
translocation of the activation loop to the neighbouring molecule (Earnshaw et aL, 
1999). The resulting enzyme contains two active sites at the opposing ends of the dimer 
(figure 1.7A).
The caspase active site is composed of residues belonging to both the large and 
the small sub-units. The aspartate at the P1 position of the substrate is buried in a deep 
pocket in the caspase active site (SI site) which is lined by R179, H237, Q283, C285 and 
R341 (figure 1.7B). The residue lining the 52, S3 and 54 pockets all belong to the small 
sub-unit.
The caspase proteolytic activity can be of different natures depending on the 
identity of its substrate and the precise position of the cleavage site. In most cases, 
cleavage by caspases results in loss of biological function. However limited proteolysis 
can also occur leading, in that case, to a gain of function of the substrate by removal of 
inhibitory domains or sub-units (e.g. Bid). The cleaved product can also antagonise the 
function of the non-processed full length product (e.g. Bcl-2) (Hengartner, 2000).
Caspases cleave a wide variety of substrates from single polypeptide chain 
enzymes (e.g. polyADP-ribose polymerase (PARP)) to complex macromolecular 
structures (e.g. lamin network). So far, more than 280 caspase substrates have been 
characterised (Fischer et aL, 2003). Caspases are able to cleave major structural 
elements of the cytoplasm, nucleus and cytoskeleton, components of the DNA repair 
machinery and several kinases and thus play important roles not only in the cellular 
dismantling associated with apoptosis execution but also in cellular differentiation
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Figure 1.7: Domain organisation of caspases
A) All caspases possess an N-terminal segment with a length varying from 3 kDa 
(caspase-3 and -6) to 24 kDa (caspase-8 and -10). Unlike other cysteine peptidases 
where the prodomains represent an activation peptide, the removal of the caspase N- 
terminal region does not always result in activation. The large (17 to 21 kDa) and the 
small (10 to 13 kDa) subunits that form the catalytic domain of the enzyme are 
represented. These two regions are separated by a linker segment of 12 to 39 kDa. 
Removal of this segment generally results in the peptidase activation. Residues 
important for catalysis (C285 and H237), maturation (D119), activation (D296, D316), 
and the SI substrate binding pocket (Q.283, R179 and R341) are shown. Activation of the 
zymogens depends of the translocation of the activation loop into the accepting pocket 
of the neighboring dimer. For initiator caspases, latent monomers are activated by 
dimérisation. For executioner caspases, zymogens exist as preformed dimers and 
activation is enabled by removal of the inter-sub-unit linker (Boatright and Salvesen,
2003). B) Space filling representation of the substrate-binding pocket of caspase 3 (by 
standard crystallographic convention, residue numbers correspond to those in caspase-
1) around its bound tetrapeptide aldehyde inhibitor Ac-DEVD-CHO (P1-P4, right to left, 
white). Taken from Earnshaw et al, 1999.
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(Zermati et aU, 2001; Fernando et al., 2002; Mogi and Togari, 2003) and cell cycle 
progression (Kim et aL, 2005; Hsu et aL, 2006).
1.3.2. Paracaspases
Metazoan paracaspases possess a prodomain composed of a death domain (DD) 
followed by either one or two immunoglobulin domains (Ig) (figure 1.6). Paracaspases 
also possess a caspase-like domain containing the universally conserved catalytic 
cysteine and histidine dyad required for catalysis by cysteine peptidases. However, no 
peptidase activity has been reported yet (Uren et aL, 2000; Snipas et aL, 2004). The 
paracaspase also possesses an ubiquitin E3 ligase domain in its C-terminus. The 
ubiquitinin E3 ligase activity of the paracaspase was shown to be involved in NF-kB 
activation following T-cell receptor ligation (Ruefli-Brasse et aL, 2003). NF-kB enters 
the nucleus and switches on the expression of genes that are essential for the 
proliferation and function of activated T cells (van Oers and Chen, 2005). Because of its 
involvement in the subsequent increased in lymphocyte proliferation and survival which 
is responsible for mucosa-associated lymphoid tissue (MALT) lymphoma, the human 
paracaspase was also termed MALT1. There is so far no evidence that MALT1 directly 
participates in the execution of cell death.
DktyosteUum discoideum possesses one paracaspase (pep) but no caspase or 
metacaspase (Roisin-Bouffay et al., 2004). The D. discoideum paracaspase does not 
possess the death domain and the immunoglobulin domains found in the metazoan 
paracaspases. Cell death can be observed in D. discoideum in vivo, upon starvation, and 
can be mimicked in vitro. However, in this organism, deletion of the paracaspase gene 
had no effect, both in vivo and in vitro, on the execution of developmental cell death. 
Furthermore, D. discoideum development was apparently not impeded by the 
paracaspase inactivation. Therefore it seems that D. discoideum does not require 
paracaspase or caspase-related molecules for the execution of developmental cell 
death.
Paracaspases are more closely related to caspases than to metacaspases (Roisin- 
Bouffay et aL, 2004). Paradoxically, the Dictyostelium paracaspase is not apparently 
involved in cell death, while the yeast metacaspase is (Madeo et aL, 2002b). It still 
remains to be seen if  other metacaspases behave the same way.
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1.3.3. Metacaspases
1.3.3.1. General
Genome database searches and sequence analyses have proven the presence of 
metacaspases in many of the non-metazoan eukaryotic cells (plants, fungi and 
protozoan). Thus it  might be considered that they are the functional homologues of the 
metazoan caspases and might therefore be involved in programmed cell death (Uren et 
al., 2000).
Metacaspases from yeast and some plants contain, in their prodomain, a proline- 
rich region preceded by a zinc finger motif (type I metacaspase). This motif is, by amino 
acid sequence, very close to those present in plant proteins involved in hypersensitive 
response pathv/ays (e.g. LSD1 protein). This plant hypersensitive response is a defence 
mechanism triggered upon infection of plants by a pathogen, which prevents the spread 
of these pathogens from the inoculation site to the neighbouring cells by activating a 
programmed cell death pathway (PCD). The cell death involved in this case has 
morphological similarities with animal apoptosis, suggesting that cell death mechanisms 
might be closely related between plant and animal (Aravind et al., 1999).
While a special form of animal programmed cell death, apoptosis, is regulated by 
caspases, caspase-like proteolytic activities were detected in tobacco tissues that were 
developing hypersensitive response - after infection with tobacco mosaic virus (TMV)- 
suggesting that caspase-like plant peptidases participate to the cell death associated 
with the hypersensitive response (del Pozo and Lam, 1998). A cysteine peptidase with 
the specificity of the mammalian caspase-6 (called VEIDase) was implicated in plant 
programmed cell death (Bozhkov et al., 2003). VEIDase activity has also been detected 
in yeast during hydrogen peroxide- or aged-induced apoptosis, and attributed to the 
yeast Yor197w protein, which apparently functions as a caspase, and so called yeast 
caspase-1 (YCA1), even though it  actually is a metacaspase (Madeo et aL, 2002b). 
Hydrogen peroxide- and nitric oxide-induced cell death in Arabidopsis were abolished by 
addition of caspase-1 inhibitor, suggesting that there might be another caspase-like 
activity involved in plant programmed cell death (Clarke et al., 2000). In addition to 
this evidence that there are plant and yeast cysteine peptidases involved in cell death 
that are able to cleave fluorogenic tetrapeptidic substrates that mimic caspase 
substrate recognition sites, other data suggest that natural caspase substrates (such as 
PARP) might also be processed during programmed cell death (Tian ef al., 2000). 
Furthermore the functionality of natural caspase inhibitors (e.g. lAP and p35) in these 
systems underpins the concept that peptidases with caspase-like specificities are
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present and actively involved in programmed cell death in plant and yeast (Hansen, 
2000; Snipas et al., 2001; Lincoln et al., 2002; Danon et al., 2003).
Although some cathepsin-like cysteine peptidases have caspase-3-like activity 
(Zangger et al., 2002), the metacaspases were, until recently, considered responsible 
for the caspase-like activities detected during the execution of programmed cell death. 
However, the silencing and biochemical characterisation of the Norway spruce {Piceo 
abies) metacaspase (mcll-Pa) recently established that although the metacaspase was 
involved in programmed cell death during plant embryogenesis, i t  did not possess a
caspase-like activity (Bozhkov et al., 2005). Instead, it  was observed that mcll-Pa had a
preference for substrates with an arginine residue in PI (Bozhkov et al., 2005).
Interestingly, similar observations were made with the Arabidopsis metacaspases 
(Vercammen et al., 2004; Watanabe and Lam, 2005).
1.3.3.2. Plant metacaspases
There are many genes coding for plant metacaspases, but only a few have been 
studied. A metacaspase gene (LeMCA) was characterised in Lycopersicon esculentum 
(tomato) (Hoeberichts et aL, 2003). Alignment with various full length metacaspase 
protein sequences revealed that LeMCA is 67% identical to one of the type II A. thaliana 
metacaspases (AtMCAS) and 14% identical to S. cerevisiae metacaspase. Botyris cinerea 
is a fungal pathogen that induces cell death in several plant species by activating the 
hypersensitive response (HR) pathway. Hoeberichts et al. showed that the LeMCA gene 
is expressed only during Botyris crnereo-induced PCD. Interestingly, chemically-induced 
PCD does not lead to LeMCA gene expression, suggesting that this gene is expressed only 
under very specific circumstances.
A type II metacaspase gene, mclPPa, in Norway spruce, was shown to be involved 
in somatic embryogenesis, which is one model system of developmental PCD in plants 
(Suarez et al., 2004). The hypothesis was risen that this metacaspase gene may encode 
a functional homologue of animal caspase-6 (VEIDase), because silencing of mcll-Pa 
resulted in a significant reduction of VEIDase activity in the cells, an activity that was 
strongly associated with the initial execution phase for this plant developmental PCD 
(Bozhkov et al., 2003). However, i t  was later established that mcll-Pa preferentially 
cleaved its substrates after arginine residues and was not directly responsible of the 
VEIDase activity detected during PCD (Bozhkov et al., 2005), Nevertheless, i t  was 
observed that in terminally differentiated cells mcll-Pa translocates from the cytoplasm 
to the nucleus and mediates their elimination by triggering the nuclear phase of the 
PCD process (Bozhkov et al., 2005).
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Recently, by characterizing two type II A. thaliana metacaspases, Vercammen et 
al. demonstrated that the plant's caspase-like activities reported earlier were not 
associated with these metacaspases. In the A. thaliana genome, nine metacaspases 
genes (AtMCA1-9) were identified. AtMCA1-3, which possess a proline- or glutamine-rich 
N-terminal extension with or without a Zinc finger domain, were classified as type I 
metacaspases while AtMCA4-9 were classified as type II metacaspases. Production of 
recombinant AtMCA4 and AtMCA9 in Escherichia coli resulted in cysteine-dependent 
autocatalytic processing of the proform into large and small subunits, in analogy to 
animal caspases (Vercammen et al., 2004), A detailed biochemical characterization, 
with a broad range of synthetic oligopeptides and several peptidase inhibitors, showed 
that both AtMCA4 and AtMCA9 are arginine/lysine-specific cysteine peptidases and did 
not cleave caspase-specific synthetic substrates (Vercammen et al., 2004). Later, 
Watanabe and Lam consolidated this finding and extended it to a type I A. thaliana 
metacaspase. By heterologous expression in yeast, it  was observed that a type I and 
type II A. thaliana metacaspases were able to induce programmed cell death in this 
organism, in response to oxidative stress and ageing, presumably through activation of 
downstream peptidases with caspase-like activities (Watanabe and Lam, 2005). 
Recently, the tetrapeptide Val-Arg-Pro-Arg (VRPR) was found to be the favoured in vitro 
substrate of AtMCA9 (Vercammen et al., 2006). Intriguingly, two hybrid screening 
revealed that a serine peptidase inhibitor, AtSerpin, was a suicide inhibitor of this 
metacaspase.
1.3.3.3. Yeast and fungi metacaspases:
Saccharomyces cerevisiae possess a single metacaspase gene, YCA1 or ScMCA or 
YOR197W. Deletion or overexpression of the metacaspase gene doesn't lead to any 
obvious phenotype (Szallies et al., 2002). Nevertheless, hydrogen peroxide-induced 
apoptosis (as attested by chromatin condensation and DNA fragmentation) could be 
completely abrogated or strongly stimulated after, respectively, disruption or 
overexpression of ScMCA (Madeo et al., 2002b). Overexpression of dead ScMCA (C296A) 
showed a reduced induction of apoptosis, compared to overexpression of the native 
ScMCA, but less survival than the wild type cells. It was also observed that ScMCA was 
autocatalytically processed between domains similar to the caspases' large and small 
sub-units. As caspase-like activities were previously detected, in yeast, during hydrogen 
peroxide-induced PCD, various biochemical experiments were performed to assess 
whether these activities could be attributed to ScMCA. A 26 hours overexpression of 
ScMCA did not result in any increase of catalytic activity toward caspase-6 (VEID-AMC) 
and caspase-8 (lETD-AMC) substrates, however, addition of hydrogen peroxide to the
Chapter 1: Introduction 37
culture medium of ScMCA overexpressing cells increased significantly the proteolytic 
activity toward these same substrates. Intriguingly, hydrogen peroxide strongly 
augmented the caspase-like activities but not the processing of ScMCA in the 
overexpressor cells (Madeo et al., 2002b). The authors suggested that the metacaspase 
processing might be rate-limited.
In contrast, another group, using yeast as a PCD model to study the function of 
two plant metacaspases, found that the yeast metacaspase was, in the presence of low 
doses of hydrogen peroxide, not able to cleave caspase-like substrates but instead 
preferentially processed substrates with an arginine/lysine residue at their PI position 
(Watanabe and Lam, 2005). It was thus considered that the caspase-like activities 
detected in yeast, during hydrogen peroxide induced PCD, were not due the 
metacaspase itself but to other peptidases. However, as the caspase-like activities 
detected during hydrogen peroxide-induced PCD were significantly reduced upon ScMCA 
deletion, it  seems that the metacaspase is involved in the activation of these peptidases 
and thus plays an important role in the PCD signalling cascade. This role is particularly 
important in ageing yeast cells. Indeed, in the absence of ScMCA and thus PCD, ageing 
cells progressively lost their ability to regrow on fresh medium. Although the lack of 
PCD seems to be advantageous for the clone, the absence of removal of the damaged 
cells and their prolonged utilisation of the restricted nutrient supplies were ultimately 
detrimental for the development of the population (Herker et al., 2004). Later it  was 
established that ScMCA was involved in PCD induced by various stresses (Wadskog et al., 
2004; Ivanovska and Hardwick, 2005; Flower et al., 2005; Khan et al., 2005; Silva et al., 
2005) or some defects in biological functions (Bettiga et a i,  2004; Mazzoni et al.,
2005).
In the fungi Aspergillus nidulans, overexpression of the single metacaspase gene 
(casA) inhibited A. nidulans growth and induced morphological changes typical of 
apoptosis (Cheng et al., 2003). However, cosA was not involved in phytosphingosine- 
induced apoptosis.
1.3.3.4. Plasmodium falciparum metacaspase
Putative metacaspase (PfMCA, PF13_0289) and metacaspase-like (PfMCA-like, 
PF14_0363) genes are present in the Plasmodium falciparum genome. Alignment with 
caspases shows that PfMCA retains the typical catalytic dyad histidine and cysteine 
residues, conserved in all proteolytically-active caspases. Nevertheless, it  has 
considerable sequence differences around the active site, when compared to vertebrate 
caspases and human paracaspase, suggesting that this distinct configuration could 
reflect a parasite-specific substrate preference (Wu et a i,  2003). Unfortunately, no
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further work has been done yet to give some clues about the plasmodial metacaspase 
expression and its function in the malaria causative agent.
1.3.3.5. Metacaspases in trypanosom atids:
Please refer to chapter 4 for a detailed presentation of the structural and 
biochemical properties of these metacaspases.
1.4. Programmed Cell Death and cysteine peptidases
In mammals, up to 11 pathways of cell death can be distinguished. Amongst 
them, 10 are genetically programmed (Melino et a i,  2005). Programmed Cell Death 
(PCD) is a physiological process of cell suicide, genetically regulated, that is essential to 
the development and homeostasis of multicellular organisms. Some examples of PCD 
include: the apoptotic form (caspase-mediated and caspase-independent (Lukovic et 
al., 2003; Lockshin and Zakeri, 2004b)), the autophagic form (Bursch et a/., 2000; 
Lockshin and Zakeri, 2004a), the non-apoptotic form (Sperandio et al., 2000) and the 
necrosis form (Bursch et al., 2000; Gozani et al., 2002; Knight, 2002; Lukovic et al., 
2003; Nicholson and Thornberry, 2003; Edinger and Thompson, 2004; Assuncao and 
Linden, 2004).
As the different cell death types are mostly defined by morphological criteria, 
without a clear reference to precise biochemical mechanisms, a unification of the 
criteria and terminologies used was recently proposed by the Nomenclature Committee 
on Cell Death (Kroemer et al., 2005).
1.4.1. Apoptosis in m ultice llu lar organisms
The classification of apoptosis as a form of cell death distinct from necrosis was 
initially based on morphological observations (Kerr et a i,  1972). Necrosis is apparently 
not genetically programmed and mainly occurs in response to severe toxic damage or 
physical insults. It results, amongst others, in breakdown of the plasma membrane, 
vacuolisation of the cytoplasm, loss of homeostasis (Choi, 1988), disruption of the 
cytoskeleton (Hall et al., 1997), swelling of various organelles (e.g. mitochondrion, ER, 
golgi) and inhibition of ATP synthesis (Edinger and Thompson, 2004). The subsequent 
release of the cellular content into the surrounding environment induces local 
inflammation and might damage the neighbouring cells.
In contrast to necrosis, cells dying by apoptosis are not lysed but are eliminated 
by phagocytosis, thus preventing the development of an inflammatory response and 
making apoptosis the most common type of physiological cell death. Apoptosis is 
characterised by budding of the plasma membrane, chromatin condensation, nuclear
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DNA fragmentation, mitochondrial membrane potential changes and formation of 
apoptotic bodies (Melino et al., 2005). These latter structures consist of organelles 
and/or nuclear material surrounded by an intact membrane. Exposing 
phosphatidylserine on their surfaces, these apoptotic bodies are rapidly engulfed by 
macrophages or neighbouring cells. Unlike necrosis, apoptosis is an active process that 
necessitates ATP hydrolysis, the expression of degradative enzymes and the activation 
of complex signalling pathways (Edinger and Thompson, 2004). Apoptosis was initially 
defined as playing a “complementary but opposite role to mitosis” in that it  regulates 
cell proliferation by a controlled elimination of cells no longer required by the organism 
or impaired in their function (Kerr et oL, 1972).
it appears that genes encoding the apoptotic machinery as well as the 
morphological and biological features of apoptosis are conserved in vertebrates (e.g. 
mammals), nematodes (e.g. Caenorhabditis elegans) and insects (e.g. Drosophila 
melanogaster) (Hengartner, 2000; Meier et al., 2000)
In mammalian cells, apoptosis is executed through two major pathways, which in 
some cases might operate together and amplify each other. The first induces 
mitochondrial membrane permeabilization and the other involves the proteolytic 
activation of the caspases. A simplified succession of events leading to apoptosis is 
exemplified in figure 1.8 (Hengartner, 2000). The death cascade starts with either an 
external stimulus or an internal defect (here DNA damage). When death receptors such 
as CD95 are triggered, the initiator caspase-8 is recruited by the adaptor molecule FADD 
and subsequently activated. Hence the caspase pathway starts. The extrinsic and 
intrinsic cell death pathways converge at the mitochondrion, with the permeabilisation 
of the outer membrane and the release in the cytosol of proteins initially present in the 
mitochondrial intermembrane space. This process mainly involves proteins of the Bcl- 
2 /Bax family. When activated, the pro-apoptotic members of this family such a Bax, 
Bad, Bim and Bid are translocated from the cytosol to the mitochondrion. Activation can 
be achieved by either dephosphorylation or proteolytic cleavage. For example, Bid is 
processed by the activated caspase-8. However, cross-talks between the death receptor 
and the mitochondrial pathway remain minimal at this point. Meanwhile other members 
of this family, Bcl2 and Bcl-XL, which are constitutively present in the mitochondrial 
membrane, play a protective role and anti-apoptotic functions. The pro- and anti- 
apoptotic Bcl-2 family members enter in competition, at the mitochondrion membrane 
to regulate the exit of cytochrome c and Smac/Diablo which will then induce the 
activation of the caspase pathway or of AIF which will subsequently involve caspase- 
independent pathways of cell death. After its release from the mitochondrion, the 
cytochrome c associates with many proteins amongst which Apaf-1 and the procaspase-9 
to form the apoptosome. This complex will then mediate the activation of the
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Figure 1.8: Two major apoptotic pathways in mammalian cells.
From Hentgartner, 2000. Refer to text for details.
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executïonner caspase-3. In parallel, Smac/Diablo, recently freed from the 
mitochondrion, antagonizes the caspase-3 inhibitor, lAP. The extrinsic and intrinsic cell 
death pathways then follow the same chronological events. The activated caspase-3 
propagates the apoptotic cascade though the cleavage of many cellular substrates, 
ultimately resulting in the dismantling of the cell and its removal.
The regulation of caspase activity can be mediated by cellular inhibitors such as 
lAP. However other regulatory mechanisms exist. For example, some anti-apoptotic 
members of the Bcl-2/Bax family and other cellular polypeptides such as the 
degenerate caspase isoform FLIP (also termed c-FLIP) are able to block the proximity- 
induced activation of certain procaspases. In addition, the control of the caspase 
activation is mediated by the regulation of caspase zymogen gene transcription 
(Earnshaw et al., 1999).
In mammalian cells, the activation of caspases is essential for the nuclear phase 
of apoptosis through its involvement in chromatin condensation and internucleosomal 
DNA fragmentation. However, in those cells, the execution of apoptosis can use 
caspase-independent pathways (Lockshin and Zakeri, 2004b). Indeed, it  was observed 
that the effects of caspase deletion on the execution of apoptosis were varying with the 
type of caspase targeted, the type of cell manipulated and the type of triggering stimuli 
used (Earnshaw et al., 1999). In contrast, PCD in C. elegans and D. melanogaster can 
not be accomplished without caspase activation. Therefore, it  was suggested that the 
cell death machinery has evolved since the origin of the metazoa and that the caspases 
might be the initial ancestral effectors of PCD (Ameisen, 1996; Aravind et a i,  2001).
It was initially proposed that PCD only arose with multicellularity and would have 
been counter selected in unicellular organisms. However, on the evolution tree, PCD is 
likely to have appeared before the origin of metazoa as attested by the presence of 
caspase-like molecules in the prokaryotes (Koonin and Aravind, 2002). Furthermore, 
several forms of PCD have now been described in various single-celled eukaryotes, 
among which are the kinetoplastid protozoa Trypanosoma cruzi, T. brucei, and 
Leishmania (see below for details). In Peridinium gatunense, execution of PCD seems to 
be mediated by cysteine peptidases that are sensitive to the clan CA inhibitor E-64 
(Vardi et al., 1999). In Dictyostelium discoideum, developmental PCD does not require 
the paracaspase (Roisin-Bouffay et al., 2004). Therefore, althought PCD pathways seems 
to be present in lower eukaryotes they differ significantly from the ones present in 
higher eukaryotes and little  is yet known about the nature of the molecules involved 
and their exact mechanisms of action.
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1.4.2. Programmed cell death (PCD) in trypanosomatids
Initially, because of the occurence of some form of PCD in prokaryotes (Lewis, 
2000; Engelberg-Kulka et al., 2006), it was hypothesised that the presence of the PCD 
machinery in trypanosomatids was only a remnant from the eukaryotic cell evolution 
and was a process without a defined function (Nguewa et al., 2004). However, in view 
of recent findings, it  has been proposed that PCD plays an active role in the 
development of trypanosomatid by enhancing their biological fitness. Indeed, by 
selecting for the fitte r cells or specific developmental forms within the population, by 
optimally regulating the cell number to adapt to the environmental constraints, and by 
tightly controlling the cell cycle and the cell differentiation, PCD could potentially 
maximise the infectivity of parasites and their survival in the host.
Inside the gut of the sandfly vector, the Leishmania promastigote forms multiply 
and differentiate into several intermediate forms until the ultimate infectious 
metacyclic form is generated. Metacyclic promastigotes are the form best able to 
establish an infection in the mammalian host. They do not divide and will differentiate 
into amastigotes only once in the host cell. It is known that only a small percentage of 
the promastigotes differentiate into metacyclic promastigotes (see section 1.1.2.). It 
has been proposed that the procyclic forms remaining in the insect gut will undergo PCD 
to limit the utilisation of the restricted supplies of nutrients to promote the survival of 
the forms better suited to transmit the disease (Debrabant and Nakhasi, 2003). More 
recently, it  was observed that apoptotic-like promastigotes are necessary for 
Leishmania virulence in vivo and the establishment of the infection (van Zandbergen et 
al., 2006). Apparently, the high ratio of apoptotic-like promastigotes present in the 
virulent inoculum allows the immune-silencing of the phagocytic process. Inside the 
mammalian host, PCD of the intracellular Leishmania amastigotes could also mediate 
the silencing of the host immune response, and especially during the chronic phase of 
the disease (Zangger et al., 2002). PCD could also be activated to maintain clonality 
within the population (Lee et a i,  2002; Madeo et al., 2002a).
In kinetoplastids, PCD appears in most cases to share nuclear and cytoplasmic 
features with mammalian apoptosis and is morphologically characterised by the 
observation of chromatin fragmentation, internucleosome-like DNA fragmentation, 
phosphatidylserine exposure on the outer leaflet of the plasma membrane, 
mitochondrial permeabilisation and loss in transmembrane potential (Moreira et al., 
1996; Ameisen et al., 1996; Welburn et al., 1997; Arnoult et al., 2002). Such 
peculiarities were detected in T. brucei procyclic forms during tsetse fly infection 
(Welburn et al., 1989; Welburn and Maudlin, 1997) or in vitro during concanavalin A
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treatment (Welburn et al., 1999; Pearson et al., 2000) and oxidative stress (Ridgley et 
al., 1999). Meanwhile very few examples of PCD have been characterized in T. brucei 
bloodstream forms (Figarella et al., 2005; Tsuda et al., 2005; Figarella et al., 2006). 
Features of apoptosis-like PCD were also observed in T. cruzi epimastigotes during in 
vitro differentiation into trypomastigotes (Ameisen et al., 1996), upon treatment with 
fresh human serum (Piacenza et al., 2001; Piacenza et al., 2002; Kosec et al., 2006) or 
Bothrops jararaca venom (Deolindo et a i,  2005). In Leishmania, apoptotis-like PCD was 
triggered in vitro by heat shock (Raina and Kaur, 2006; Alzate et al., 2006), nitric oxide 
(Holzmuller et al., 2002; Raina and Kaur, 2006; Holzmuller et al., 2006), hydrogen 
peroxide (Mukherjee et al., 2002; Das et al., 2004), staurosporine (Arnoult et al., 2002), 
amphotericin B (Lee et al., 2002), camptothecin (Sen et al., 2004a; Sen et al., 2004b; 
Sen et al., 2006b), miltefosine (Chowdhury et al., 2003; Verma and Dey, 2004), 
antimonial (Sereno et al., 2001) or other drug treatments (Mittra et al., 2000; 
Jayanarayan and Dey, 2005; Singh et al., 2005; Sen et al., 2006a; Sen et al., 2006c) but 
also under physiological conditions (e.g. in cells subject to serum deprivation, in late 
stationary phase cultures (Lee et al., 2002)) and in amastigotes within antileishmanial 
drug-treated macrophages (Sudhandiran and Shaha, 2003) (Debrabant et al., 2003).
However, the mechanisms involved in the parasite PCD remains poorly described 
at the molecular level. In T. cruzi epimastigotes, the translocation of the elongation 
factor 1-alpha (EF1a) from the cytoplasm into the nucleus of the dying cells is 
suspected to mediate transcriptional processes that regulate cell death genes (Billaut- 
Mulot et a i,  1996). In the same parasites, arginine metabolism was found to inhibit 
human serum-induced PCD via production of polyamines that favours cell growth 
(Piacenza et a i,  2001; Piacenza et al., 2002). In T. brucei rhodesiense procyclic forms, 
prohibitin, an orthologue of a mammalian proto-oncogene and RACK, a receptor for 
activated protein kinase C were found to be up-regulated during lectin-induced cell 
death (Welburn and Murphy, 1998). In T. brucei brucei procyclic forms, it  was observed 
that the PCD induced by reactive oxygen species (ROS) was Ca^^ -^dependent but could 
not be prevented by the expression of the mouse anti-apoptotic protein Bcl-2 (Ridgley 
et al., 1999). Another group found that, again in T. brucei brucei procyclic forms, co­
expression of the human anti-apoptotic Bcl-XL with the human pro-apoptotic Bax was 
sufficient to inactivate the Bax-induced mitochondrion fission (Esseiva et al., 2004). In 
addition, it  appeared from this study that the early phases of the PCD mitochondrial 
pathway were comparable to the mammalian system. In bloodstream form parasites, 
prostaglandin Dz (and, more precisely, its J series metabolites) was found to induce PCD 
through production of ROS but in a caspase-independent manner (Figarella et al., 2005; 
Figarella et al., 2006).
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In Leishmania, although PCD has been more extensively studied, very few 
reports actually contribute to the molecular characterization of the external and 
internal stimuli controlling apoptosis-like PCD. Surprisingly, most of them point to 
stage-specific mechanisms of PCD. In addition, apoptosis-like PCD seems to be triggered 
in response to a cell cycle block. While deletion of centrin, a Ca^^ -^binding cytoskeletal 
protein involved in duplication of basal bodies, had no visible effect on promastigotes 
growth, Leishmania amastigotes failed to duplicate this organelle, could not enter 
cytokinesis, and lost their infectivity in vivo. The G2/M cell cycle block induced in 
amastigotes by centrin removal was shortly later accompanied by caspase-3/-7 
activities, loss of membrane integrity and nuclear DNA fragmentation - which are 
features commonly observed during apoptosis-like PCD execution (Selvapandiyan et al.,
2004).
In amastigotes, the cytoplasmic Silent Information Regulator 2 (SIR2), a NAD- 
dependent deacetylase, was found to possess a fundamental role in cell proliferation. 
Partial gene deletion or specific inhibition (with Sirtinol) of this molecule resulted in 
amastigotes growth arrest and PCD induction (Vergnes et al., 2005a; Vergnes et al., 
2005b). Overexpression of SIR2 decreased the amastigotes susceptibility to Sirtinol- 
induced PCD (Vergnes et al., 2002). While SIR2 gene knock-out was not achievable in 
promastigote forms, the growth of the heterozygote parasites was not affected in vitro 
(Vergnes et al., 2005a) and Sirtinol treatment had no effect of the wild type 
promastigote development (Vergnes et al., 2005b). Nevertheless, overexpression of SIR2 
significantly increased the promastigotes survival under starvation conditions (Vergnes 
et al., 2002).
Present only in the kinetoplast in promastigotes but distributed throughout the 
mitochondrion in amastigotes, the differentially-expressed peroxiredoxin, a 
mitochondrial enzyme involved in peroxide detoxification, participates to the stabilisa­
tion of the mitochondrial membrane potential. In the parasite, its overexpression has a 
protective role against hydrogen peroxyde-induced PCD (Harder et al., 2006). Also, 
expression of high levels of peroxiredoxin might aid the survival of the amastigote forms 
which are exposed to high oxidative stress during their stay in the macrophage.
It was reported that promastigotes lacking the GPI-anchored metallo-peptidase 
gp63 (leishmanolysin), their major surface protein, are more susceptible to apoptosis- 
like PCD induced by antimicrobial peptides (Kulkarni et al., 2006). Because of the 
protective role of gp63 against the sandfly immune system, but also its role as a 
promastigote virulence factor (Joshi et al., 2002), apoptosis-like PCD appears to control 
the infectivity of the parasite population.
In this chapter I have conveyed the notion that PCD in trypanosomatids 
resembles mammalian apoptosis by use of the term “ apoptosis-like PCD". Indeed, these
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parasites can be killed in a way that provides morphological features of mammalian 
apoptosis and notably the activation of caspase-like activities. Also, because of their 
distant relationship with caspases and in the absence of better candidates, the 
trypanosomatid metacaspases were assumed to be responsible for the detected 
caspase-like activity and the nuclear phase of the apoptotic-like PCD (Kosec et al.,
2006).
However, when compared to apoptosis in higher eukaryotes (e.g. mammalian 
cells), there clearly are differences in the apoptosis-like PCD of parasitic protozoa, 
exemplified by L  donovani (Lee et al., 2002) and L. major promastigotes (Arnoult et 
al., 2002). In these parasites, the permeabilisation of the plasma membrane seems to 
occurs simultaneously with the activation of caspase-like activity, rather than following 
it  like in mammals; no apoptotic bodies are formed; the caspase-like activities are only 
partially inhibited by caspase inhibitors, underpinning the involvement of other cysteine 
peptidases (Arnoult et al., 2002; Lee et al., 2002). It was also suggested that in L. 
major and L  mexicana the nuclear phase of the apoptosis-like PCD was likely to be 
mediated by uncharacterised nucleases and apparently not directly by caspase-like 
peptidases (Zangger et a i,  2002). Most importantly, in the strain initially used for the 
sequencing of the Leishmania genome, L. major, the vast majority of the proteins 
involved in the mammalian PCD are absent (Uren et al., 2000). Notably, most 
representatives of the mitochondrial pathways are lacking (e.g. Bcl-2, Bid, Bax, Bcl-XL, 
Smac/Diablo, AIF), all the caspases and the PCD regulators such as cell death receptors 
(CD95/L, FADD), FLIP, lAP or Apaf-1.
In conclusion, although PCD appears to exist in trypanosomatids and in some 
cases has features comparable to mammalian apoptosis, the molecules involved remain 
mostly uncharacterised and the function of the metacaspase is still a big unknown.
1,5. Aims of my thesis project
My thesis project aimed to answer the following questions:
1 ) Is the Leishmania major metacaspase expressed? Is it  constitutively expressed or 
only under stress conditions?
2) Is the L. major metacaspase an active enzyme? What are its biochemical 
properties?
3) Is the L. major metacaspase involved in PCD or does it play a different role 
within the cell?
4) Why does L. major have only one metacaspase, yet T. brucei has five?
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MATERIAL
2.1. Cell lines used in this study
2.1.1. Trypanosomatid cells
Leishmania major (MHOM/JL/80/Friedlin) amastigotes, freshly extracted from 
mouse lesions, were transformed into promastigote forms by cultivation in the 
appropriated medium. Stabilates of the freshly differentiated and virulent promastigote 
cells were made and used for the rest of the study (WUMP3888).
Trypanosoma brucei strain 427 (WUMP4496) was used for the genetic knockouts 
in the bloodstream forms (BSF). For the RNAi study, the bloodstream form 427 pLew13 
pLew90-6 cell line was used (Wirtz et al., 1999). The ATbmca2/3ATbmca5 (WUMP4499) 
and the TbMCA2, TbMCA3 and TbMCAS triple RNAi (WUMP4148 and WUMP4149) 
bloodstream form cell lines were generated by Matthew J. Helms (Helms, 2004). The 
M0B1 RNAi bloodstream form cell line (WUMP4674) was produced by Tansy C. 
Hammarton (Hammarton et a i,  2005).
2.1.2. Bacterial cells
Host strain: Escherichia coli XL1- Blue {recA1 endAI gyrA96 thi-1 hsdR17 supE44 
relA1 lac [FproAB lacl^lacZAMIS Tn10 (Tet" )^]) (Stratagene) or E. coli DH5a(F' 
tp80/acZAM15 A(/acZYA-argF)U169 recAl endAI hsdR17(rk , mk"^ ) phoAsupEAA thi-i gyrA96 
re/AI V) (Invitrogen). The /acZAMIS marker provides a-complementation of the p- 
galactosidase gene encoded by the pGEMT cloning vector, allowing white/blue screening 
of vector-bearing colonies, on plates containing X-gal.
Expression strain: E. coli BL21(DE3) (P ompT hsdSBirs mg ) go/ dcm (DE3)) 
(Novagen). (DE3) strains are lysogenic for a X prophage that contains an IPTG-inducible 
T7 RNA polymerase and are specially designed for protein expression from pET vectors. 
Alternatively, E. coli BL21(DE3)pLysS (P ompT hsdSB{r  ^ me") go/ dcm (DE3) pLysS 
(Cam*^ )) (Novagen) cells were used. This strain carries a pACYCI 84-derived plasmid that 
encodes the T7 lysozyme, a natural inhibitor of the T7 RNA polymerase, which allows 
the repression of the background expression of target genes.
2.1.3. Yeast cells
The methylotrophic yeast Pichia pastoris was used as the host for high-level 
recombinant protein expression in the Pichia Expression System. In the absence of 
glucose, Pichia pastoris uses methanol as a carbon source. The alcohol oxidase {A0X1)
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promoter controls expression of alcohol oxidase, which catalyzes the first step in 
methanol metabolism. Typically, 30% of the total soluble protein in methanol-induced 
cells is alcohol oxidase. The pPIC9 Pichia expression vector take advantage of the 
powerful A0X1 promoter and use methanol to induce high-level expression of your gene 
of interest.
Expression strain: Pichia pastoris KM71 (h/s4, aox1 ::ARG4, ars4) (Invitrogen), 
The Pichia host strain KM71 has a mutation in the histidinol dehydrogenase gene (his4) 
which prevents them from synthesizing histidine (His ). The parent strain of KM71 has a 
mutated argininosuccinate lyase gene {arg4) that prevents it  from growing in the 
absence of arginine but, in the KM71 strain, the wild-type ARG4 gene was used to 
disrupt AOX1 thus reastoring their ability to grow without arginine (Arg^). The loss of 
the AOX1 gene, and thus a loss of most of the celTs alcohol oxidase activity, results in 
a strain that is phenotypically methanol utilization slow (Mut^). This results in a 
reduction of the cells' ability to metabolize methanol and they therefore exhibit poor 
growth on methanol medium. Thus, cells are grown to high density and concentrated, 
before induction, to increase the total cell mass.
In addition to the expression strain, a GS115 (his4) control stain was provided in 
the Pichia expression kit (Invitrogen). The GS115/albumin (His  ^ MuT*) was used as the 
control for secreted expression and the Muf phenotype when screening Pichia 
transformants. The gene for serum albumin was cloned with its native secretion signal, 
then integrated into Pichia at the AOX1 locus. This strain secretes albumin (67 kDa) into 
the medium at levels > 1 gram per liter.
2.2. Cell cultivation
2.2.1. Leishmania major promastigotes
The wild type Leishmania major Friedlin promastigotes cells were grown in 
HOMEM medium (For 500 ml of medium: 5.29 g S-MEM, 1 g glucose, 0.15 g NaHCO], 
0.055 g sodium pyruvate, 0.5 mg Para Amino Benzoic Acid, 0.05 mg biotin, 2.98 g 
HEPES, 5 ml MEM-essential aminoacids (50x), 5 ml MEM-non essential ami noacids (100x) 
(Invitrogen, ref 041-946-99M)) + 10-20% (v/v) of heat inactivated Foetal Calf Serum 
(Labtech International, cat No 4-101-500) at 25°C in a phenolic-style cap flask. In order 
to maintain the cells alive a sub-passage in fresh medium was done twice a week. The 
required antibiotics were added to the cultures of generated transgenic cell lines 
typically as follows: hygromycin B (Calbiochem) at 50 mg ml ;^ phteomycin (Cayla) at 10 
mg ml'^; puromycin (Calbiochem) at 10 to 100 mg ml^; blasticidin S (hydrochloride, 
Calbiochem) at 10 mg ml^; and neomycin (G418, Geneticin, Calbiochem) at 15 to 50 mg
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ml \  Stabilates were made by diluting 500pl of cells with SOOpl of HOMEM + 20% FCS+ 
10% DMSG in a 1.5 ml cryotube and then were stored at -80°C overnight and then in 
liquid nitrogen.
2.2.2. Trypanosoma brucei bloodstream forms
Bloodstream form (BSF) 427 T. brucei were cultured at 37°C with 5% CO2 in HMI- 
9 medium (Hirumi and Hirumi, 1989) supplemented with 10% (v/v) of heat inactivated 
FCS and 10% (v/v) serum plus. For the BSF TbMCA2, TbMCAS and TbMCAS RNAi cell lines 
and M0B1 RNAi cell line, antibiotic pressure was maintained by addition of hygromycin 
(Calbiochem) at 5 pg ml \  neomycin (Calbiochem) at 2 pg ml^ and phleomycin (Cayla) 
at 2.5 pg ml \  When needed, blasticidin (Calbiochem) and puromycin (Calbiochem) 
were used at 2 pg ml ^ RNAi was induced with 1 pg ml^ tetracycline hydrochloride when 
the cells were at a density of 1x10  ^cells ml \
2.2.3. Escherichia coli cells
Cells were transformed with the desired vector which, with either the J3- 
lactamose or kon genes, would confer resistance to ampicillin or kanamycin, 
respectively. Selection of the transformants was performed with 100 pg ml"' ampicillin 
(100 mg ml ' stock solution in 50% ethanol) or 25-50 pg ml ' kanamycin (25 mg ml ' stock 
solution in 50% ethanol). Cells were culture in liquid LB medium (Lennox Both base, 10 g 
I ' bacto-tryptone, 5 g I ' yeast extract, 10 g I ' NaCl), complemented with the relevant 
selective antibiotics, at 37°C. Transformant clones were obtained after spreading on a 
LB-agar plate (LB medium, 15 g I ' bacto-agar) with antibiotics.
2.2.4. Pichia pastoris cells
The wild type KM71 (Mut ,^ Arg"^ , His ) strain grows on complex medium such as 
YPD (Yeast extract Peptone Dextrose medium, 1% yeast extract, 2% peptone and 2% 
dextrose (glucose)) and on minimal media supplemented with histidine (Minimal 
Dextrose Histidine medium, MDH, 1,34% YNB, 4 x 10'^ % biotin, 2% dextrose, 0.004% 
histidine). Until transformed, KM71 cells do not grow on minimal medium alone as they 
are His . All expression plasmids carry the HIS4 gene which, after introduction into the 
host cell, complements the host his4 and allow the selection of the transformants by 
their newly acquired ability to grow on histidine-deficient medium. Spontaneous 
reversion of KM71 to His^  prototrophy is less than 1 out of 10®. The growth temperature 
of Pichia pastoris is 28-30°C for liquid cultures and plates. Growth above 32°C during 
induction can be detrimental to protein expression and can even lead to cell death.
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The doubling time of log phase Mut  ^Pichia in YPD is ~2 hs and -18 hs in methanol- 
containing medium. During methanol induction, methanol was added every day, to the 
culture medium, to compensate for loss due to evaporation or consumption. Cells were 
stored for weeks to months on YPD medium or YPD agar plates at 4°C. For longer 
storage cells were stored at -80°C in YPD containing 15% glycerol. After long-term 
storage at 4°C or -80°C, the His^  transformants were checked for correct genotype and 
viability by streaking them on Minimal Dextrose plates (MD medium, 1.34% YNB, 4 x 10'^  
% biotin, 2% dextrose), before using again.
2.3. Vectors used in this study
2.3.1. Subcloning vectors
The pGEM-T vector (Promega) was used for the cloning of PGR fragments 
amplified with the Taq DNA polymerase (NEB). For PGR fragment generated with proof 
reading DNA polymerases such as the Pfu Turbo (Stratagene) or the Taq Plus Precision 
polymerase mixture (Stratagene), the blunt-ended pPGR-Script vector (Stratagene) was 
favoured. Both plasmids confer ampicillin resistance to the host strain and, when 
transformed into E. coU XL1 Blue cells, allow a white/blue screening of the vector- 
bearing bacteria. The sub-clonings were performed following the manufacturer's 
protocol.
2.3.2. Expression vectors 
2.3.21. For £. coU: pET28a(+) (Novagen)
The pET-28a (+) vectors carry an N-terminal His-Tag/thrombin/T7-Tag 
configuration plus an optional G-terminal His-Tag sequence. This vector was used to 
generate N- or G-terminally His tagged protein. The vector contains strong transcription 
signals for the control of the T7 RNA polymerase of the E. coli BL21 host. Expression of 
the target gene is induced upon addition of IPTG to the culture medium of the vector- 
bearing BL21 cells. MGA, MGA^ ^®'^ , MGA^ ^®''^ °^ °, MCA''^ ®^ ,^ and MGA"'^^* were cloned into 
the pET28a(+) to give the pGL1421 to pGL1425, respectively.
2.3.2 2. For P. pastoris: pPIC9 (Invitrogen)
This vector allows multicopy integration of the gene of interest thus potentially 
leading to a higher expression of the protein of interest in P. pastoris. The pPIG9 carries 
an A0X1 promoter for high-level inducible expression, a HIS4 gene for identification of
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transformants, 5' and 3' A0X1 gene fragments for targeted integration into the Pichia 
host genome and the a-factor secretion signal to target recombinant protein expression 
to the growth medium (figure 2.1).
The pPIC9 is linearised by Sac! to allow insertion at the 5' of the A0X1 region and 
generate a His"^  Mut  ^ phenotype when transformed into the Pichia KM71 strain. MCA, 
AproMCA, AeproMCA, AeproMCAACterm, MCAACterm and AproMCAACterm were cloned 
into the pPIC9 (pGL1426) to give the pGL1112, 1113, 1419, 1420, 1427 and 1428, 
respectively.
Comments for pPlC9:
8023 nucleotides
S' AOX1 promoter fragment; bases 1-948 
5 'AOX1 primer site: bases 855-875 
a-Factor secretion signal(s): bases 949-1215 
a-Factor primer site: bases 1152-1172 
Multiple Cloning Site: bases 1192-1241 
3' A0X1 primer site: bases 1327-1347 
3' A0X1 transcription
termination (TT): bases 1253-1586 
HIS4 ORF: bases 4514-1980 
3' A0X1 fragment: bases 4870-5626 
pBR322 origin: bases 6708-6034 
Ampicillin resistance gene: bases 7713-6853
— ÛÛ Qi =
I x œ u j < z  I
3' AOX1 (TT)
pPIC9
8.0 kb
Bgl II
Figure 2.1 : Schematic of the pPIC9 Pichia expression vector
2.3 2.3. For Leishmania major
2.3.2.3.1. pNUS vectors
It is known that, in trypanosomatids, 5 -trans-splicing signals and poorly defined 
regions within the 3’-untranslated regions of genes are required for optimal expression 
of genes. Based on the pUC18 vector, the pNUS vectors also possess intergenic region of 
the Crithidia fasciculata phosphoglycerate kinase (PCK) genes A and B, which allows 
polyadenylation of the target gene and spliced leader addition to the selectable marker 
gene. Part of the intergenic region of the PGK locus was added upstream of the target 
gene to permit its trans-splicing. A 3’-untranslated sequence from the C. fasciculata 
glutathionylspermidine synthetase (GSPS) was also added to allow the polyadenylation
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AmpR
AmpR
H m d lll( l)  MCS (Sé5) N a«I Bglll.Kpml (992)
M y - H i t  (637-657)
EceRI(658) 
MK43' \
P6KB5'
pNUS-HcN P6KB5
6 290 kb
Xb<ir(1155)
S all(l717 )
9*tl(1900)
Neomycin
Bo«HI(2518)
EcoRl(559)
H m d lll( l)
P6KB5
pNU5-6FPcN
6 959 kb
AACS (565) N 6 # I-B flII.K p # I (582) 
GFP
MK43’
P*tl(1434)
X b«I(l«24)
P6K85'
SolI(2386)
9*tl(2549)
Neomycin
Bo«bH I(3187)
pNUS-Hc
EcoRI N</el Bgni Kpnl
Throm bin  
cle#v#ge ^ EcoRV Notl Xhol
GAATTC CATATG AGATCT GGTACC C TGG TGCCACGCGG TTCC ATGGC GATATC GGATCAGCTT GCGG CCGC A CTCGAG
EcoRI
CACCACCACCACCACCACTGA GAATTC  
Poly HI# x6
pNUS-GFPc
EcoRI Ndol Bfirfll Kpnl G re e n  F lu o re s c e n t P ro te in Xhol EcoRI
GAATTC CATATG AGATCT GGTACC ATG nnnnnnnn GFP nnnnnnnn TAG CTCGAG CACCACCACCACCACCACTGA GAATTC
pNUS-GFPn
Thrombin
ECORI Ndel G re e n  F lu o re s c e n t P ro te in  i  EcoRV
GAATTC CATATG ATG nnnnnnnn GFP nnnnnnnn TAG AGATCT GGTACC CTGG TGCCACGCGG TTCC ATGGC GATATC
Notl Xhol EcoRI
GGATCAGCTT GCGGCCGC A CTCGAG CACCACCACCACCACCACTGA GAATTC
Poly HI# x6
Figure 2.2: Schematic o f the pNUS Leishmania  expression vectors and the ir 
m ultip le cloning sites
Maps were obtained from http://www.ibcc.u-bordeaux2.fr/DNUS/
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of the selectable marker gene. Genes can be readily inserted using a multiple cloning 
site and can be expressed as a fusion protein with a poly-histidine sequence or with the 
Aequorea victoria green fluorescent protein (GFP), at either the N- or C-terminus 
(Tetaud et al., 2002). The vectors used in this study were the pNUS-HcN (pGL1137), the 
pNUS-GFPcN (pGL1132) and the pNUS-GFPnN (pGL1135) (figure 2.2) (kindly provided by 
Dr E. Tetaud). They all possess a neomycin resistance marker. For a detailed list of the 
vectors generated please refer to section 2.5.
2.3.2.3 2. pTEX
Based on the pBlueScript vector, this shuttle vector possesses, in addition, the 
intergenic and flanking regions of the two Trypanosoma cruzi glyceraldehyde 3- 
phosphate dehydrogenase (GAPDH) genes (figure 2.3). The two tandem GAPDH genes 
themselves have been replaced by a multicloning site and a selectable marker gene. 
The cloned target gene and the neomycin resistance gene will therefore be properly 
trans-spliced and polyadenylated and thus optimal expressed (Kelly et al., 1992). 
MCA, MCA^ °^^ ,^ AproMCA, AproMCA^ ”^ ^, MCA^ °^^ ,^ MCA^ °^^ °^^  ^ and MCA"^ ^^  ^were cloned 
into the pTEX (pGL83) to give the pGL1128, 1129,1130, 1131, 1294, 1296 and 1406, 
respectively.
Ampicillin (4682-5542)
GAPDH I 5'UTR (653-1113)
ATx j I  (1 1 0 3 )
B a m  H I  (1115)
PART OF GAPDH I (1171-1328) 
INTERGENIC GAPDH (1329-1838)
5 66 7  bp
Neomycin (1905-2708)
GAPDH II 3'UTR (2723-3463)
Figure 2.3: Schematic of the pTEX Leishmania expression vector
2.3.2.3 3. pRIB
Based on the pFW31 vector (Benzel et al., 2000), the pRIB vector allows gene 
addback and heterologous expression studies (Garami and llg, 2001). This vector uses 
the S'-trans-splicing signals and 3 - polyadenylation sites of the L. major dihydrofolate 
reductase-thymidylate synthase {DHFR-TS) gene to allow the optimal expression of the
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target gene (figure 2.4). Once excised by Pac\ and Pme\, the linearised integration 
cassette, containing the 5’ and 3’ untranslated regions of the 18S ribosomal RNA small 
subunit gene {18S rRNA), will recombine into the ribosomal locus of Leishmonia, and 
allow the expression of the target gene under the control of the rRNA promoter. This 
promoter is known to lead to high level expression not only in promastigote but also in 
amastigote forms (Misslitz et a i,  2000). MCA and MCA"^ '*^  ^ were cloned into the pRIB 
(pGL631) to give the pGL1399 and 1400, respectively.
Foci (411)
Ampicillin (6738-7598)
ORI (5796-6535)
Pm el (5551)
3' 18S (4591-5550)
-V 9 8  bp
5' 188 (414-667)
5' DHFR-TS (668-854)
ATio 1 (856 )
MGS
BglU  (956)
3'DHFR-TS (970-2635)
PAG (2651-3247)
LmexGPB 2.8 IR (32504590)
Figure 2.4: Schematic of the pRIB Leishmania expression vector
2.3.3. Gene knock-out vector for Leishmania
The backbone vector used here is the pGL896 (Besteiro et a i,  2004). The 
recombination cassettes containing the 5’ and 3’UTRs of L. mexica ICP can be easily 
replaced by the ones of the gene of interest by Hindlll/Sa/I and Xmal/6g/ll digestions, 
respectively (figure 2.5).
For antibiotic selection, this vector contains a blasticidin resistance cassette 
flanked by the 5’ and 3'UTR of DHFR-TS. Once excised by Hindi 11 and 6g/ll, the 
linearised integration cassette, containing the 5’ and 3’ UTRs of the gene of interest, 
will allow homologous recombination into the chromosomal locus of the gene of 
interest, therefore achieving a knock-out.
The 5’ and 3’ flanking regions of MCA were cloned into pGL792 to give pGL842. 
The selectable marker cassette (Spel/BamHI) was then replaced by either a hygromycin 
(pGL849) or a bleomycin (pGL1033) resistance gene. Alternatively the 5’ and 3’ of MCA
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itself were used as recombination cassettes (pGL968 and 971 with blasticidin and 
hygromycin resistance genes, respectively)
H i f i d l l K i )
LmexICP 5' FR (1-602)
S a i l  (6 0 3 )
\ Y  5* DHFR-TS (608-1531 )
Ampicillin (4852-5709)
S p e l (1 5 4 6 )pGL896
6 6 2 7  bp Blasticidin (1551-1946)
B a m H l  (1951)
3* DHFR-TS (1956-3317)B<7/ I I ( 3825 )
LmexICP 3' FR (3321-3824)
A'niol (3319)
Figure 2.5: Schematic of the pGL896 Leishmania knock-out vector
2.4. Oligonucleotides used in this study
Sequences are written in 5’ 3’ sense. The orientations of the primers are
indicated in brackets after theirs names (5’ for forward and 3’ for reverse). When the 
oligonucleotides contain restriction sites, their sequences are underlined and the 
corresponding cleaving enzymes are named in brackets. Oligonucleotides removing the 
natural stop codon of MCA to allow the fusion of a C-terminal tag are pointed by the 
mention “ stop deleted” . Oligonucleotides designed to be in frame with the start codon 
of an N-terminal tag are indicated by the mention “ a-factor” . For the active site 
mutagenesis, the codon that has been modified is underlined, the mutated nucleotide(s) 
indicated in bold and the resulted mutation written in brackets.
OL1188 (5’ ): aac gaa CTC GAG ATG GCA GAG CTT TTT GAT 
OL1189 (3’ ): acg ttc GGA TCC ATG TTA GGG AGG GGG GAG 
OL1190 (S'): gag cga AAG GTT TGA TGG TGT GAA GAA GGT 
0L1191 (3’ ): teg t t t  GTG GAG TAT AGT ATT AGG GGT ATT 
OL1192 (S’): gtg gag GGG GGG ATG TTT TGG GAG GGG TTG 
OL1193 (3’ ): ccg ctg AGA TGT GGT TGA AGA GAG GGT TGT
(Xhol)
(BamHl)
(Hmdlll)
(Sa/I)
(Xmol)
(Bg/ll)
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OL1215 5'):
OL1216 3’ ):
OL1304 5'):
OL1305 3’ ):
OL1396 5'):
OL1397 5'):
OL1398 3’ ):
OL1399 5’):
OL1400 5’):
OL1401 5'):
OL1402 3’):
OL1446 5'):
0L1447 5'):
OL1570 3’):
OL1571 5'):
OL1572 5’ ):
OL1573 3'):
OL1774 5’ ):
OL1775 3'):
OL1841 5'):
OL1842 3’ ):
OL2005 5'):
OL2006 31:
OL2007 5'):
OL2008 31:
OL2064 51:
OL2065 31:
2.5. Plas
tgg tea CCA TGG GAG AGG TTT TTG ATA TTT 
tga tgt GTG GAG GGG AGG GGG GAG TGG GGT 
GGT TGG AGA TAT GGA GTG AT 
GG AGT AGA GAG GAG CTG AAG 
gaa ate GAT ATG GGA GAG GTT TTT GAT ATT 
egg gtc GAT ATG AAT GGG GGA AGG GGG GTG 
tga tgt GGT ACG GGG AGG GGG GAG TGG GGT 
aac gaa TGT AGA ATG GGA GAG GTT TTT GAT ATT 
aaa egg TGT AGA ATG AAT GGG GGA AGG GGG GTG 
TGG GTG TTT GAG TGG GGT GAG TGA GGG AGG ATG
(Nco\)
(Xhol, stop deleted)
GAT GGT GGG TGA GTG AÇÇ GGA GTG AAA GAG GGA 
aac gaa GGA TGG ATG GGA GAG GTT TTT GAT ATT 
aaa egg GGA TGG ATG AAT GGG GGA AGG GGG GTG 
gta ctg GGT AGG GAG GGA ATG GAT GAT 
aac gaa TAG GTA ATG GGA GAG GTT TTT GAT 
egg gtc TAG GTA AAT GGG GGA AGG GGG GTG 
acg ttc GGT AGG ATG TTA GGG AGG GGG GAG 
AGG TGG GTC TTT GAG GGG TGT GAG TGA GGG AGG
(Ndel)
{Nde\)
(Kpnl, stop deleted) 
(Xhol)
(Xhol)
(G201G)
(G201G)
(BomHI)
(BomHI)
(Kpnl, stop deleted) 
(SnoBI)
(SnoBI, a-factor) 
(Avril)
(G202G)
GGT GGG TGA GTG AGA GÇÇ GTG AAA GAG GGA GGT (G202G)
AGG TGG GTG TTT GAG GGG GGT GAG TGA GGG AGG AT (G201-202G) 
GAT GGT GGG TGA GTG AÇÇ GÇÇ GTG AAA GAG GGA GGT (G201-202G)
aac tac TAG GTA ATG GGG AAG GGA GTG GGT 
GAG GAT CATATG GTG GGT AAT GGG GAA GGA 
AGG AGG GTG GAG GTG GAG AAG GGG GGG GAG 
GGA AGG GAG GTG TTA GGG AGG GGG GAG TGG 
GAG TGG AGA GGG TGG GGA 
GAG GTA GAG GTA GGT TGT
(SnoBI, a-factor) 
(Nde\)
(Xhol)
(Sod)
Schematics of the MGA constructs generated are shown in figures 2.7 and 2.8.
Active site mutagenesis 
PGL1429: pPGR-Script + MCA OL1215/1216 (Xhol/Xhol)
pGL1231; pPGR-Script-0L1400/1189 (Xhol/Xhol) + C202G cassette (Xhol/Xhol from 
PGL1421)
pGL1291: pGL1231 (Xhol/Xhol) + C201G cassette 0L1174/1175 (Xhol/Xhol) 
pGL1292: pGL1231 (Xhol/Xhol) + C201-202G cassette OL1841/1842 (Xhol/Xhol)
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Expression in pET28a(+>
MCA-His
pGL1421: pET28a(+) AMP (Xhol/Xhol) + MCA (Xhol/Xhol from pGL1429)
MCA‘^ “ ’°-His
pGL1422: pET28a(+) AMP (Xhol/Xhol) + MCA""'" (Xhol/Xhol from pGL1291) 
MCA^^’-^^-His
PGL1423: pET28a(+) AMP(Xhol/Xhol) + MCA^"' ” ®^ (Xhol/Xhol from pGL1292) 
MCA“ '’“ -His
pGL1424: pET28a(+) AMP (Xhol/Xhol) + MCA™^ "^  (Xhol/Xhol from pGL1231)
MCA"""*-His
PGL1425: pGL1422 (Nru/I/Xhol) + MCA"” ''* (Nru/I/Xhol from pGL1401)
Expression in pPIC9 
Backbone plasmid
pGL1426: pPIC9 vector for inducible expression in Pichia (multicopy + secretion in
medi um -1 nvitrogen K171001
MCA with a-factor signal in N-terminus
pGL1112: pPIC9 (SnaBI/Avrll) + MCA OL1571/1573 (SnoBI/Avril)
AproMCA with a-factor signal in N-termlnus
pGL1113: pPIC9 (SnoBI/Avril) + AproMCA 0L1572/1573 (SnoBI/Avril)
AeproMCA with a-factor signal in N-terminus
pGL1419: pPIC9 (SnoBI/Avril) + AeproMCA OL2005/1573 (SnoBI/Avril)
AeproMCAACterm with a-factor signal in N-terminus
pGL1420: pGL1419 digested by Mlu\/Avr\\, filled in with Klenow and ligated on itself to 
remove the C-terminal extension of MCA 
MCAACterm with a-factor signal in N-terminus
pGL1427: pGL1112 digested by Mlu\/Avr\\, filled in with Klenow and ligated on itself to 
remove the C-terminal extension of MCA 
AproMCAACterm with a-factor signal in N-terminus
pGL1428: pGL1113 digested by M/ul/Avrll, filled in with Klenow and ligated on itself to 
remove the C-terminal extension of MCA
Expression in pNUS vectors 
MCA-His
pGL981: pNUS-HcN (A/cfel/Kpnl) + MCA {Nde\/Kpn\ from pPCR-Script-OLI 396/1398) 
Mca“ 02g_h|s
pGL982: pNUS-HcN {Nde\/Kpn\) + MCA^ °^^  ^ {Nde\/Kpn\ from pPCR-Script-OLI396/1398 
C202G)
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AproMCA-His
pGL983: pNUS-HcN {Nde\/Kpn\) + AproMCA {Nde\/Kpn\ from pPCR-Script-OLI397/1398) 
AproMCA^“ ^°-His
pGL984: pNUS-HcN {Nde\/Kpn\) + AproMCA^^^^  ^ {Nde\/Kpn\ from pPCR-Script-
0L1397/1398 C202G)
M c a »^i 47a_h ,s
pGL1401: pGL981 {Nru\/Mlu\) + H147A cassette {Nru\/Mlu\ from pGL 1406)
MCA-GFP
pGL985: pNUS-GFPcN (Ndel/Kpnl) + MCA {Nde\/Kpn\ from pPCR-Script- 0L1396/1398) 
MCA “^ ^°-GFP
pGL986: pNUS-GFPcN (Ndei/Kpnl) + MCA^ °^^  ^ (Nde\/Kpn\ from pPCR-Script-OLI396/1398 
C202G)
AproMCA-GFP
pGL987: pNUS-GFPcN (Ndel/Kpnl) + AproMCA {Nde\/Kpn\ from pPCR-Script-
0L1397/1398)
AproMCA'^ ^^ '^-GFP
pGL988: pNUS-GFPcN (Ndel/Kpnl) + AproMCA^ ^^ *^^  (Ndel/Kpnl from pPCR-Script- 
0L1397/1398 C202G)
Cterm-GFP
pGL1108: pGL985 digested by Nde\/Mlu\ , filled in with Klenow and ligated on itself to
remove the rest of MCA ORF. ATG in frame naturally presents.
proregion-GFP
pGL1109: pGL985 digested by Nru/Acc65\, filled in with Klenow and ligated on itself to 
remove the rest of MCA ORF.
MCAACterm-GFP
pGLIIIO: pNUSGFPcN (Ndel/Kpnl) + MCAÆferm OL1396/1570 {Nde\/Kpn\} 
AproMCAACterm-GFP
pG LIIII: pNUSGFPcN {Nde\/Kpn\) + AproMCAACterm 0L1397/1570 {Nde\/Kpn\) 
MCA^ °^^ -^GFP
pGL1293; pGL985 (Bg/ll/M/ul) + C201G cassette {Bgl\\/Mlu\ from pGL1291) 
McaC2oi*202g_qfp
pGL1295: pGL985 (Bg/ll/M/al) + C201-202G cassette (BglW/Mlul from pGL1292) 
MCAHi^’'^-GFP
pGL1402: pGL985 {Nru\/Mlu\) + H147A cassette {Nru\/Mlu\ from pGL 1406) 
eNterm-GFP
pGL1403: pNUS-GFPnN (Ndel) + eNterm OL1396/OL2006 (Ndel/Ndel)
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N-terminal region 
M A D .. .S .X IP M N L A L L L V D R P K R V D IN ^ A G  39...
Extented N-terminal region 
M A D ...M „ R N A L R G  Q IS F P IS E .„ ,C C IL V D D P S  110.
Active site region and catalytic residues
...141 F F H F S C H ,^ ^ G G Q  150. ...198 V F D  C jo jH S A S  206...
C-terminal region (PQY-rich)
...323 T V N A S M M H C V P jj jQ Q Y Q Q R P Q  341...
Extended C-terminal region (PQY-rich)
...249 D R G T S A D V ;^ Q N G G H ...P ,, ,Q Q Y Q Q R P Q  341.
Eoisomal constructs using the pTEX vector
MCA
M C A C 2 0 2 G
AproMCAAproMCACzozG
MCAC201G
M CA«=201-202G
MCA ’^^^ ^
47.2 kDa 
43.6 kDa
47.2 kDa
47.2 kDa
47.2 kDa
pGL1128
PGL1129
pGL1130
PGL1131
pGL1294
pGL1296
pGL1406
Eoisomal constructs using the pNUS-HcN vector
MCA-His
MCA“ 02G_His
AproMCA-HisAproMCAC202G.His
MCAH^ '^ A^-His
H IS 50.0 kDa pGL981
pGL982
46.4 kDa pGL983
pGL984
50.0 kDa pGL1401
Eoisomal constructs using the pNUS-GFPcN vector
M CA-GFP  
MCAC202G.GFP
AproMCA-GFP
AproMCAC202G_Gpp
MCAACterm-GFP  
AproMCAACterm-GFP
Nterm-GFP
Cterm-GFP
GFP
74.3 kDa pGL985pGL986
70.6 kDa pGL987
pGL988
63.4 kDa PGL1110
59.7 kDa PGL1111
29.1 kDa pGL1109
38.6 kDa pGL1108
26.9 kDa pGL1135
Figure 2.6: Schematic representation of the MCA constructs generated for 
this study (part A).
Upper panel: key regions of MCA. Regions of interest and important amino acids are 
shown in black and red, respectively. The numbers indicate their positions in the MCA 
sequence. Lower panel: Schematics of the various constructs created. All the constructs 
represented here were expressed (except pGL1406) in L. major, E. coU or P. pastoris 
(see part B in figure 2.7). The protein encoded, its molecular weight and the 
corresponding plasmid used for the expression (pGL numbers) are indicated. For the 
legend of the color code please refer to figure 2.7.
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E GFP
GFP
r I GFP
MCA-TAP
MCA
M C A H 1 4 7 A
integrative constructs 
in p-tubulin locus (TAP vector)
in 18S rRNA locus (pRIB vector)
pGL1293
74.3 kDa pGL1295
pGL1402
41.1 kDa pGL1403
48.5 kDa pGL1404
59.7 kDa PGL1405
68.3 kDa pGL958
47.2 kDa PGL1399pGL1400
E. coli (pET28a-AMP in BL21(DE3) and others
MCA-His
MCAC201G.|_|js
MCA“ “ G_His
MCAC201-202G_Hjs
MCAH'^ '^ -^His
PGL1421
PGL1422 
50.0 kDa pGL1424
pGL1423
pGL1425
P. pastoris {p P IC 9  in KM71) 
a-factor MCA
a-factor AproMCA  
a-factor MCAACterm  
a-factor AproMCAACterm  
a-factor AeproMCAACterm 
a-factor AgproMCA  
a-factor (pPIC9)
60
Eoisomal constructs using the pNUS-GFPc/(*n)N vector
MCAC201G-GFP 
MCAC201-202G_GFP 
MCA"^ '»"A-GFP 
eNterm -GFP-His  
eCterm -GFP  
eNterm -GFP-eCterm
56.8 kDa pGL1112
53.0 kDa PGL1113 1
46.2 kDa PGL1427
42.2 kDa pGL1428 1 ■1
37.5 kDa PGL1420 i
49,0 kDa pGL1419 i \
10.4 kDa pGL1426 .■ | | i
LegendE N-terminal region
m Extented N-terminal region g  Histidine 147 mutated into Alanine a-factor secretion tag
C-terminal region Q  Cysteine 201 mutated into Glycine 1 Polyhistidine tag
Extented C-terminal region Q  Cysteine 202 mutated into Glycine Green Fluorescent Protein tag
Figure 2.7: Schematic representation of the MCA constructs generated for 
this study (part B).
The asterisks indicate constructs designed using the pNUS-GFPnN.
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GFP-eCterm
pGL1404; pNUS-GFPnN {Xho\/Sac\) + eCterm OL2007/OL2008 {Xhol/Sad) 
eNterm-GFP-eCterm
pGL1405: pGL1403 (Xhol/ Sad) + eCterm OL2007/OL2008 {Xho\/Sad)
Expression in pTEX
MCA
pGL1128: pTEX {Xba\/BamH\) + MCA fu ll {Xba\/BomH\ from pPCR-Script- OL1399/1189)
pGL1129: pTEX {Xba\/BamH\) + {Xba\/BamH\ from pPCR-Script-OLI399/1189
C202G)
AproMCA
pGL1130: pTEX (Xhol/BomHI) + AproMCA (Xhol/BomHI from pPCR-Script-OLI400/1189) 
AproMCA^^°“
pGL1131: pTEX (Xhol/BomHI) + AproMCA^^^^  ^ (Xhol/BomHl from pCR-Script-OL1400/1189 
C202G)
MCA“ °^°
pGL1294: pGL1128 {Bgl\\/Mlu\) + C201G cassette (Bgl\\/Mlu\ from pGLI291)
MCAC201-202G
pGL1296: pGL1128 (Bg/ll/Ai/ul) + C201-202G cassette (Bg/ll/M/ul from pGL1292)
MCA"'""^
pGL1406; pGL1128 (Nrol/BstEII) + H147A cassette (Nrol/BstEII from pESC-His +
(from Iveth Gonzales (Nicolas Fasel's lab))
Expression in pRiB 
Integration of MCA into ribosomal locus 
pGL1399: pRIB {Xho\/Bgl\\) + MCA OL1188/OL1189 (Xhol/BomHI)
Integration of MCA"^^^* into ribosomal locus
pGL1400: pGL1399 (Nrul/BstXl) + H147A cassette (Nrul/BstXl from pGL 1406
MCA knock-out 
Gene replacement
pGL842: pGL896 (blasticidin selection marker) + 5TR MCA OL1190/OL1191 (Hmdlll 
/Sat\) + 3’FRMCA OL1192/OL1193 (Xmol/Bg/ll),
pGL849: pGL842 (Spel/BomHI) + hygromycin selection marker (Spel/BomHI) from 
pGL720
pGL1033: pGL842 (Spel/BomHI) + bleomycin selection marker (Spel/BomHI) from 
pGL726
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Gene disruption
pGL967; pGL842 (BstEII/Bg/ll) + new 3' region (BsfEII/SamHI from pPCR-Script-
OL1188/OL1189)
pGL968: pGL967 (Hindi 11/So/I) + new 5’ region (H/ndlll/ So/I from pPCR-Script
OL1397/OL1216)
pGL970: pGL967 (Spel/BomHI) + hygromycin selection marker (Spel/BomHI) from
pGL849 (cl1 23/09/03).
pGL971: pGL970 (Hindill/So/l) + new 5’ region (Hindlll/ So/I from pPCR-Script
OL1397/OL1216).
METHODS
2.6. Preparation of genomic DNA from Leishmania major
Around 5x10  ^cells were washed twice in PBS, resuspended in 500 jul of TELT (50 
mM Tris-HCl pH 8, 62.5 mM EDTA pH 8, 2.5 M LiCl, 4% Triton X-100) with 10 pi of RNAse 
A (Sigma, 10 mg ml"" stock ) and incubated at room temperature for 5 mins. Two phenol 
extractions were then performed followed by two chloroform (24:1 with isoamylic 
alcohol) extractions. DNA was subsequently ethanol-precipitated by addition of 2 
volumes of 100% ethanol and 10% 3 M NaAc pH5.2 and incubation at -20° C for at least 30 
mins prior to centrifugation at 20,000 g for 30 mins. The DNA pellet was then washed 
twice v/ith chilled 70% ethanol. Once air-dried the genomic DNA pellet was resuspended 
in 50 pi TE (10 mM Tris-HCl, 1 mM EDTA pH=8) or water. Alternatively, genomic DNA was 
prepared following the “cultured animal cells” protocol of the DNeasy tissue kit 
(Qiagen). DNA was quantified by measuring the absorbance of a 1:10 dilution, in water, 
at a wavelength of 260 nm. Genomic DNA concentration was deduced from the Beer- 
Lambert Law: Concentration (pg/ml) = Abs i=260nm x sample dilution x 50pg ml"* (where 
50pg ml  ^ represent the concentration of DNA necessary to obtain 1 unit of absorbance at 
%=260nm).
2.7. Southern blot
2.5 pg of genomic DNA were digested for 18 hs with 30 units of the appropriate 
restriction enzymes under the temperature and buffer conditions mentioned by the 
manufacturer (NEB). The various fragments of the digested genomic DNA were then 
separated by electrophoresis through a 0.8 % agarose gel (SeaKem LE Agarose, BMA) in
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O.SxTBE. The agarose gel was then immersed in a depurination solution (0.25 M HCl) for 
15 mins then in a denaturing solution (0.5 M NaOH, 1.5 M NaCl) for 30 mins and then 
twice 15 mins, in a neutralisation solution (0.5 M Tris-HCl pH 8, 3 M NaCl). Between 
each of those steps, the agarose gel was washed with distilled water. After 5 mins 
incubation in a 20x SSC solution (3 M NaCl, 3 M trisodium citrate), the agarose gel was 
transferred to a positively charged nylon membrane (Hybond N+, Amersham Pharmacia 
biotech) by upward capillarity (Sambrook J. and Russell D.W., 2001)
On the following day the membrane was rinsed in 2 x SSC, air dried and then the 
DNA were fixed to the membrane by UV exposure (UV Stratalinker: 2 times “ autocross 
link” ). The membrane was then incubated in 10 ml of hybridation solution (1 M NaCl, 
10% SDS and 10 pg ml^ salmon sperm DNA) for 1 h at 65°C. The membrane was then 
probed at high stringency (65X), overnight, with the radiolabelled probe (prepared 
by random primer labelling with the Prime-lt II kit (Stratagene) according to the 
manufacturers instructions). 20 mins washes were then performed at 60°C with 2x SSC, 
0.1 % SDS and then with 0.2x SSC, 0.1% SDS. A ^^ P sensitive screen was then exposed to 
the radioactive membrane and revealed using the storage phosphor acquisition 
parameter (Typhoon Image Control) of a Phospholmager (Typhoon 8600, Amersham 
Bioscience Labcrew). The data were then analysed using the ImageQuant 5.1 software 
(Molecular Dynamics).
2.8. Polymerase Chain Reactions (PGRs)
PCR reactions were, depending on the requirements, performed using either the 
Taq DNA polymerase (AB gene or NEB) or the high-fidelity Taq Plus Precision polymerase 
mixture (Stratagene).
For analytic PCRs, 100 ng of DNA were hybridised with 100 ng of each 
oligonucleotide and amplified by 0.5 units of Taq polymerase in a final volume of 20 pi. 
For the polymerase to be fully active, 2 pi of lOx PCR mix (1.13 mg ml^ BSA, 450 mM 
Tris pH 8.8, 110 mM ammonium sulphate, 45 mM MgClz, 68.3 mM p-mercaptoethanol, 44 
pM EDTA pH 8.0, 10 mM dCTP, 10 mM dATP, 10 mM dGTP, 10 mM dTTP, water) were 
included in the reaction tube. Amplifications were ultimately performed in a PCR 
Express machine (Hybaid) during the following successive steps: 95°C 5 mins, 50°C 30 
secs, 72°C y mins) x1 then (95°C 30 secs, 55°C 30 secs, 72°C y mins) x25 and finally 
72°C for 10 mins.
For proof-reading amplification from genomic DNA, PCRs were usually performed 
in 100pl reaction with 150 ng of DNA, 250 ng of each oligonucleotide, 5 units of Taq Plus 
Precision polymerase mixture, 0.8 mM of dNTP and 10 pi of lOx Taq Plus Precision 
buffer (Statagene). PCRs were performed using the following program: (95°C 1 min) x1
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then (95°C 1 min, 55°C 1 min, 72°C y mins) x25 and finally 72°C 10 mins. The 
elongation time (y) was estimated from the size of the fragment to be amplified, 
knowing that a typical DNA polymerase synthesises around 1 Kb per min.
2.9. DNA gel electrophoresis and gel extraction
Day to day analysis was performed using 0.8% agarose (Gibco) in 0.5x TRIS borate 
EDTA buffer (TBE, 20 mM Tris, 20 mM boric acid, 0.5 mM EDTA pH 7.2). For gel destined 
for DNA extraction or Southern blot, low melting point extra-pure agarose was used 
(SeaKem). Ethidium bromide (Sigma) was added to the agarose gel, at a final 
concentration of 0.5 pg ml % to later allow the visualisation of the DNAs by exposure to 
UV light (Gel Doc 2000 (BioRad)). A 1 kb ladder molecular weight marker (Invitrogen) 
was used at a concentration of 0.5 pg per lane to determine the size and concentration 
of the analysed DNAs (e.g. in those conditions the 1.6 Kb marker band is composed of 50 
ng of DNA, therefore, fragment of similar size and similar intensity are at the same 
concentration). For PCR sample analysis, 10 pi of the reaction were mixed with 1 pi of 
lOx DNA loading buffer (50% (v/v) glycerol, 0.25% (w/v) bromophenol blue in TBE).
Following PCR reactions or enzymatic digestion, DNA fragments of interest were 
isolated and purified using the Gel Extraction Kit (Qiagen) as specified in the 
manufacturer’s instructions. To be concentrated or when used for transfection, the DNA 
was ethanol-precipitated as described earlier. The obtained DNA pellet was then re­
suspended in a suitable volume of sterile water and kept at -20°C until required.
2.10. Cloning of PCR products
2.10.1. Ligations
PCR products generated, as described previously, with the Taq DNA polymerase 
or the high fide lity Taq Plus Precision polymerase mixture were ligated into the pGEM-T 
(Promega) or pPCR-Script (Stratagene) vectors, respectively, following the 
manufacturer’s guidelines.
For ligation into the final cloning vector, the digested insert and 100-200ng of 
digested vector were, after gel purification, mixed together at a molecular ratio of 10:1 
and incubated with 40 units of T4 DNA ligase (NEB) and 1 pi of lOx T4 DNA ligase buffer 
(NEB) in a final volume of 10 pi, overnight at 16®C.
These ligations were then used to transform heat-shock competent f .  coU XL-1 
blue cells and transformants were selected on LB agar plates supplemented with the 
appropriate antibiotics.
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2.10.2. Generation of heat-shock competent E. coli strains
The strain of interest was first plated on an LB agar plate without any antibiotic 
(or containing tetracycline in the case of XL1 cells). One colony was then used to 
inoculate 10 ml of LB medium, overnight at 37°C. The overnight culture was then 
diluted 1:100 in 50 ml of LB medium and grown at 37°C, until reach of an 00=0.7 (at 600 
nm). Cells were then transferred to a 50 ml tube and put on ice for 10 mins before 
centrifugation at 350 g for 15 mins. The cell pellet was then resuspended in 16 ml of 
RF1 buffer (100 mM rubidium chloride, 50 mM MnClz 4 HzO, 30 mM potassium acetate, 10 
mM CaClz, 15% glycerol, with a final pH of 5.8, adjusted with 0.2 M acetic acid) and 
incubated on ice for 15 mins. The suspension was then centrifugated 15 mins at 540 g. 
The cell pellet was then resuspended, with careful pipetting, in 4 ml of RF2 buffer (10 
mM MOPS ph 6.8, 10 mM rubidium chloride, 75 mM CaCb, 15% glycerol, with a final pH of 
6.8, adjusted with NaOH) and incubated on ice for 1 h. Heat-shock competent cells 
were then aliquoted and deep freezed with dry iced. Aliquots were subsequently stored 
at -80X.
2.10.3. Heat-shock transformation
Frozen heat-shock competent E. coli cells were placed on ice to defrost. The 
DNA of interest was then added to the cells and incubated with them, still on ice, for 15 
mins. Transformation was then performed by incubation of the cells-DNA mix at 42°C for 
45 secs. The suspension was then placed on ice for a further 15 mins before being 
spread on LB agar plate containing the relevant antibiotic. Alternatively, LB medium 
was added to the transformed cells to allow their recovery, 1 h at 37T, before plating.
2.11. Colony screening by PCR
When using the pGEM-T or the pPCR-Script vectors, addition of 0.5 mM IPTG and 
80 pg ml^ X-gal to the transformant plates allowed white/blue screening of the colonies 
and the identification of cells potentially containing the DNA insert. However when the 
number of positive colonies was too important, to exclude false positives or when the 
system used did not allow such primary screening, the presence of the insert was 
assessed by PCR on colonies. Bacterial colonies were taken from their plate with a 
sterile 200 pi pipette tip and resuspended in 20 pi of sterile distilled water. 10 pi of this 
suspension were then used as template DNA for the Taq DNA polymerase mediated PCR 
reaction (see above). For screening the presence of insert in the pGEM-T or pPCR-Script, 
the SP6 / T7 and T3 /  T7 primer couples were used, respectively. When using different 
plasmid, the couples of oligonucleotides used were determined using the Vector-Nti
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map of the contructs and the “ research motif” function of this software (Vector-Nti 
Advance 10, Invitogen). Only the primers with a level of homology superior to 80% were 
used.
PCR products were analysed on an agarose gel as described previously. The 
clones of interest were then selected and the 10 pi of bacterial suspension left were 
used to inoculate 10 ml of LB medium. After an overnight incubation at 37°C, 1 ml of 
the culture was pipetted, mixed with 1 ml of a 2% (w/v) peptone 40% (v/v) glycerol 
solution, and placed at -20°C or -80° C for cryopreservation and long term storage.
2.12. Plasmid preparation
The 9 ml of bacterial culture left were then processed with a MiniPrep kit 
(Qiaspin mi ni prep, Qiagen), following the manufacturer’s guideline, to allow the 
extraction of the plasmid DNA. The plasmid DNA was eluted in water or TE and stored at 
-20^ C until needed. When larger amount of DNA were required, particularly in 
preparation for transfection of Leishmania cells, 50 ml of bacterial culture were grown 
and the DNA was extracted using either several miniprep column or a MidiPrep k it 
(Qiagen). The obtained DNA was then ethanol-precipitated as described before.
2.13. Plasmid generation
Transfer of DNA insert from one vector to the other was unable by the use of 
single-cutter restriction enzymes. To do so, the relevant restriction sites were added in 
the 5’ end of the oligonucleotides used for the PCR amplifications. Thus, after 
sequencing and verification of its conformity, the obtained DNA fragment was easily 
freed from the sub-cloning vector by enzymatic digestion. Restriction enzymes (NEB) 
were used at 10 units per pg of DNA in the appropriate reaction buffer (NEB) and 
following the manufacturer’s recommendations.
Most of the enzymes used were generating 5’ or 3’ overhangs. However, when, 
during the preparation of the vector DNA, there was no other possibility than to use 
restriction enzymes creating blunt-ends fragment, the calf intestinal alkaline 
phosphatase (CIP from NEB) was used, as indicated by the manufacturer, to 
dephosphorylate the digested DNA and forbid the linearised plasmid from relegating on 
itself.
When the number of possible single-cutting sites was limited, isoschizomers, 
enzymes that recognize the same DNA sequences but cleave at different positions 
within it, were used (e.g. Kpnl and Acc65l). Alternatively, enzymes with compatible 
cohesive ends were used (e.g. BomHI and Bg/ll for pGL1399). Also, the DNA Polymerase 
I, Large (Klenow) Fragment (NEB) was used for its 5’-3’ exonuclease activity and its
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ability to fill-in 5’ overhangs and generate blunt end fragments. Doing so, the C- 
terminal extension of MCA was conveniently removed following a Mlu\/Avr\i digestion 
(e.g. pGL1420).
2.14. DNA sequencing and analysis
DNA sequencing was performed by the University of Glasgow Molecular Biology 
Support Unit (MBSU), using an ABI automatic sequencer. Electrophoregrams were then 
edited and compiled into contigs using AlignX (a module of Vector Nti Advance 10, 
Invitrogen).
2.15. Sequences alignments and phylogenetic analyses
Amino acid sequences were imported either from the GeneDB (www.genedb.org) 
or the National Center for Biotechnology Information (NCBI) (http:/ /www.ncbi.nlm. 
nih.gov/) websites and into Vector NTI Advance 10. Alternatively, the amino acid 
sequences were obtained from translation of nucleotide open reading frames (in Vector 
NTI Advance 10). Alignments were performed using the Clustal W algorithm of the Align 
X program (included in the Vector NTI Advance 10 package, http://www.1nformaxinc. 
com/). The set of data could be exported as a multiple sequence file (MSF) format and 
used to build a phylogenetic tree with the MEGA 3.1 software (Kumar et al., 2004). The 
tree was made using the Neighbor-Joining method and Poisson-corrected amino acid 
distance was used. The reliability of clustering patterns in the tree was tested by 
bootstrapping (1000 pseudoreplicates).
2.16. Transfection of Leishmania mayor ceils
2.16.1. Plasmid DNA preparation
For the knock out or integrative constructs, 45 pg of plasmid were linearised by 
digestion with the appropriated restriction enzymes (see molecular constructs for 
details). The digested DNA fragments were then separated by electrophoresis on an 
ethidium bromide-free 0.5x TBE /  0.8% agarose gel (SeaKem LE Agarose, BMA). The 
migrated DNA fragments were then revealed by immersion of the agarose gel in a 
methylene blue solution (approximately 1 ml of a 0.065% (w/v) methylene blue stock in 
50 ml water). The band corresponding to the fragment of interest was purified using the 
Qiaquick gel extraction kit (QIAGEN) and then ethanol- precipitated.
For the episomal constructs, 20 pg of circular plasmid was directly precipitated 
with ethanol. The last washing step would be done under a sterile hood. The
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precipitated DNA would then be resuspended in 20pl of sterile water and used for 
transfection of 4x10  ^Leishmania.
2.16.2. Electroporation and cloning
Promastigote cells at a density of around 0.5-1.5x10^ cells ml^ were 
preferentially used. 4x10  ^ Leishmania and 20pg of purified (linearised or not) plasmid 
DNA (in 20pl water) were necessary for the transfection. After counting, the 
appropriate volume of cells was centrifuged 10 mins at 540 g at 4°C and washed with 
ElectroPoration Buffer (EPB, 20 mM HEPES pH 7.4, 135 mM NaCl, 5 mM KCt, 1 mM 
sodium phosphate buffer pH 7.4, 0.12% glucose). The washed cell pellet then was 
resuspended in 400pL of EPB (1x10® cells ml 1 and incubated with the plasmid DNA, in a 
sterile ice-cold screw cap eppendorf tube, for 15 mins, on ice. The cells/DNA mix was 
transferred to an ice-cold 2 mm gap cuvette (Gene Pulse, Biorad) and left an additional 
5 mins, on ice, before proceeding to the electroporation. The electroporation was done 
with a BIORAD Gene Puiser II apparatus by application of a 450 Volts-500 pFarads pulse 
to the cuvette. The transfected cells were kept on ice for 15 mins, then transferred into 
a phenolic-style cap 25cm  ^flask (Corning) containing 5 ml of HOMEM medium + 20% FCS 
and left to recover overnight at 25°C. The following day, cells were aliquoted into a 
flask (1 ml of cells), a 24 (2 ml) and a 96 (2 ml) well plates containing, respectively, 4 
ml, 22 ml or 8 ml of HOMEM medium + 20% FCS + antibiotics (see section 2.2.1). 
Alternatively, 5 ml of HOMEM medium + 20% FCS + 2x antibiotics could be added to the 
5 ml overnight culture. Thus, after using twice the previously indicated volumes of cells 
for the aliquoting, the remaining 4 ml were centrifuged 10 mins at 540 g, resuspended 
in 200 pi of HOMEM and finally spread on two plates of 0.7% low melting point agarose 
(Seaplaque) in HOMEM medium + 20% FCS + antibiotics.
2.16.3. Cell extracts
Leishmania, growing in HOMEM medium + 10-20% FCS +/- antibiotics, were 
counted, centrifuged 5 mins at 540 g, washed with 15ml PBS, and the pellet stored at - 
20°C. Cells are then resuspended at 1x1 O^cells 10pl'  ^ in a peptidase inhibitors mix (lOx 
solution: 0.1 mg ml^ leupeptin, 1 mM phenantroline, 0.5 mg ml‘  ^ Pefabloc SC, 5 pg ml'  ^
Pepstatin A and 0.1 mg ml^ PMSF) + 2% SDS + 1x SDS-PAGE loading buffer (5x: 250 mM 
Tris-HCl pH 6.8, 10% (w/v) SDS, 50% (v/v) glycerol, 0.5% (w/v) bromophenol blue, 500 
mM p-mercaptoethanol). Cells extracts were stored at -20 or -80°C.
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2.16.4. Preparation of cytoskeieton
The first method used was based the one used in mammalian cells and previously 
applied to L  tropicana (Kratzerova et al., 2001). Cells were lysed with 0.5% Triton X- 
100 in microtubule-stabilising buffer (MSB, 20 mM Mes, pH 6.9, 2 mM EGTA, 2 mM MgClz) 
and in the presence of a cocktail of peptidase inhibitors for a 15 mins at RT. The 
lysates were then centrifuged at 20,000 g for 15 mins and the soluble fractions (S) were 
collected. The insoluble fractions (I) were washed twice with MSB buffer and ultimately 
resuspended a volume of 0.5% Triton X-100 in MSB corresponding to the one of the 
equivalent soluble fractions.
The second method used was adapted from the ones used for the purification of 
T. brucei cytoskeieton (Woods et al., 1989; Robinson et al., 1991; Broadhead et al., 
2006). Promastigote cells were lysed in 0.5% Nodi net P40 in PEME buffer (100 mM Pipes, 
pH 6.9, 2 mM EGTA, 1 mM MgSO^ , 0.1 mM EDTA, Woods et al), on ice for 5 mins. A few 
microliters of the total extract (T) were kept before proceeding to the centrifugation of 
the rest of the sample at 250 g for 30 mins at 4%. The soluble fraction (S) was collected 
and the insoluble pellet was washed twice in PEME before being finally resuspended in 
0.5% NP40-PEME (I, insoluble fraction).
The T, S and I fractions were separated by SDS-PAGE in a 12% (w/v) acrylamide 
gel. The quantity of protein within the T, S or P fraction groups was normalised after 
BCA protein quantification (Pierce) and Coomassie staining. The samples were then 
processed for immunoblotting.
2.17. Production of recombinant iViCA
2.17.1. In E. coli:
Heat-shock competent cells of E. coU BL21 were transfected with the 
appropriate plasmids. After selection on ampicillin LB agar plates, a single colony was 
grown in LB medium until reaching an OD=0.8. Recombinant protein expression was then 
induced by addition of 1 mM of IPTG for at least 2 hs at 37“C (or alternatively 16°C for a 
longer period). Cells were then placed on ice for 10 mins and centrifuged 10 mins at 350 
g (4°C). The pellet was then resuspended in 2% SDS, sonicated (tune 40% total time 1.5 
mins, on ice) and centrifuged 30 mins at 20,000 g. The soluble (supernatant) and the 
insoluble (pellet) fractions (induced or not) were then analysed by Western Blot. 
Alternatively, when nickel-affinity purification of the produced His-tagged proteins was 
needed, the cell pellets were resuspended in 5 ml (for an initial 100 ml culture) of 1x
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Binding buffer +/- urea (see section 2.19.1 for composition) and either processed 
immediately or stored at -80°C.
2.17.2. in P. pastoris
These protocols are based or extracted from the Pichia expression kit manual 
(Invitrogen, catalog no. K1710-01).
Various versions of the MCA were cloned into the pPIC9 Pichia expression vector 
(refer to section 2.5). Prior to transfection, the plasmids were amplified in DH5a E. coli 
cells to allow the obtention of “ clean” DNAs and thus increase the transfection 
efficiency. 15 pg of the DNAs were then linearised by Sod digestion, purified by phenol- 
chloroform extraction, ethanol-precipitated and resuspended in sterile water. 
Electrocompetent P. pastoris KM71 cells (made following the Pichia expression kit 
manual) were then transfected with the digested DNA by electroporation using a 
MicroPulser (Biorad) (one pulse at 2 kVolts in a 0.2 cm cuvette). Cells were immediately 
resupended in 1 ml ice-cold 1M sorbitol and then spread on RDB plates (100, 200 or 350 
pi per plate. Regeneration Dextrose medium, 1 M sorbitol, 1% dextrose, 1.34% YNB 
(yeast nitrogen base with ammonium sulfate and without amino acids), 4x10^% biotin, 
0.005% amino acids, 20 g 1^  agar). Transformants started to be visible on the plates 
after about 4-6 days at 30°C. A few transfectants were then choosen and grown in liquid 
MD medium. Genomic DNAs of these transfectants were then extracted and analysed by 
PCR for integration in the aox1::ARG4 locus of the Pichia KM71 genome. Transfectants 
with the correct integration were then selected for induction of the expression of the 
recombinant protein. Transfectants were grown, at 30°C in a shaking incubator (260 
rpm), in liquid BMGY medium (Buffered Glycerol-complex Medium, 1% yeast extract, 2% 
peptone, 100 mM potassium phosphate pH 6.0, 1.34% YNB, 4x10^% biotin, 1% glycerol) 
until reaching an OD of around 8 and were then centrifuged, washed with sterile water 
and resuspended in BMMY medium (Buffered Methanol-complex Medium, BMGY where 
the glycerol has been replaced by 0.5% methanol) to induce the expression of the 
protein of interest. Induction was then maintained for up to 10 days by adding each day 
methanol at a final concentration of 0.5% to the culture. Culture sample were taken 
every 24 hs and centrifuged. The culture medium supernatant, containing the secreted 
recombinant protein, was separated from the cells pellet and both were stored at -20°C 
or -80°C. The medium samples were then directly analysed by SDS-PAGE and western 
blot for presence of the secreted desired recombinant protein. Alternatively, the cell 
pellets were lysed with Y-PER buffer (Pierce) following the manufacturer’s protocol, 
before conducting similar analyses to assess the expression and potential retention 
within the cells.
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2.18. In vitro translation
Alternatively, recombinant MCA was produced by in vitro translation, using 
plasmid DNA as template (EasyXpress Protein Synthesis Mini Kit, Qiagen). The matrix 
vector was pET28a(+)-MCA (pGL1421), thus allow the expression of C-terminally His- 
tagged MCA. Proteins were produced and purified following the manufacturer protocol. 
Basically, the reactions were performed in a final volume of 50 pi containing: 20 pi of 
EasyXpress reaction buffer, 2.5 pi of RNase-free water, 17.5 pi of E. coli extract, 0.8 pg 
of pGL1421 or 2.5 pi of the positive control plasmid, 1 mM of IPTG, sterile water. The 
reactions were then placed at 37°C for 1 h and finally stopped by placing on ice and 
proceeding with the sample purification and analysis. The His-tagged proteins were 
purified using Ni-NTA Superflow resin (Qiagen) under native conditions. Shortly, 100 pg 
of Ni-NTA agarose slurry was washed with 1 ml of Binding buffer, in a 1.5 ml column. 5 
pi of the in vitro translation samples were reserved while the remaining 45 pi were 
mixed with 400 pi of ice-cold Binding buffer and placed on the washed resin. His-tagged 
proteins were allowed to bind the resin for 2 hs at 4°C on a rotating shaker. The bottom 
cap of the column was then removed and the flow-through collected and saved, before 
proceeding to a 500 pi wash (with Washing buffer) and elution of the His-tagged 
proteins twice with 50 pi of Elution buffer. Note that to facilitate the elution of small 
volumes a 30 secs spin at 6,000 g was performed. Samples from the total, flow-through, 
wash and elution fractions were then analysed by SDS-PAGE and Western blot using anti- 
His antibodies. Please refer to next section for the recipe of the buffers used in this 
experiment.
2.19. Protein purification (and enzymatic assays)
2.19.1. His-tagged proteins
Induced bacteria cell pellets were frozen on dry ice and defrosted several times 
to facilitate cell lysis. Cells were then sonicated for 1 min at 40% amplitude. The lysate 
were then spun 20 mins at 10,000 g. The pellets were then resuspended in 5 ml of 1x 
Binding buffer, incubated on ice for 15 mins, sonicated again and centrifuged as above. 
When purification in denaturing conditions was necessary, this step was successively 
repeated with 4 M, 6 M and finally 8 M urea. Every time, both the supernatant and 
pellet fractions were kept for further analysis. Samples were then analysed by SDS-PAGE 
followed by a Coomassie staining and a Western blot. Upon determination of the
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optimal solubilisation conditions, the experiment was repeated and the Nickel-affinity 
purification of the His-tagged proteins carried over.
A 10 ml polypropylene column (Pierce) was loaded with 2 ml 50% Ni-NTA agarose 
and equilibrated with 10 ml of 1x Binding buffer +/- urea. The samples were then added 
and the His-tagged proteins were allowed to bind the resin for 2 hs at 4”C. After 
washing with around 40 ml of 1x Washing buffer +/- urea (10 fractions), the proteins 
were eluted in 10 fractions of 1.5 ml with 1x Elution buffer +/- urea. The various 
fractions were then further analysed. The Ni-NTA column was rinsed with 1x Washing 
buffer and kept in 1x Binding buffer at 4°C, for later use.
Concentrated stock solutions of the various buffers were made and stored at 4°C. 
8x Binding buffer: 40 mM imidazole, 4 M NaCl, 160 mM Tris-HCl ph 7.9. 8x Washing 
buffer: 480 mM imidazole, 4 M NaCl, 160 mM Tris-HCl pH 7.9. 4x Elution buffer: 4 M 
imidazole, 2 M NaCl, 80 mM Tris-HCl pH 7.9. For purification under denaturing 
conditions, urea was added, at the appropriate concentration to the 1x buffers.
2.19.2. TAP-tagged proteins
The protocol used was the one described by 0. Puig for the yeast model (Puig et 
al., 2001)
2.20. Peptide synthesis and antibodies production
A peptide corresponding to the C-terminal 15 amino acids of the predicted MCA 
sequence (QPPPAQYTFSPLPPG) was synthesized (Seqlon) and used to immunize animals 
(Seqlon). The rabbit antiserum was then affinity-purified. Affinity purified rabbit 
antibodies raised against the TbMCA2 and TbMCA3 active site region 
([DAKPGD...(68)...MDLPFT]) were previously produced in the laboratory (Helms et at., 
2006).
2.21. Affinity purification of antibodies
In a 5 ml polypropylene column (Pierce), 1 mg of MCA peptide (QPPPAQYTF 
SPLPPG) was covalently linked to 500 pi of Aminolink Coupling Gel (Pierce) following the 
manufacturer protocol. The peptide/aminolink resin was then equilibrated with 10 ml 
of IgG binding buffer (0.14 M NaCl, 8 mM sodium phosphate buffer pH=7.5, 2 mM 
potassium phosphate buffer pH 7.5, 0.01 M KCl). 2 ml of anti- MCA rabbit antisera 
(rabbit 3122, 3^  bleed) were then diluted by half in IgG binding buffer and incubated 
3 hs at room temperature with the peptide/aminolink resin. The resin was washed with 
20 ml of IgG binding buffer before eluting the bound antibodies with multiple
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500 |il fractions of Immunopure IgG elution buffer (Pierce). Note that 25 \ii of 1M Tris- 
HCl pH 9.5 were present in the collection tube to instantly equilibrate the acidic pH of 
the elution buffer and thus ensure the stability of the eluted antibodies. The proteins in 
the various elution fractions were then quantified by measurement of their OD at 
À=280nm. The fractions having the highest OD were pooled and concentrated on a 
Vivaspin 2 ultrafiltration unit (regenerated cellulose 10,000 MWCO, Vivascience), at 
3000g. The filter was then washed 3 times with 2 ml of IgG binding buffer, and a last 
time with 2 ml of IgG binding buffer + 0.05% sodium azide. 200 |xl of concentrated 
antibodies were finally recovered by turning the Vivaspin 2 column upside-down and 
spinning 5-15 mins at 3000g. The purified antibodies were stored at -20°C (in aliquots).
2.22. SDS-PAGE, Coomassie staining and Western blot
After dénaturation at 100°C for 5 mins, cell lysates or recombinant protein 
extracts were loaded on a 12% bis-aerylamide SDS-PAGE gel. This gel was cast and run 
according to the protocol from “Molecular cloning, a laboratory manual“ (Sambrook J. 
and Russell D.W., 2001) and using the Mini-PROTEAN ill system (Biorad). After migration 
at 200 Volts (for two gels), the gels were processed for direct visualisation of the total 
proteins (Coomassie stain) or for immunodetection (Western blot).
Coomassie staining of the gels was performed by immersion in a solution of 0.25% 
(w/v) coomassie blue, 45% ethanol, 9.2% acetic acid for 1 h at room temperature. A 
maximum of staining background was then removed by several washes with destain 
solution (30% ethanol, 5% acetic acid). Gels were then washed in water and air-dryed 
between two sheets of gelatine using a drying frame (Easy breeze, Hoefer Scientific 
instrument).
To proceed for the Western blot method, the gels were firstly incubated 10-15 
mins in transfer buffer to equilibrate (48mM Tris, 39mM Glycine, 20% ethanol). A semi­
dry transfer of the gels on PVDF membranes (previously activated in absolute ethanol, 
Perkin Elmer Life Science) was then performed with a Trans-blot SD Semi-Dry transfer 
cell (Biorad) for 30 mins at 20 volts (constant) or 10 volts for 1 gel. The membranes 
were then saturated with PBS + 0.05% Tween + 5% milk for 10-15 mins, before 
incubating, from 1 h (at room temperature) to overnight (at 4°C) with the appropriated 
antibodies.
The affinity purified rabbit antibodies against MCA and TbMCA2/3 were used at 
1:50 and 1:10,000 dilutions, respectively. Monoclonal anti-tetra HIS (Qiagen) and anti- 
TbEFIa (Upstate) antibodies were used at 1:1000 and 1:20,000, respectively. L  major 
cysteine synthase (Williams,R.A.M and Coombs, G.H., unpublished data) and L. 
mexicana transketolase (Veitch et al., 2004) specific rabbit antibodies were used at
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1:1,000. Mouse IgGZb anti-(3-tubulin (KMX-1, (Birkett et aL, 1985)) and rabbit anti- 
TbRABII (Jeffries et aL, 2001) antibodies were used at 1: 10,000.
After at least six washes of 5 mins each with PBS + 0.05% Tween + 5% milk, the 
western blot membranes were incubated with goat anti-mouse, goat anti-rabbit or 
donkey anti-sheep Horse Radish Peroxidase (HRP) conjugated antibodies at 1:2000, 
1:2000, 1:5000 respectively, for 1 h at room temperature. After washes, the western 
blots were revealed using an ECL k it (SuperSignal West Pico Chemoluminescent 
Substrate, PIERCE).
2.23. Direct fluorescence analysis
Slides were examined under UV light on a Zeiss Axioplan microscope, and images 
were processed using a Hamamatsu ORCA-ER digital camera and Open lab version 3.5 
software.
2.23.1. 4,6-Dlannidino-2-phenyUndole (DAPI) staining
1 ml of cells were centrifuged 5 mins at 250 g, washed with PBS, resuspended in 
200 pi of PBS + 10 pg DAPI (10 mg ml^ stock) and incubated 5 mins in the dark. After a 
wash in PBS, the cells were then resuspended in 20pl of PBS on spread on a Twin frosted 
76x26mm microscope slide (BDH) with a 22x64mm coverglass (BDH).
Alternatively 0.5% of 1,4-diazabicyclo[2.2.2]octane (DABCO) was added to the 
slide as anti-fading agent. The fluorescence was observed with the DAPI filter 
(A,=480nm) of the UV light microscope and pictures were taken with an exposure time of 
50 ms. Phase was observed against bright visible light and pictures were taken with an 
exposure time of 50 ms.
2.23.2. Green Fluorescent Protein (GPP)
1 ml of cells were washed in PBS and resuspended in 20 pi of PBS or PBS + 2% 
formaldehyde and prepared as described before. The GFP fluorescence was observed 
with the FITC filter (l=540nm) of the UV light microscope and pictures were taken with 
an exposure time of 300 ms.
2.23.3. FM4-64 labelling
500 pi of promastigotes were pelleted, washed with 1.5 ml of HOMEM and 
resuspended in lOOpl of HOMEM + 0.5 pi of FM4-64 (16 mM stock in dimethyl sulfoxide 
[DMSO]; Molecular Probes) and incubated 30 mins at 25°C. Cells were then washed with 
HOMEM and resuspended in 1 ml HOMEM to perform a 1h chase at 25°C. Cells were then
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washed with PBS and prepared as exposed before. The FM4-64 fluorescence was 
observed with the Rhodamine filter (^=580nm) of the UV light microscope and pictures 
were taken with an exposure time of 50 ms.
2.23.4. Lysotraker labelling
500 pi of promastigotes were pelleted, washed with 1.5 ml of HOMEM, 
resuspended in 100pl of culture medium + 1 pi of LysoTraker Red DND-99 (ImM stock in 
DMSO; Molecular Probes) and incubated 30 mins at 25°C. Cells were then washed with 
PBS and prepared as exposed before. The Lysotraker fluorescence was observed with 
the Rhodamine filter (À= 580nm) of the UV light microscope and pictures were taken 
with an exposure time of 50 ms.
2.23.5. Mitotraker labelling
1 pi of a 1 pM stock solution of Mitotraker Red CMXRos (Molecular probes, M7512, 
in DMSO) was added to 1 ml of promastigotes and incubated for 2-5 mins at 25°C. 
Alternatively, 1 pi of a 1mM stock solution of Mitotraker Green FM (Molecular probes, 
M7514, in DMSO) was used. 1pl of DAPI at 10 mg ml'  ^was added at the same time. The 
cells were then centrifuged at 1,000 g for 30 secs, washed with cold PBS and 
resuspended in 20 pi PBS or 15 pL PBS + 5 pi of 4% formaldehyde. Finally, the cells were 
mounted between slide and coverslide and sealed with nail varnish. The Mitotraker Red 
CMXRos and the Mitotraker Green FM fluorescences were observed with the Rhodamine 
filter (A,= 580 nm) or the FITC filte r (1= 540 nm) of the UV light microscope, 
respectively. Pictures were taken with an exposure time of 100 ms.
2.24. Immunofluorescence analysis (IFA)
2.24.1. Fixation
Leishmania were washed twice in PBS while T. brucei BSFs were washed in 
trypanosome dilution buffer (TDB: 20 mM NazHPO^ , 2 mM NaH2HP0 4 , 80 mM NaCl, 5 mM 
KCl, 1 mM MgS0 4 , 20 mM glucose, pH 7.4) before fixation in 200 pi of 1% 
formaldehyde/PBS for 30 mins at RT. The cells were then permeabilised by addition of 
20 pi of 1% Triton X-100/PBS for 10 mins. 20pl of 1M glycine/PBS were added to 
neutralise the free aldehyde bonds resulting from the formaldehyde fixation, in order to 
diminish any background fluorescence. The cells were incubated a further 10 mins. In 
the meanwhile, glass slides were washed with 70% ethanol before being coated with 
0.01% poly-L-lysine (0.1% stock. Sigma) for 5 mins and air dried. A small square-shaped
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border of nail varnish was drawn on the surface of the slide in order to limit the 
spreading of the cells and later of the antibody solutions. The treated cells were then 
pipetted on these poly-L-lysine-coated slides and left to sediment and adhere to the 
surface for 15-30 mins in a dark box containing PBS-soaked tissues, to prevent the cells 
from drying.
2.24.2. Immunofluorescence
The primary antibodies diluted in 0.1% Triton X-100, 0.1% BSA (TB) were added 
to the slide and incubated with the cells for at least 1 h at RT or alternatively overnight 
at 4°C. The cells were then washed with 10ml of PBS, and the maximum of the 
remaining liquid was removed by applying a tissue to a corner of the slide. The Alexa 
Fluor 488 (green) or Alexa Fluor 594 (red) - conjugated secondary antibodies (Molecular 
Probes), diluted at 1/1000 in TB, were then added to the cells and incubated in the 
dark for 1h at RT. 0.5pg ml'  ^ of DAPI (Sigma) was then added for 1 min before 
proceeding to a 10ml PBS wash. A maximum of liquid was removed, as well as the nail 
varnish frame, and a mounting solution (2.5% DABCO in 50% glycerol) was applied to the 
coverslip before its application to the slide. The fluorescence was observed with the 
“ DAPI" (A,=480nm), “ FITC" (%=540nm) or “ Rhodamine” (:l=580nm) filters of the UV light 
microscope. Cells were viewed with a Zeiss UV microscope, and images were captured 
by an Orca-ER camera (Hammamatsu) and Openlab software version 4.0.3 with 
deconvolution module (Improvision). Images were prepared for presentation using 
Adobe Photoshop CS.
2.26. VSG recycling
Bloodstream form (BSF) 7. brucei were harvested at mid-log phase and after 
three washes with ice-cold TDB (see above), the cell density was adjusted to 1x10® cells 
ml^ and the cells were incubated with 1 mM sulfo-NHS-SS-biotin (Pierce) for 10 mins on 
ice. 10 mM Tris-HCl, pH 7.5, was added to stop the reaction. After three washes with of 
ice-cold TDB, parasites were re-suspended to density of 1x10  ^ml  ^ in pre-warmed HMI-9 
and endocytosis allowed for 5 mins at 37°C. Endocytosis was stopped and sulfo-NHS-SS- 
biotin removed from the cell surface by addition of ice-cold stripping-solution (HMI-9, 
10% (v/v) FCS, 50 mM glutathione, pH 9) and a further 30 mins incubation on ice. 
Parasites were subsequently washed a further three times in ice-cold TDB before 
returning them to HMI-9 at 37°C. Samples were taken at 5 and 10 mins for analysis by 
immunofluorescence and processed as previously described. Biotin was detected using 
either a streptavidin-Texas Red conjugate (Molecular Probes) at 1:5000.
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2.26. Anti-VSG antibodies degradation
BSF parasites expressing VSG221 were harvested at mid-log phase and labelled 
with anti"VSG221 antibodies at 4°C for 30 mins in HMI-9 at a concentration of 1x10  ^
parasites ml \  Parasites were then washed three times in ice cold serum-free HMI-9 and 
incubated, in pre-warmed, serum-free HMI-9, at 37°C for 10 or 30 mins. Following this 
incubation period, samples were prepared for immunofluorescence as previously 
described. Rabbit anti-VSG IgG was detected directly using an anti-rabbit IgG-FITC 
conjugate (Molecular Probes) at 1:5000.
2.27. Prostaglandin D2 treatment
A 4 mM stock of prostaglandin 0% (P5172, Sigma, MW: 352.5 g mol^) was made by 
resuspension of 1 mg of powder in 700 pi of ethanol. 0, 2.5, 5 and 7.5 juM of PGDz were 
added to the BSF at a density of 2x10® cell ml^ and cell count were made at different 
time points.
2.28. Partial cell cycle synchronisation of L. ma/or cells
Promastigote cells at 0.5x10^ cells ml^ were partially synchronised in G1/S phase by 
treatment with 5 mM hydroxyurea (HU, MW:76.06 g mol^) for 12 hs at 25°C (Soto et a i,  
2004), Semi-synchronisation in G2/M phase could be achieved by treatment with 2.5 pM 
flavopiridol (MW: 401.84 g mol^) for 12 hs at 25X (Hassan et a i,  2001). Both solutions 
were used fresh. Cells were then released from the specific phase block by washing 
them twice in PBS and resuspending them in the same volume of pre-warmed HOMEM + 
10% FCS. Aliquots of the cells were taken at several time points to perform Western blot 
and FACS analysis.
2.29. DNA content analysis
2.29.1. Cells preparation
Mid-log phase promastigotes were spun at 250 g, 4“C for 5 mins, then washed 
with PBS, centrifuged again and finally resuspended in 1 ml of 70% methanol/PBS. Cells 
were then stored at 4°C for at least an hour or overnight. Prior to analysis, the cells 
were centrifuged at 350 g, 4“C for 5 mins, washed with 1 ml PBS once, spun , 
resuspended in 1ml of PBS with 10 pg ml^ propidium iodide (Sigma) and 10 pg ml  ^
RNAse A (Sigma), and finally incubated at 37°C for 45 mins, in the dark.
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2.29.2. Fluorescence Activated Cell Sorting (FACS) analysis
FACS analysis was performed with a Becton Dickinson FACSCalibur using the FL2- 
A (fluorescence intensity at 585/642nm, note X emission Propidium Iodine = 620 nm under 
an X excitation = 488nm (blue, Uniphase Argon Ion laser)), the Forward Scatter (FSC, 
relative cell size) and the Side Scatter detectors (SSC, cell granulometry or internal 
complexity). Introduction of the prepared samples into the cytometer was automated 
with a FACS Loader (Worklist manager and Loader manager softwares). For each 
sample, 10 000 events (cells) were analysed. Data were interpreted using the 
CellQuestPro software (BD Bioscience).
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3.1. General presentation of the cell cycle in eukaryotes
The duration of the cell cycle varies greatly from one cell type to another. The 
time during which the cell divides is termed M phase. The M phase is divided between 
the nuclear division (mitosis) and cell fission (cytokinesis). The whole of M phase covers 
only a small fraction of the total cell cycle. The period between one mitosis and the 
next is called interphase.
Interphase
G,; S:ONArapHcalioo/  Ceil grows and / canies out normal and chromosome
metabolism;
»
Figure 3.1: The successive phases of a standard eukaryotic cell cycle
From h ttp://fig.cox.miami.edu/-cmallerv/255/255mitos/cvcle.ipg
Interphase is a period during which preparations for cell division are occurring in 
a closely ordered sequence. First, the organelles start to duplicate and as a result the 
cell increases its volume (G1 phase). Then the nuclear DNA replicates (S phase). And 
finally the cell ensures that DNA replication is complete and finishes the doubling of its 
mass before mitosis, during the “safety” gap G2 (G2 phase) (figure 3.1).
Mitosis is a crucial period of the cell cycle during which the nuclear envelope 
breaks down, the content of the nucleus condense into visible chromosomes and the 
cellular microtubules reorganise to form the mitotic spindle that w ill separate the 
chromosomes (prophase and prometaphase, figure 3.2a,b) (Scholey et al., 2003). 
During progression into mitosis, the cell seems to briefly pause in metaphase, when 
duplicated chromosomes align on the mitotic spindle, halfway between the spindle 
poles (metaphase plate, figure 3.2c). The immobilised chromosomes w ill remain so 
until the metaphase-to-anaphase transition checkpoint has controlled that the cell is
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Figure 3.2: The s ix  stages o f ce ll d iv is ion
From Scholey et al., 2003.
a) Prophase. The duplicated centrosomes, each composed of two centrioles, migrate 
around the nucleus, nucleating the assembly of microtubules (MTs) and organising the 
spindle poles, b) Prometaphase. The nuclear envelope breaks down. The spindle MTs 
can now capture the chromosomes and move them to the equator (e). c) Metaphase. 
The pairs of sister chromatids (double arrowheads) face opposite spindle poles (p). MTs 
are oriented vdth their plus ends distal to the poles, and are organized into the astral 
MTs, which link spindle poles to the cell cortex; chromosomal MTs, which link 
chromosome arms to poles; kinetochore MTs, which link poles to kinetochores; and 
interpolar MTs (ipMTs), which link the two poles, d) Anaphase A. The sister chromatids 
cohesion is lost and they are moved to opposite poles. The spindle delivers message to 
the cell cortex to indicate the position and orientation of the forming contractile ring, 
e) Anaphase B. The spindle poles move further apart. The actin-myosin II contractile 
ring (inset) begins to ingress and forms the cleavage furrow, f) Telophase/cell-cell 
scission (or abscission). The nuclear envelopes reassemble around the sets of 
decondensing sisters chromatids. Meanwhile, the furrow ingression has created a barrier 
between the daughter cells and progressed until only a small bridge remained 
(midbody). This structure contains the remnants of the ipMTs, which were initially lying 
between separated chromatids. The contractile ring then disassemble and the two 
daughter cells plasma membranes are sealed and separated by a mechanism thought to 
involve vesicle transport/exocytosis (inset) (e.g. Rabll-mediated).
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ready to enter anaphase. Once this point is passed, the cell will carry on to the end of 
mitosis (anaphase and telophase, figure 3.2d, e, f) through cytokinesis and into a new 
interphase.
During cytokinesis, the cytoplasm divides by a process called cleavage. Although 
nuclear and cytoplasmic division are generally linked, they are separable events and in 
some cases like embryogenesis, nuclear division is not followed by cytokinesis. 
However, in typical cells, cytokinesis accompanies every mitosis, beginning in anaphase 
and reaching completion at the end of the telophase, when the following interphase 
starts. The cleavage is carried out by the contraction of a thin ring composed mainly of 
an interconnected array of actin and myosin filaments. This contractile ring determines 
the cleavage furrow (figure 3.2e, f). The cleavage first appears during anaphase when 
the plasma membrane starts to furrow. The furrowing invariably occurs in the plane of 
the metaphase plate, at right angle to the axis of the elongated mitotic spindle. It 
ensures the cleavage between the two groups of dividing chromatids and the 
distribution of identical copies of the genome to the two daughter cells. It is established 
that the m itotic spindle microtubules determine the position of the cleavage furrow 
within the dividing cell (Field et al., 1999; D'Avino et al., 2005).
In addition to the previously described anaphase-to-metaphase checkpoint, 
which regulates the exit from mitosis, there are at least two others cell cycle 
checkpoints, one at the transition between the G1 and S phase (G1/S), which triggers 
the DNA replication machinery, and one at the transition between the G2 and M phase 
(G2/M) activating the mitosis machinery. This system of control is represented as a 
clock that turns, triggering essential processes when it  passes specific points on the dial 
(4pm, tea time!). The processes controlling the cell cycle are mainly based on 
interactions between cyclin-dependent kinases (Cdks) and cyclins. There are two main 
classes of cyclins, the mitotic cyclins, which bind to Cdks during the G2 phase and 
mediate the entry into mitosis, and the G1 cyclins that associate with the Cdks during 
the G1 phase and are required for the entry into S phase. Cdk activation is stopped by a 
proteasome-mediated degradation of the cyclins.
The organisation of mitosis in fungi and protozoa differs significantly from that 
of animals and plants (Field et aL, 1999). Cell division in Leishmania and Trypanosoma 
harbours many features that are unique to single-celled organisms but also possesses 
particularities which are species- and stage-specific.
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3.2. State of current knowledge on the cell cycle of
trypanosomatids
As described in chapter 1 section 1.1.4., the ultrastructure of a trypanosomatid 
cell resides around a nucleus, a single mitochondrion with its kinetoplast DNA and a 
flagellum. The flagellum emerges from the flagellar pocket and is linked to the 
kinetoplast through the basal body and the microtubules/filaments of the tripartite 
attachment complex (Ogbadoyi et al., 2003). For the cell cycle to progress, these 
various organelles w ill have to be replicated with accuracy and then divided with 
precision. Trypanosomatids possess cell cycle peculiarities compared to mammalian 
cells. First, while the replication (S phase) of the nuclear and kinetoplast DNAs starts 
almost synchronously, the ir other phases of the cell cycle are separated in time. 
Second, the chromosomes do not visibly condense and the nuclear envelope remains 
intact during mitosis (Ogbadoyi et aL, 2000). Thirdly, there are no structural 
equivalents to the mammalian spindle poles bodies (centrosomes) in kinetoplastids. 
However, the centrioles of the flagellar basal bodies are directly involved in the 
partitioning of the mitochondrial genome (Robinson and Gull, 1991). In the dividing 
nucleus, chromosome segregation involves not only kinetochores, but also interpolar 
microtubules (Ersfeld and Gull, 1997; Ersfeld et aL, 1999). And finally, the extensive 
remodelling during cytokinesis that occurs in mammalian microtubular cytosketelon has 
not yet been observed. Furthermore, the mechanisms involved in the plasma membrane 
furrowing are still obscure.
Meanwhile, the chronology of the cell cycle events remains poorly characterised 
in trypanosomatids. One exception is for the procyclic form of T. brucei (Sherwin and 
Gull, 1989; Woodward and Gull, 1990).
It is well established that in these parasites progression throughout the cell cycle 
is dependent on microtubule-mediated events. Indeed, those cells possess several 
microtubule-based structures. The cytoplasmic microtubules of the sub-pellicular corset 
define the shape of the cell, while flagellar microtubules form the axoneme and 
intranuclear microtubules mediate the creation of the mitotic spindle. Microtubular 
structures are also densely packed in the area of the kinetoplast, such as in the basal 
bodies (Ogbadoyi et aL, 2003). Interfering with microtubule polymerisation/ 
depolymerisation was shown to affect basal body duplication, kinetoplast segregation, 
flagellar axoneme growth, mitosis, cell growth and cytokinesis of trypanosomes 
(Robinson and Gull, 1991; Robinson et al., 1995; Ploubidou et al., 1999). Interestingly, 
the parasite tubulin shows a different level of sensitivity to antimicrotubule agents than 
mammalian cells, indicating that it  might constitute a good drug target (Robinson and
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GuU, 1991). Through the inhibition of specific cell cycle events i t  was possible to 
establish, with a satisfactory accuracy, their order and duration during the growth of T. 
brucei procyclic forms (Woodward and Gull, 1990; Ploubidou et al., 1999; McKean, 
2003). While the sub-pellicular microtubules are constantly dynamic along the duration 
of the complete procyclic form cell cycle (8.5 hours), the maturation and duplication of 
the basal bodies are some of the first events taking place. These processes are tightly 
linked with the generation and growth of a daughter flagellum (figure 3.3a). 
Meanwhile, the nuclear and kinetoplast DNAs enter their respective S phases and 
duplicate their genomic content. The segregation of the kinetoplast, driven mainly by 
the separation of the basal bodies, then starts and achieves completion before the 
triggering of nuclear mitosis. The generated daughter nucleus subsequently migrates 
between the two kinetoplasts. Cytokinesis finally starts at the anterior end of the cell 
and the helical progression of the cleavage furrow along the cell body determines 
accurate organelle partitioning and ultimately leads to cell scission.
In mammalian cells, the cleavage furrow is formed by the contraction of an 
actin/myosin-based ring. Also, it  has been shown that the cytoskeleton of those cells is 
complexly composed of intertwined arrays of microtubules, actin and intermediate 
filaments. The cross-talk between these various networks mediates essential cellular 
processes such as vesicle and organelle transport, cell division and signal transduction 
(Goode et al., 2000; Rodriguez et al., 2003; Chang and Goldman, 2004). In 
trypanosomes, while the existence of intermediate filaments remains obscure, little is 
known about the cellular functions of actin filaments. Apparently, in procyclic forms, 
actin is distributed throughout the cell (Garcia-Salcedo et al., 2004). Interestingly, 
silencing of this protein by RNA interference, while slightly modifying the morphology of 
the cell body, nucleus and kinetoplast, did not affect cell growth and division. Also it 
was suggested that, in the in v/fro-cultured insect stages, actin might either play non- 
essential functions or could be compensated for by others proteins. Surprisingly, actin 
was found to be essential for bloodstream form growth and via its association with the 
endocytic pathway, for vesicular traffic from the flagellar pocket. Thus, although the 
potential involvement of actin in cleavage furrow formation remains elusive, these data 
indicates that actin likely possesses stage-specific roles.
Other proteins, while present in both bloodstream and procyclic forms, were 
found to harbour discrete functions. Indeed, studies of cyclin- dependent kinases and 
their cyclin partners revealed differences, between the different life stages, in many 
aspects of cell cycle control (Hammarton et aL, 2003). As exemplified with the RNAi of 
the cyclin CYC6, which in procyclic forms inhibited mitosis but not cytokinesis when 
blocking both processes in bloodstream forms, the mechanisms behind cell division and 
its control present many stage-specific features.
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Figure 3.3: Representation of the major morphological events of the T. 
brucei cell cycle
Adapted from McKean, 2003 and based on the data in Woodward and Gull, 1990. 
a) Chronology of the nuclear and kinetoplast phases of the procyclics cell cycle. The 
microtubules-mediated events are indicated below. Even if  the nuclear and kinetoplast 
S phases (SN and SK, respectively) are overlapping, the SN is longer than the SK. The 
division of the kinetoplast (D) is completed before the start of the segregation of the 
duplicated nucleus (mitosis, M). The basal bodies continue to move apart even once the 
kinetoplast division is terminated (apportioning. A). Cytokinesis starts upon completion 
of the mitosis, b-c) Schematic representations of the morphological events leading to 
cell division in procyclic (b) and bloodstream (c) forms. N: nucleus, K: kinetoplast, F: 
flagellum. The black arrow points the direction and position of the cleavage furrow.
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Although less is known about the chronology of the events leading to cell division 
in bloodstream forms, the cell shape and growth rate differences between the two life 
stages of the parasite indicate that the basic biology of the cell cycle might have 
variations. And indeed, whereas the bloodstream forms possess a short and thick cell 
body, the insect stages have an elongated shape. It is estimated that the PCF and BSF 
complete their cell cycles within around 13 and 8.5 hours, respectively. One other 
major peculiarity was observed after mitosis, when the parent and daughter nuclei of 
the bloodstream form cell remain juxtaposed while, in procyclics, the latter migrates 
between the two kinetoplasts (figure 3.3b, c). Also, in G1 phase, the bloodstream form 
kinetoplast is closely associated with the nucleus, while in the insect stage it  is 
positioned approximately midway between the posterior part of the cell and its nucleus 
(Robinson et al., 1995). However, both stages share many cell cycle features, with the 
division of the kinetoplast occurring before nuclear segregation. While the Leishmania 
cell cycle remains even more obscure, it  seems that, in this trypanosomatid, mitosis 
happens before the kinetoplast separation (Milligan, 1996; Havens et al., 2000). But 
apparently, some species of Leishmania (e.g. L. tarentolae) undergoes these two 
processes in reverse order (Simpson, 1968). Like in trypanosomes, microtubule- 
mediated events plays major roles in cell cycle progression (Jayanarayan and Dey, 2002; 
Borges et at., 2005; Jayanarayan and Dey, 2005). Indeed, treatment with anti­
microtubule agents of in vitro-cultivated Leishmania promastigotes resulted in the 
inhibition of nuclear mitosis and cytokinesis and a disturbance of the accurate 
positioning of the kinetoplast within the cell (Havens et al., 2000).
So far, there has been no published report of descriptive or quantitative analyses 
of the morphological events associated with Leishmania cell cycle progression. Thus, I 
attempted to generate a chronological map of the processes during the promastigote 
cell cycle by using microscopic observations and immunofluorescent labelling.
3.3. Chronological events leading to L. /nayor division
A major requirement for the analysis of the L. major cell cycle was the ability to 
follow the dynamics of the kinetoplast and nucleus. As the flagellum is tightly 
associated with the kinetoplast DNA through a microtubular structure comprising the 
basal bodies, the presence and length of the newly synthesized flagellum is an 
indicative parameter for progression of kinetoplast segregation (Robinson et at., 1995). 
Simultaneously, anti-p-tubulin immunofluorescence coupled to DAPI staining was used 
to visualise the appearance and further elongation of the intranuclear mitotic spindle 
and monitor the progression of nuclear mitosis (Ogbadoyi et at., 2000). These two 
morphological markers were theoretically enough to position the cell precisely within its
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division cycle. However, another antibody raised against T. brucei RAB11, a 
characterised constituent of recycling endosomes in this parasite {Jeffries et a i,  2001), 
has unexpectedly showed its utility in the visualisation of kinetoplast segregation in L  
major.
In interphase promastigotes, the anti-p-tubulin antibody mainly labelled the sub- 
pellicular microtubules (figure 3.4A). However, the fluorescent staining rapidly evolved 
during cell cycle progression, indicating the highly dynamic nature of this cytoskeletal 
structure. Cells with a wider nucleus and cell body and probably in S phase had only the 
microtubules of their posterior end labelled (figure 3.48). However, for a more precise 
assignment of these cells to the S phase of the cell cycle, a more comprehensive study 
based, for example, on 5-bromo-2-deoxyuridine (BrdU) incorporation is needed 
(Woodward and Gull, 1990). At the onset of mitosis, a bright fluorescent p-tubulin signal 
accumulated at the centre of the nucleus, in a rhomboid structure excluded from the 
DAPI staining (figure 3.4C, D). This structure became bigger with time, until the parent 
and daughter genomic contents started to migrate apart and the structure elongated 
(figure 3.4E, F). A characteristic mitotic spindle was then observed. Interestingly, this 
structure was able to form along either the longitudinal or lateral axis of the dividing 
nucleus (thus being respectively perpendicular (figure 3.4E) or parallel (figure 3.4F) to 
the kinetoplast). The orientation of the mitotic spindle would later define the 
orientation of the dividing nucleus vrithin the cell. After completion of mitosis, the 
fluorescent signal progressively returned to the sub-pellicular microtubules. At that 
stage, the divided nuclei were positioned laterally within the cell, thus ensuring their 
distribution on both sides of the division plane and their accurate allocation to the 
parent and daughter cells. In one particular instance, p-tubulin was also found to occur 
in a structure that resembled the mammalian contractile ring (figure 3.4G cr). Later 
during cytokinesis, the p-tubulin fluorescent signal became brighter in the proximity of 
the cleavage furrow and especially during cell-cell scission (figure 3.4H cr).
in T. brucei, RAB11 is present on endosomes involved principally in recycling 
processes (Jeffries et aL, 2001; Hall et al., 2005). Within the L. major genome, a gene 
(LmjF10.0910) encoding a putative RAB11 protein, with a predicted molecular mass of 
23.4 kDa, was identified. Because of it  has 78% sequence identity with its T. brucei 
orthologue (TbRABII), the expression of RAB11 in L. major promastigotes was assessed 
by Western blot using an anti-TbRABII antibody (figure 3.5). A protein with a size close 
to the predicted molecular mass for LmajRABU was detected (figure 3.5 red arrow 
head). An additional protein of about 27 kDa, however, was also revealed (figure 3.5 
black arrow head). Interestingly, in T. cruzi insect forms, an antibody raised against 
TcRABU recognised a protein of 26kDa rather than the predicted 24 kDa protein
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Figure 3.4: 
cell cycle
Immunofluorescence analysis of p-tubulin location during the
Fixed cells were labelled with mouse anti- p-tubulin (KMX, (Basse and Gull, 1988)) and 
Alexa 488-conjugated anti-mouse antibodies (green). The nuclear and kinetoplast DNA 
was stained with DAPI (blue). Left: merge pictures of the p-tubulin labelling and DAPI 
staining. Right: Corresponding DIG pictures. The white arrow heads indicate the 
microtubules of the mitotic spindle, cr: contractile ring. Representative pictures are 
shown except in G, where a single cell out of the 130 examined had such a developed 
ring-like labelling. Scale bar = 10 pm.
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Figure 3.5: RAB11 expression in L. mayor promastigotes
The equivalent of 10^  promastigotes were loaded per lane of a 12% (w/v) SDS-PAGE gel 
before electrophoresis and transfer to a PVDF membrane. The blot was then hybridised 
with anti-TbRABII at a 1:10,000 dilution in PBS + 0.05% Tween + 5% milk and then 
revealed with HRP-conjugated anti-rabbit antibodies (1:2,000) and an ECL kit. The 
expected size protein is shown by a red arrow head. The black arrow head indicates an 
additional protein of unknown identity.
(Mauricio de Mendonca et aL, 2000). The authors then hypothesised that this larger 
protein might represent a geranylgeranyl modified TcRABII as this post-translational 
modification is required for membrane anchoring of RAB proteins (Calero et al., 2003; 
Leung et al., 2006). The prediction software PrePS (Prénylation prediction site, 
http://mendel.imp.ac.at/sat/PrePS, (Maurer-Stroh and Eisenhaber, 2005)) revealed 
that LmajRAB11 potentially possess a geranylgeranylation site in its C-terminus. The 27 
kDa protein, therefore might result from geranylgeranyl modification of LmajRABU and 
its association with lipids. Although less likely, it  can not yet be excluded that this 
cross-reacting protein might possess a different identity. Despite this observation, 
immunofluorescence experiments were performed in L. major promastigotes using the 
anti-TbRABII antibody.
In interphase cells the antibody labelled a compartment composed mainly of a 
structure at the base of the flagellum but also of a two pronged forked structure, 
positioned between the first structure and the kinetoplast and coming in close proximity 
to the mitochondrial membrane (figure 3.6Aa, B1). This observation was most 
surprising as none of the endosomal compartments characterised so far in 
trypanosomatids have a similar shape. However, co-localisation with concanavalin A (at 
4°C) showed that the main structure of the RAB11-positive compartment was actually 
corresponding to the flagellar pocket while the two pronged forked structure was 
coming from it, thus confirming that this compartment belonged to the endosomal 
system (Besteiro, S, unpublished data). This RAB11-positive compartment was closely
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Figure 3.6: Analysis of Rab11 localisation during the kinetoplast division
A) Schematic of the various signals observed using anti-RAB 11 antibodies. The letters 
also refer to figure 3.8 and indicate cells with 1 NIKI F or 1N*1K*1F (a, a’ , b, c, d), 
1N*1K*2F (e, e’ ), 1N*'*1K*2F (f, f ,  g, g’ , h, h’ , i, j, k), 1N***2K2F (I, m), 2F2K2F (I’ , m’ , 
n, n’ ) or 2N1K*2F (I” , m” ). B) Immunofluorescence pictures illustrating the 
observations presented in A. Rabbit anti-TbRABII (Jeffries et al., 2001) and Alexa 488- 
con jugated anti-rabbit (green) antibodies were used to label the fixed cells. Nucleus
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and kinetoplast are shown in blue (DAPI staining). The insets pictures are 2x 
enlargement of the kinetoplast area. Scale bar = 10 p,m.
associated with the kinetoplast and its morphology evolved with the kinetoplast division 
cycle. During the early events of the cell cycle the RAB11-positive compartment had a 
two-pronged fork-like form in the majority of the cells (figure 3.6Aa, B1). 
Nevertheless, for a small proportion of the cells, the compartment was modified and it  
possessed only one fork (figure 3.6Aa’ , B2). It was noted that this particular 
morphology was more abundant in cells blocked in S-phase (data not shown). As the 
parasites moved through the cell cycle the shape of the RAB11-positive compartment 
evolved. Firstly, at the base of the flagellum, a small additional structure appeared 
next to the existing one, suggesting the creation of the daughter flagellar pocket 
(figure 3.6Ad-e’ , B3, B4). Next, the two-pronged forked structure progressively 
extended from the newly synthesized flagellar pocket. Meanwhile, the duplicated 
kinetoplast had apparently slightly rotated on its axis, as if  to make some space for the 
synthesis of the new RAB11-positive structure (figure 3.6Ae’, B4). In addition, the 
existing RAB11-positive compartment had shifted its position so that instead of being 
closely associated with the two sides of the kinetoplast, one of its prongs was now 
placed midway along the longitudinal axis of the mitochondrial DNA. The elongation of 
the newly synthesized fork structure was found to be concomitant with the daughter 
flagellum outgrowth. Ultimately, both the old and new compartments appeared to 
associate with the same elongated kinetoplast (figure 3.6Af-k, B5). From that point, it  
seemed that the extension of the daughter flagellum was driving the segregation of the 
kinetoplast (figure 3,6Al-n*, B6).
The division of the kinetoplast finished when the parent and daughter flagella 
had reached similar lengths. Ingression of the cleavage furrow and subsequent 
cytokinesis was then triggered. In most cases, the completion of kinetoplast division was 
achieved before the end of mitosis, as shown by the continued presence of the mitotic 
spindle (figures 3.71, 3.81). In that configuration, the subsequently formed cleavage 
furrow would progress from the anterior part of the cell, between the duplicated 
flagellar pockets, toward the posterior end (figures 3.7n, 3.8n). However, in some 
cells, the timing of kinetoplast segregation and nuclear separation was either reverted 
or almost synchronous. These alternative sequences of events could account for the 
presence of cells in which cleavage furrow ingression was occurring at the posterior end 
or at both extremities.
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Figure 3.7: Observation by Immunofluorescence of the events leading to cell 
division In L. major promastigotes
Nuclear and kinetoplast DNA of the fixed cells were stained with DAPI (blue). The 
microtubular events associated with nuclear division and shape remodelling were 
visualised with anti-p-tubulin and Alexa 488-conjugated anti-mouse (green) antibodies. 
Events associated with kinetoplast segregation and daughter flagellum growth were 
visualised with anti-RAB 11 and Alexa 548-con jugated anti-rabbit (red) antibodies. These 
three labellings are merged in the pictures on the right. The letter code refers to the 
nomenclature in figure 3.8. On the left, the DIG image of the corresponding cell is 
shown. The black arrow heads indicate the growing daughter flagellum. For each cell, 
the number of nuclei (N), kinetoplasts (K) and flagella (F) are shown. The presence of 
an asterisk after N or K indicates that the DNA of this organelle is duplicated. The white 
arrow heads indicate a disassembling mitotic spindle. A structure similar to the 
contractile ring is arrowed with “ cr” . Scale bar = 10 |im.
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Thus, using these two morphological markers, I was able to establish a list for 
the successive processes leading to cell division in L. major promastigotes (see figure 
3.7. for additional illustrations). I subsequently used the created data to quantify the 
proportion of cells harbouring such morphological configurations. Figure 3,8 
summarises these findings. Cells with one nucleus, one kinetoplast and one flagellum 
(1N1K1F) were grouped with those that had duplicated their DNA content (1N*1K*1F) as 
this study could not accurately discriminate them. However, the presence of a daughter 
flagellum was indicative that DNA replication had occurred and thus, the 1N*1K*2F cells 
were pooled separately. About two thirds of the cells with one nucleus, one kinetoplast 
and two flagella had a m itotic spindle, indicating ongoing mitosis. These cells were 
identified as 1N*'^1K*2F. Cells where the kinetoplast segregated before (1N*^2K2F) or 
after (2N1K*2F) completion of mitosis are also represented. Note that most of the 
2N2K2K cells were undergoing cytokinesis. Therefore, termination of organelle division 
seems to trigger the start of cell partitioning. The cleavage furrow formed at the 
anterior end (2.30%) but was also found to be present at the posterior part of the cell 
(1.54%) or at both ends (0.77%). Finally, I classified as “ others” the configurations 
observed in less than 0.5% of the total cells (mostly these were clumps of dividing cells 
like those shown in figure 3.7).
3.4. Discussion
It has previously been reported that, in their insect vector Lutzomyia 
lonsipalpis, L. mexicana and L. infantum are mainly present under seven 
morphologically distinct promastigote forms (Rogers et al., 2002; Gossage et a i,  2003). 
Of these, only two cell types, the procyclic promastigotes and the leptomonad 
promastigotes (during the sandfly bloodmeal and sugar meal phases, respectively) are 
able to replicate (Gossage et al., 2003). Their multiple differentiation steps w ill 
ultimately lead the cells to the non-replicative infectious form of the parasite, the 
metacyclic promastigote. In L. mexicana, both procyclic and leptomonad promastigotes 
possess a body length of about 6.5-11.5 pm but for the procyclics the flagellum length is 
shorter than the cell body while the leptomonads have a longer flagellum (Rogers et aL, 
2002). When lesion amastigotes were used to initiate an in vitro culture of L. mexicana 
or L. infantum promastigotes, the differentiation processes and the sequential 
appearance of the various promastigote forms followed the same order as in the sandfly 
host. In freshly differentiated cultures, dividing procyclic and leptomomad 
promastigotes, defined by their possession of two nuclei and/or kinetoplasts, were 
found to respectively represent 56.5% and 12.0% of the L. mexicana promastigotes or 
9.9% and 4.8% of the L. infantum promastigotes (Gossage et aL, 2003). These
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Figure 3.8: Schematic representation of the configurations observed through 
the L. major promastigote cell cycle and their relative abundance
130 cells were counted for this analysis. For each cell, the number of nuclei (N), 
kinetoplasts (K) and flagella (F) were scored. Cells with similar configuration were then
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grouped (colour codes). The percentage of each of these populations over the total cell 
number are showed. The asterisk after the N or K indicates that the replication of the 
DNA of the specified organelle has occurred. Cells classified in “others” possess unique 
configurations. On the right, the chronology of the cell cycle phases of the nucleus, 
kinetoplast and the associated morphological events are shown. Please note that this 
time frame is not to scale.
differences were attributed to the observation that fresh in vitro cultures of L. 
mexicana cells were growing at faster rates than those of L. infantum. However, it  was 
noted that, for both Leishmania species, the synchronicity and timing of the appearance 
of the different forms of promastigotes was lost after several sub-passages in culture 
(Gossage et al., 2003). Thus, in vitro, it  is commonly accepted that cells in their 
logarithmic phase of growth are principally procyclic promastigotes while non- 
replicative cells in the ir stationary phase are metacyclic promastigotes.
The cell cycle studies presented here were performed on cultures of L. major 
promastigotes at low number of sub-passages. Promastigotes in the ir early logarithmic 
phase of growth (0.3x10^ cells ml )^ were observed but no distinction was made between 
the possible different forms of the parasites. Indeed, while the morphological 
characteristics of the various types of L. major promastigote remain unclear, they are 
anyway most likely to be modified during progression within the cell cycle. When using 
the same classification as Gossage et al., the percentage of dividing cells within culture 
of L. major promastigotes was found to be of 15.38% (part of 1N*^1K*2F, 1N*^2K2F, 
2N1K*2F and 2N2K2F). In a report characterising the effect of anti-tubulin inhibitors on 
L. donovani, it  was roughly estimated that, under normal growth conditions, about 10 to 
20% of the wild type cells were in dividing process (Havens et al., 2000). However, it  is 
difficult to directly compare the different sets of data, as the experiments were either 
performed in different conditions and/or on different Leishmania species. The study 
presented here represents one of the first descriptions of the cell cycle in L. major 
promastigotes. Many interesting observations were made, but the collected data need 
to be strengthened by the analysis of a larger number of cells. For their determination 
of the timing of the nuclear and kinetoplast phases of the cell cycle, Woodward and 
Gull analysed between 1,000 and 2,000 T. brucei cells (Woodward and Gull, 1990).
As discussed previously, differences in the chronology of cell cycle events were 
observed not only between different Leishmania species but also among different life 
stages of the parasite. The data accumulated in this study suggest that differing 
patterns of division could occur within the same population of promastigote cells. 
Indeed, it  was first observed that during the nuclear mitosis, the m itotic spindle was 
able to form either longitudinally or laterally within the cell (figures 3.4 and 3.8). This 
tightly packed array of interpolar and kinetochore microtubules is involved in the
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segregation of the 36 chromosomes of the L. major genome (ranging in size from 0.28 to 
2.8 Mb) (Wincker et al., 1996; Ivens et al., 2005). Unlike in mammalian cells, in 
Leishmania, the number of kinetochore structures (only six) does not match the number 
of chromosomes (Urena, 1986; Urena, 1988). Therefore, it  was speculated that, like in 
T. brucei, the interpolar microtubules of the mitotic spindle could participate to the 
division of the smaller chromosome pairs (Gull et al., 1998). The ultrastructure of the 
dividing nucleus has been studied in detail in T. brucei. In addition to electron 
microscopy, the structure of the m itotic spindle was observed by immunofluorescence 
using the KMX anti-p-tubulin antibodies (Ogbadoyi et al., 2000). As observed in the 
present study, the mitotic spindle was found to form within the intact nucleus. There it 
elongates between the opposing ends of the nucleus, being anchored at the intranuclear 
spindle poles. Meanwhile, the nuclear membrane contracts at the centre of the nucleus, 
until the constriction zone extends along the central spindle. At this point, it  is 
difficult, without the labelling of the m itotic spindle to distinguish between dividing and 
divided nuclei. The ingression of the nuclear envelope constriction ultimately results in 
the completion of karyokinesis. Also, the present study revealed that while at the 
mitosis onset the majority of the Leishmania cells had a longitudinal mitotic spindle, 
after mitosis completion most of the parent and daughter nuclei were arranged laterally 
within the dividing cell. Therefore, it  seems likely that this latter orientation results 
from the rotation of the two nuclei. Interestingly, this 90° clock or anti-clockwise 
movement is apparently happening during mitosis, as most of the rotating nuclei 
possessed a mitotic spindle (figures 3.4E and 3,7i). Also, it  is interesting to note that 
radical body shape changes are timely associated with nuclear mitosis. Thus, these 
morphological modifications might be attributed to the spatial re-organisation necessary 
for nuclei re positioning.
Meanwhile, most of the cells had completed the segregation of their duplicated 
kinetoplast. This finding contradicts previous observations indicating that the division of 
the kinetoplast was mainly occurring after the partitioning of the daughter and parent 
nuclei (Milligan, 1996; Havens et a i,  2000). Also, as these studies were performed on L. 
mexicana and L. donovani, it  is possible that the order in which kinetoplast division and 
mitosis happen varies between different species, as previously suggested. However, 
these older studies were based on observations of DAPI staining, so it  is possible that an 
elongated nucleus that had not completed the division process was considered as 
divided nuclei. This bias would therefore suggest that kinetoplast division occurs after 
mitosis. Thus methods like the one presently used, allowing the visualisation of the 
mitotic spindle, can more accurately indicate whether mitosis has or not reached 
completion. Indeed, while in most mammalian cells remnants of the m itotic spindle are 
still present after completion of karyokinesis (Scholey et a i,  2003) (figure 3.2f), in T.
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brucei (Ogbadoyi et a i,  2000) but also here in L  major (figure 3.7 I” ), the disassembly 
of the mitotic spindle seems to be concomitant with the end of nuclear division. 
Furthermore, the observation that cytokinesis was mainly starting at the anterior part 
of the cell, between the two flagella, and was following a longitudinal axis toward the 
posterior end of the cell, fits with the kinetoplast segregation occurring before the end 
of mitosis. Therefore, apparently, the succession of events leading to the division of 
Leishmania kinetoplast and nucleus resemble the one observed in T. brucei cells.
A major difference, however, was observed during cytokinesis. While in T. 
brucei, the cleavage furrow has to progress in a helical fashion to adapt to the presence 
of the attached flagella, in Leishmania, its ingression follows a longitudinal axis. 
Interestingly, i t  was observed that a structure closely similar to the mammalian 
contractile ring was visualised with the anti-p-tubulin antibodies (figures 3.4G and 
3.7n). So far there are no published reports of the detection of a contractile ring in 
trypanosomatids. In most eukaryotes, this structure is composed of an array of actin and 
myosin II filaments (Field et a i,  1999). However, RNAi studies performed in T. brucei 
failed to establish the necessity of actin for the creation of a contractile ring and 
cytokinesis progression (Garcia-Salcedo et al,, 2004). Thus, it  is possible that 
kinetoplastids possess a contractile ring with an unusual composition. In bacteria as well 
as in many eukaryotic organelles (e.g. mitochondrion), a tubulin-like protein, FtsZ, is 
the main constituent of a ring-like structure, the Z ring, which mediate cytokinesis or 
organellokinesis through its contraction (Errington et a i,  2003).The trypanosomatids p- 
tubulin might have retained some of the properties of this ancestral tubulin and might 
share a role in cytokinesis (de Pereda et al., 1996; Addinall and Holland, 2002). 
Furthermore the fact that the m itotic spindle and contractile ring are both composed of 
p-tubulin could explain why both mitosis and cytokinesis are blocked by tubulin 
inhibitors (Havens et al., 2000).
Apart from the detection of p-tubulin in a ring-like structure potentially involved 
in L. major cytokinesis, another intriguing finding was the localisation of RAB11 within 
this parasite. Although RAB11 apparently remains associated with the endosomal system 
like in other organisms, the shape of the RAB11-positive compartment in Leishmania is 
most peculiar. Anchored at the flagellar pocket, this compartment then ramifies toward 
the mitochondrion membrane and the kinetoplast. The observed two pronged forked 
structure might result from the spatial hindrance caused by the tripartite attachment 
complex (TAG). Characterised in T. brucei but not yet in L. major, this complex, 
composed of series of filaments, connects the kinetoplast DMA network to the 
mitochondrial membrane and the basal body from which originates the flagellum 
(Ogbadoyi et a i,  2003). The TAC constitutes a mechanical link by which kinetoplast 
segregation is associated to the division of the basal body and the flagellum. Tightly
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anchored at the base of the flagellum, the flagellar pocket follows a division cycle that 
is intimately correlated to the one of the flagellum. The formation of the daughter 
flagellar pocket starts with the appearance of the daughter flagellum and its 
development is linked to the growth of the new flagellum. Also the presence of RAB11 
at the site of the flagellar pocket allowed us to follow the development and positioning 
of this organelle in relation to kinetoplast division and flagellum extension. However the 
reason why the RAB11-positive compartment adopts such a two pronged forked 
structure remain obscure and its function in the cell remain uncertain. In mammalian 
cells, RAB11-positive recycling endosomes were recently characterised for their role in 
membrane trafficking during cytokinesis (Wilson et al., 2005; Matheson et al., 2005; 
Fielding et al., 2005). Also, because of the close association of the RAB11-positive 
compartment with the Leishmania mitochondrion, and because this organelle needs to 
acquire new membranes before its division to allow its equal partitioning between 
parent and daughter cells, then we might wonder whether the RAB11-positive 
compartment might promote membrane trafficking between the flagellar pocket and 
the mitochondrion. Nevertheless, such a process has never been characterised and 
membrane vesicles are classically derived from the endoplasmic reticulum and the Golgi 
apparatus. In mammalian cells, traffic of lipids to the mitochondrion involves ER-like 
mitochondrion-associated membranes (MAMs) (Vance and Shiao, 1996). But the 
existence of such membranes in Leishmania remains unknown. Therefore the 
mechanisms by which the mitochondrion acquires the new membrane required for 
division are, in Leishmania, largely uncharacterised and an involvement of the RAB11- 
positive compartment can not be excluded. Furthermore, during mammalian 
cytokinesis, the RAB11-positive recycling endosomes uses motor proteins to move along 
microtubules to the site of the cleavage furrow (Fielding et aL, 2005), also we might 
wonder whether in Leishmania, the RAB11-positive compartment could interact with 
some of the TAG filaments to mediate exchanges between the flagellar pocket and the 
mitochondrion. This would explain the shape adopted by this compartment and its 
structural modulation during kinetoplast division. However, the immunofluorescence 
data suggest that this compartment is more likely a continuous and defined structure 
rather than an association of multiple vesicles moving along a filament. In T. cruzi 
insect forms (epimastigotes), RAB11 is present in a pre-lysosomal compartment 
composed of multiple organelles termed reservosomes (Mauricio de Mendonca et al., 
2000). In addition to the flagellar pocket, T. cruzi possess an additional site involved in 
nutrient endocytosis, the cytostome, which is connected to a vesicular-tubular network 
of early endosomes (the cytopharynx) that ultimately deliver their content to the 
reservosomes for storage. In Crithidia fasciculata, the cytostome appears to be 
connected to the flagellar pocket and not directly to the external medium like in T.
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cruzi (Brooker, 1971; Clayton et al., 1995). Although Leishmania appears to a lack 
cytostome, cytopharynx or reservosomes, it  cannot be excluded that in this organism 
RAB11 might be present in a yet uncharacterised type of structure connecting the 
flagellar pocket to the lysosomal compartment. Thus, further ultrastructural analyses 
need to be performed, by electron microscopy, to answer this point and most 
importantly to clearly identify the nature of this RAB11-positive compartment in 
Leishmania and its intriguing function in the cell.
101
Chapter 4:
Structural and biochemical properties of 
trypanosomatid metacaspases
Chapter 4: Properties of the trypanosomatid metacaspases 102
4.1. Presentation of the trypanosomatid metacaspases
Little is known about metacaspases in trypanosomatids. Five metacaspase genes 
have been identified in the Trypanosoma brucei genome, encoding for proteins (TbMCAl 
to TbMCAS) that have different features and levels of sequence identity (table 4.1). 
Interestingly, although the meaning of this observation remains obscure. Trypanosoma 
cruzi and Leishmania, which spend part of their life cycle as intracellular forms, in the 
mammalian host, possess fewer metacaspases. It was recently reported that T. cruzi 
possesses only two metacaspases. These proteins, TcMCA3 and TcMCAS, were named 
after the T. brucei metacaspases with which they share closest sequence identity 
(Kosec et aL, 2006). The parasites responsible for cutanous (L major) and visceral (L 
infantum) leishmaniasis were both found to contain a single metacaspase gene, which 
were named LmajMCA and LinfMCA, respectively.
TbMCA2 TbMCAS TbMCA4 TbMCA5 LmajMCA LinfMCA TcMCAS TcMCAS
TbMCAl 40.8 42.4 41.9 26.2 26.2 25.5 42.1 28.8
TbMCA2 88.2 48.4 32.0 36.0 34.5 58.9 36.0
TbMCAS 48.5 30.5 33.5 32.3 61.5 34.6
TbMCA4 26.6 28.6 27.7 46.4 30.4
TbMCA5 48.1 49.7 31.0 55.8
LmajMCA 93.5 33.1 54.4
LinfMCA 32.3 53.8
TcMCAS 36.1
Table 4.1: Percentage of Identity between Trypanosoma brucei, Leishmania 
major, L. infantum and T. cruzi metacaspase proteins.
These two metacaspases share about 94% identity at the amino acids level (table 
4.1) and are both most closely related to TbMCAS (48.1% and 49.7%, respectively) and 
TcMCAS (54.4% and 53.8%). Large scale comparative genomics recently performed with 
trypanosomatids showed that T. brucei, T. cruzi and L. major exhibit a striking 
conservation of gene order (termed synteny) (Ghedin et al., 2004). Indeed, comparison 
of the LmajMCA, TbMCAS and TcMCAS loci revealed that these genes are syntenic 
orthologues.
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Furthermore, these three metacaspases share a structural peculiarity, compared 
to the other trypanosomatids metacaspases, in the form of a proline-, glutamine- and 
tyrosine-rich C-terminal extension. While divergent between the metacaspases, 
repetitive motives have been identified in these regions (figure 4.3, light blue 
underlined letters). The presence of homologous repetitive modules in other proteins 
(wheat gliadin, human rhodopsin) suggests that these domains might fu lfil specialised 
roles within the cells.
Further analysis of the properties of the metacaspases was performed by 
reconstruction of the phylogenetic relationships between the trypanosomatid 
metacaspases and those of other representative organisms (figure 4.1 ). The full lengths 
of the selected proteins were used for this analysis. The reconstructed tree shows that 
the metacaspases from T. brucei, T. cruzi and L  major cluster together, well separated 
from the other metacaspases. However, it  has to be noted that the trypanosomatid 
metacaspases seem more similar to the type I metacaspase group. As expected, the 
syntenic orthologues of LmajMCA, TbMCAS and TcMCAS form a distinct clade. 
Interestingly, examination of the genomes of the yeasts Saccharomyces cerevisiae and 
Schizosaccharomyces pombe and the filamentous fungus Aspergillus nidulans, revealed 
the presence of a single metacaspase with closer sequence identity to MCA5 than any 
other trypanosomatid metacaspases, suggesting that MCA5 might represent the basal 
metacaspase gene.
4,2. Focus on TbMCAl and TbMCA4
Two (TbMCAl and TbMCA4) of the five T. brucei metacaspases have substitutions 
in their predicted active site residues. Indeed, while the active site of most 
metacaspases has a pair of histidine and cysteine residues, TbMCAl possesses a tyrosine 
residue instead of the conserved predicted catalytic histidine and, like in TbMCA4, the 
predicted active site cysteine is replaced by a serine residue (figure 4.2, red arrow 
heads). Phylogenetic analysis revealed that TbMCAl and TbMCA4 proteins are clearly 
separated from the other metacaspases (figure 4.1). Indeed, the branch that leads to 
these atypical proteins departed from the apparently ancestral MCA before the split 
that gave rise to the other trypanosomatids metacaspases, thus suggesting that TbMCAl 
and TbMCA4 have evolved independently. Also, as the histidine-cysteine dyad is 
predicted to be essential for clan CD cysteine peptidase activity, then TbMCAl and 
TbMCA4 potentially lack cysteine peptidase activity (Mottram et al., 2003).
Indeed, due to the replacement of putative active site histidine by a tyrosine 
residue, which lacks the imidazolium group essential for the stabilisation of the thiolate 
ion involved in the nucleophilic attack of the peptide bond, it  is highly unlikely that
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Figure 4.1: Phylogenetic analysis of selected metacaspases from
trypanosomatids, plants, fungi and apicomplexan parasites.
Metacaspases in the tree are from Arabidopsis thaliana (At), Aspergillus nidulans (An), 
Leishmania major (Lmaj), Lycopersicon esculentum (Le), Plasmodium berghei (Pb), P. 
falciparum (Pf), Saccharomyces cereviciae (Sc), Schizosaccha-romyces pombe (Sp), 
Theileria annulata (Ta), Trypanosoma brucei (Tb) and Trypanosoma cruzi (Tc). 
Bootstrap values from 10,000 pseudorepUcates are shown on the nodes. The scale bar 
represents a distance of 0.2 substitutions per site. AnMCA (AA013381.1), AtMCAl 
(AAP84706.1), AtMCA2 (AAP84707.1 ), AtMCA3 (AAP84708.1 ), AtMCA4 (AAP84709.1 ), 
AtMCAS (AAP84713.1), AtMCA6 (AAP84714.1), AtMCA7 (AAP84710.2), AtMCA8 
(AAP84711.1), AtMCA9 (AAP84712.1), LmajMCA (AAZ14381, LmjF35.1580), LeMCA 
(AY114141), PbMCAl (CAD88480.1, PB001074.02.0), PbMCA2 (CAD88481.1,
PB000485.03.2), PfMCA (ABC84559, PF13_0289), PfMCA-like (PF14_0363) SpMCA 
(AAG38593.1), ScMCA (NP_014840), TbMCAl (CAD24802.1, Tbi 1.02.0730 ), TbMCA2 
(CAD24803.1, Tb927.6.940), TbMCA3 (CAD24804.1, Tb927.6.930), TbMCA4 (CAD24805.1,
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Tb10.70.5250), TbMCAS (CADSS946, Tb09.211,4760), TcMCAS (e.g. XP_818074, 
Tc00.10470S3S09399.20) and TcMCAS (XP_816130, Tc00.10470S3510759.160) are 
represented (EMBL accession number, genedb designation (www.genedb.org)).
TbMCAl w ill be an active peptidase (Barrett A.J. et aL, 2003). Markedly, one of the two 
metacaspases encoded by the Plasmodium falciparum genome possesses the predicted 
active site histidine and cysteine residues while the other has tyrosine and threonine 
substitutions at these respective positions (figure 4.2, red arrow heads). Thus, for the 
reasons previously discussed for TbMCAl, this latter protein is predicted to be a "dead" 
metacaspase. That two divergent protozoa have maintained apparently inactive 
proteins suggests that these "dead” metacaspases might have a specialised role within 
the cell. Interestingly, the human FLIP, an inactive structural homologue of caspases-8 
and -10, which contain two death effector domains and an entire caspase domain 
mutated in the catalytic residues as well as the residues forming the substrate-binding 
SI subsite, has been shown to act as a dominant negative inhibitor of apoptosis (Thome 
et al., 1997; Irmler et al., 1997). Indeed, FLIPs, which still possess their ability to bind 
to active caspases-8 and caspases-10, were hypothesized to act as competitive 
inhibitors preventing the binding of these caspases to adapter molecules and, 
consequently, the activation of death receptor-induced apoptosis (Hu et aL, 1997). 
Whether the potentially catalytically inactive TbMCAl might act in a similar way 
remains an open question. TbMCAl might only be a pseudogene. However, it  seems less 
likely that TbMCA4 might act as a "dead” metacaspase.
Indeed, in TbMCA4 the active site histidine residue is intact. Also, even though 
the active site cysteine residue has been replaced by a serine, a similar substitution is 
present in the single Theileria annulata metacaspase, TaMCA. Furthermore, in TbMCA4, 
a cysteine residue (figure 4.2, orange arrow head) is immediately adjacent to the 
substituted active site serine (figure 4.2, second red arrow head). This second 
cysteine residue is conserved in all trypanosome and Leishmania metacaspases but not 
in the yeast and plant metacaspases which possess a serine residue at this position. 
Therefore, TbMCA4 might have retained its peptidase activity by either using this 
adjacent cysteine as the active site residue or by being a mixed type peptidase. This 
would be similar to the situation with the serine repeat antigen 5 (SERAS) from P. 
falciparum, a protein with a high level of sequence identity to papain and potentially a 
Clan CA, Cl family cysteine peptidase, which has been shown to possess a catalytic 
activity even though it  has a serine residue at the position of the active site cysteine 
(Hodder et aL, 2003).
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Figure 4.2: Alignments of selected domains of the active site region between 
several metacaspase proteins
Identical and conserved amino acids are shown in white on a black or dark grey 
background, respectively. Weakly similar amino acids are shown in black on a clear grey 
backgroung. Groups of similar amino acids are shown in blue. Catalytic residues from 
the active site are shown in red. Sequences were aligned using the Clustal W algorithm 
of the Align X program (Vector NTI Advance 10 package, 
http: / Zwww.informaxinc.com/ ). For details of the sequences used in this alignment, 
refer to figure 4.1. The red arrow heads indicate the position of the predicted catalytic 
residues while the orange and yellow arrow heads indicate potential alternative active 
site residues. The blue asterisks indicate the aspartate residue involved in the 
coordination of the substrate PI residue.
Also, it cannot yet be excluded that, maybe, within the metacaspase active site, 
additional catalytic residue(s) still remain(s) to be characterised. Indeed, whereas the 
cysteine-histidine catalytic dyad is sufficient for cysteine peptidases of clans CK and CJ, 
other cysteine peptidases possess an additional highly conserved amino acid that is 
involved in the catalytic mechanism (Mottram et al., 2003). The third amino acid 
residue of the catalytic triad differs between clans. In clan CA cysteine peptidase, it  is 
either an asparagine or aspartic add residue, and serves to orientate the active site 
histidine. The catalytic dyad of clan CD cysteine peptidases was predicted to be 
sufficient for their activity. Nevertheless, analysis of the catalytic activity of the human 
clan CD paracaspase revealed that an additional residue (cysteine-539) might be playing 
a role in the protein activity (Snipas et al., 2004). Thus we cannot rule out that the
Chapter 4: Properties of the trypanosomatid metacaspases 107
same might be true in metacaspases. Indeed, Szallies et al. reported that all 
trypanosomatid metacaspases possess, between the first strand and helix motifs of their 
predicted secondary structures, a conserved cysteine residue (figure 4.2, yellow arrow 
head), which, by superposition of the predicted metacaspase secondary structures upon 
the known structures of caspase-1 and gingipain, was found to be in the spatial 
proximity to the catalytic dyad (Szallies et al,, 2002). As these structure comparisons 
were not accessible online, we conducted a similar analysis with selected 
trypanosomatid metacaspases and caspases and concluded that, indeed, an additional 
cysteine residue might interact with the catalytic dyad of the metacaspases (refer to 
section 4.5.).
Consistent with these various observations concerning the TbMCA4 putative 
enzymatic activity, it  was observed that heterologous expression of TbMCA4 in the yeast 
Saccharomyces cerevisiae led to a petite phenotype due a complete abolishment of 
respiration competence (Szallies et al., 2002). This phenotype was abrogated when the 
predicted TbMCA4 active site residue histidine-164 was mutated to an alanine. 
Furthermore, the phenotypes induced by TbMCA4 expression in yeast were completely 
lost when the cysteine-218, the residue flanking the substitutive active site serine 
residue (figure 4.2, orange and red arrow heads, respectively), was mutated. Even 
more unexpected was the finding that mutation of the cysteine-98 (figure 4.2, yellow 
arrow head), together with the flanking cysteine-99, which, in the predicted secondary 
fold, are in the close proximity of the catalytic dyad, also resulted in the disappearance 
of the expression phenotype. Consequently, it  seems that the atypical TbMCA4 possess 
an enzymatic activity when expressed in yeast cells. However, the nature of this 
activity remains to be established. More importantly, similar analyses remains to be 
performed in T. brucei to assess whether the phenotypes observed in yeast are 
physiologically relevant.
4.3. Focus on TblVICA2, TbMCAS and TcMCAS
TbMCAZ and TbMCA3 share a very high level of sequence identity (88.2%). 
TbMCA3 possesses a 10 amino acids N-terminal extension compared to TbMCA2, a region 
that might contain a signal peptide (figure 4.3, blue letters). This is suggestive that the 
N-terminal domain may be important for selective targeting of the two proteins or some 
differential function(s). However, the fact that T.cruzf possesses a TbMCAS but no 
TbMCA2 homologue suggests that these two proteins might be playing a similar role in 
the cell or that TbMCAZ might possess a T. brucei-specific role. However, as both 
TbMCA2 and TbMCAS share almost 100% sequence identity over the remainder of their 
sequences, we can speculate that they w ill have very similar, if  not identical, substrate
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specificity. Furthermore, the tandem positioning of TbMCAl and TbMCA3 on 
chromosome 6 of T. brucei is consistent with a gene duplication event and suggests that 
these genes might have similar functions. In T. cruzi, TcMCAS is present in 
approximately 16 copies, distributed in at least two clusters of tandemly repeated 
genes and located on two different-sized chromosomes (Kosec et aL, 2006). It was 
observed that the intergenic region of the TcMCAS tandem copies was composed of the 
3'-end of the cysteinyl-tRNA synthetase gene and a truncated retrotransposon-like 
element. Upstream of at least one the tandem repeats, a complete cysteinyl-tRNA 
synthetase gene is present. Therefore it  is likely that the increased copy number of 
TcMCAS results from the activity of transposable elements. Indeed, despite over 
hundreds of millions of years of independent evolution, T. cruzi, T. brucei and L. major 
exhibit a high level of gene synteny and the very few sites of genome rearrangement 
are all marked by the presence of retroposon-like sequences (Ghedin et oL, 2004). In 
accordance to this, the closely related TbMCA2 and TbMCAS genes are located, like 
their T. cruzi homologue TcMCAS, downstream of the cysteinyl-tRNA synthetase gene 
(in the chromosome 6 of T. brucei) (www.genedb.org). Henceforth, gene synteny 
between T. cruzi and T. brucei was probably disrupted by, on T. cruzi side, extensive 
retrotransposon activity and, on T, brucei side, duplication of the original MCAS gene to 
give rise to TbMCAl. The reason why these two parasites would replicate a metacaspase 
that is absent from L. major remains obscure. As L. major does not possess a similar 
metacaspase, we can postulate that this function might be Trypanosoma-specific.
4.4. Metacaspases interactions
Mammalian caspases have protein interaction modules within their prodomains. 
Caspases with large prodomains are thought to be involved in the initiation of the 
apoptotic response (hence they are termed initiator caspases) while those with short 
prodomains are apparently activated by the initiator caspases and thus are termed 
effector caspases. Within these prodomains, related motifs have been identified. The 
death effector domain (DED)(Chinnaiyan et al., 1995) is found in caspases 8 and 10 and 
appears to be involved in interactions with DEDs of signaling adapter proteins such as 
M0RT1/FADD (Chinnaiyan et aL, 1995; Boldin et aL, 1995) and TRADD (Hsu et al., 
1995). The CAspase REcruitment Domain (CARD) (Hofmann et aL, 1997) is found in 
caspases 1,2 ,4,  and 9 and appears to be important in promoting interactions of these 
caspases with one another and with a range of other regulatory and adapter proteins. 
CARD and DED motifs, together with the Death Domain (DD), the recently characterized 
PYRIN domain (Fairbrother et aL, 2001) as well as many others (Aravind et aL, 1999), 
are members of the death domain-fold superfamily and are well established mediators
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of protein-protein interactions in many proteins. Interestingly, the plant metacaspases 
are divided in two groups (termed type I and II) that might be analogous to the 
mammalian initiator and effector caspases (Vercammen et al., 2004). The Arabidopsis 
thaliana type I metacaspases (AtMCAl, AtMCA2 and AtMCAS) possess N-terminal 
extensions ranging from approximately 80 to 120 amino acids in length that could 
represent prodomains similar to those found in mammalian upstream initiator caspases. 
However, instead of harboring interaction modules of the Death Domain-superfamily, 
the prodomains of the type I A. thaliana metacaspases are rich in proline (AtMCAl and 
AtMCA2) or glutamine (AtMCAS) and all contain two putative CxxC-type zinc-finger 
structures, similar to the lesion-simulating disease-1 protein (LSD1), a negative 
regulator of the hypersensitive response with homology to GATA-type transcription 
factors (Dietrich et aL, 1997; Uren et aL, 2000) (figure 4.3, light blue and underlined 
pink letters, respectively). While none of the trypanosomatid metacaspases possess 
any Death Domain-like motifs or zinc-finger structure, it  is possible that the proline rich 
domain present in the C-terminal of LmajMCA, TbMCAS and TcMCAS might be involved 
in protein-protein interactions (figure 4.3, light blue letters).
In yeast, many large-scale two-hybrid screens were undertaken to identify 
protein-protein interactions between full-length open reading frames predicted from 
the Saccharomyces cerevisiae genome (Uetz et aL, 2000; Drees et aL, 2001; I to et al., 
2001; Tong et al., 2002; Hazbun et al., 2003; Krogan et al., 2006). Interestingly, many 
potential partners of yeast metacaspase, ScMCA, were thus discovered. Among others, a 
physical interaction between ScMCA and Wwmlp (YFLOlOp), a potential hydrophilin 
which has been implicated in osmotic stress responses (Garay-Arroyo et oL, 2000), was 
identified. Overexpression of Wwmlp led to phenotypes closely related to the ones 
observed during TbMCA4 expression, nevertheless these effects were independent of 
ScMCA (as a AScMCA harboured the same phenotype during Wwmlp overexpression). 
Simultaneous expression of Wwmlp and ScMCA resulted in the suppression of the 
phenotypes observed with the former alone, even when the ScMCA active site histidine 
and cysteine residues were mutated. However, a truncated form of ScMCA lacking its 
proline-rich N-terminus was not able to suppress the Wwmlp overexpression phenotype. 
It is established that WW domains, characterized by two signature tryptophan residues 
located 20-23 amino acids apart (Andre and Springael, 1994; Bork and Sudol, 1994), are 
protein-protein interaction modules that bind to short proline-rich motifs (termed WW 
binding domains), in proteins, in a variety of signalling pathways (Sudol and Hunter, 
2000). Wwmlp possess one such WW domain. Consequently, the suppression of the 
Wwmlp overexpression phenotype by ScMCA overexpression could be explained by a 
titration of these two proteins mediated by their WW domain and proline-rich region, 
respectively. The physiological significance of this interaction remains uncharacterised.
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Figure 4.3: Sequence alignment of selected metacaspases
identical and conserved amino acids are shown on a black or grey background, 
respectively. Sequences were aligned using the Clustal W algorithm of the Align X 
program (Vector NTI Advance 10 package, http: / Zwww.informaxinc.com/). Signal 
peptides predicted by Signal? 2.0 HMM are in dark blue (predicted cleavage site 
between residue 28 and 29 for LmajMCA, 26 and 27 for TbMCAl, 20 and 21 for TbMCA3, 
15 and 16 for TbMCAS, 18 and 19 for TcMCAS). A signal peptide is predicted for TcMCA3 
but vrith a low level of probability (blue line, cleavage between residues 20 and 21). A 
probable transmembrane helix was predicted for TbMCAl by TMHMM2.0 at amino acids 
7-29 (green letters and green line). The zinc finger domains of AtMCAl are shown in 
pink. Proline-rich domains are in light blue and repetitive motifs are underlined by 
double headed arrows. The predicted Class III WW binding domain of TbMCAS is shown 
in purple; a potential similar domain is underlined in purple in LinfMCA. The active site 
histidine and cysteine residues are shown in red and are marked with red arrow heads. 
Putative alternative active site cysteines are indicated by orange and yellow arrow 
heads. The blue asterisks indicate the aspartate residue involved in substrate PI 
coordination. The 80-mer peptide used to generate anti-TbMCA2/3 antibodies is lined by 
a discontinuous black line. The 15-mer peptide used for the generation of the LmajMCA 
antibodies is lined by a dotted black line.
Interestingly, possible Class III WW binding domain motifs were identified within 
the T. brucei metacaspases. Class III WW binding domains are characterised by motifs of 
at least two proline residues flanked by arginine or lysine residues (Macias et al., 2002). 
Such motifs were identified in the N-terminal regions of TbMCAl, TbMCA2 and TbMCAS 
and the C-terminal extension of TbMCAS (figure 4,3, purple letters) and potentially of 
LinfMCA (figure 4.3, purple line). Meanwhile, LmajMCA and TbMCA4 do not seem to 
possess identifiable WW binding domains. However, ScMCA does not possess any 
classifiable WW binding domains but nevertheless interacts with Wwmlp through its 
proline-rich N-terminus (Szallies et al., 2002). Indeed, while the amino acid composition 
of the WW binding domains could differ considerably from one protein to the other, 
there are also many other modules that can bind proline-rich ligands and mediate 
protein-protein interactions (Kay et al., 2000).
In an attempt to characterise any potential metacaspase partners, searches of 
proteins harbouring WW motif(s) were performed (using Pfam search, 
www.genedb.org). Within T. brucei, eight proteins are predicted to possess WW 
domains. Most of them possess L. major orthologues. Three of these are hypothetical 
proteins (Tbi 1.01.3520 - LmjFI7.2390, Tb927.1.3560 - LmjF12.0510 and Tb927.4.158 - 
LmjF34.3140), while two are putative myosin heavy chain proteins (Tb927.4.3380 and 
Tb927.5.2440 - LmjF17.1140), one possesses similarities to the yeast ubiquitin-ligase 
Rsp5p (Tb927.8.5290 - LmjFI61140) and the last two are the zinc finger protein 2 (ZFP2, 
Tbi 1.01.6590 - LmjF32.1740) and a putative isoform (Tb927.3.720 - LmjF27.01). While 
most of the functions of these proteins remain obscure, TbZFPZ is, in T. brucei, among
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the very fev/ published examples of protein with a WW domain (Hendriks et al., 2001). 
In addition to its CCCH zinc finger, and it WW domain, TbZFP2 possess an E3 ubiquitin 
ligase domain in its N-terminal region. While protein(s) interacting with TbZFPZ 
remain(s) to be characterised, this protein belonging to the CCCH zinc finger family 
plays a major role in the T. brucei bloodstream to procyclic forms differentiation 
process by principally mediating extension of the posterior end-cytoskeletal 
microtubules (Hendriks et al., 2001). Type I plant metacaspases have proline-rich 
proregions with zinc finger domains (Uren et al., 2000). The paracaspase possess a 
proregion mediating protein-protein interactions through a Death Domain (DD) but 
surprisingly harbour a functional E3 ubiquitin ligase domain in its C-terminus (Uren et 
oL, 2000). It is thus tempting to postulate that trypanosomatid metacaspases, and 
notably the WW binding domain harbouring-TbMCAS might interact with this TbZFPZ to 
acquire, as a complex, the biological functions that other members of their protein 
family or clan would later obtain during evolution (Koonin and Aravind, 2002).
Many datasets for protein-protein interactions have now been produced in 
various organisms. Two of them, BioGRID (Stark et aL, 2006) (http://www. 
thebiogrid.org) and DIP (Xenarios et aL, 2000) (http://dip.doe-mbi.ucla.edu), were 
browsed to observe the experimentally characterised protein-protein interactions with 
the yeast metacaspase YOR197w (ScMCA). A compilation of the proteins found to 
associate with ScMCA is shown in table 4.2. Potential partners for the metacaspase are 
proteins involved in signal transduction (kinases), control of transcription, intracellular 
transport, and regulation of the actin cytoskeleton. It is thus tempting to postulate that 
the trypanosomatid metacaspases might be involved in similar networks. However, Blast 
searches revealed that most of the ScMCA partners identified are absent from the T. 
brucei, L. major and T. cruzi genomes (table 4.2). Furthermore, it  was observed that 
different screens gave different interactions, thus lowering the probability that these 
are real interactions. In trypanosomatids, methods such as immunoprécipitation or 
affinity-purification, together with immuno-colocalisation, might help identify 
interacting partners and further aid in the understanding of metacaspase functions.
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Name Aliases Description Evi­dences Reference Tryps
TFB1 YDR311W
Subunit of TFIIH and nucleotide excision repair factor 3 complexes, required for 
nucleotide excision repair, target for transcriptional activators.
NO
SRB4 MED17YER022W
Subunit of the RNA polymerase II mediator 
complex; associates with core polymerase 
subunits to form the RNA polymerase II holoenzyme; essential for transcriptional 
regulation.
NO
KRE11 TRS65YGR166W
Protein involved in biosynthesis of cell wall beta-glucans; subunit of the TRAPP (transport 
protein particle) complex, which is involved 
in the late steps of endoplasmic reticulum to 
Golgi transport.
(Ito et aL, 
2001)
NO
YAK1 YJL141C
Serine-threonine protein kinase that is part of 
a glucose-sensing system involved in growth 
control in response to glucose availability; 
translocates from the cytoplasm to the nucleus and phosphorylates PopZp in response 
to a glucose signal. Two-hydrib
YES?
JSN1 PUF1YJR091C
Member of the Puf family of RNA-binding 
proteins, interacts with mRNAs encoding membrane-associated proteins; overexpression 
suppresses a tubZ-150 mutation and causes 
increased sensitivity to benomyl in wild-type 
cells.
YES
SR077
SNI2
S0P2YBL106C
Protein with roles in exocytosis and cation 
homeostasis; functions in docking and fusion 
of post-Golgi vesicles with plasma membrane; homolog of Sro7p and Drosophila lethal giant 
larvae tumor suppressor; interacts with 
SNARE protein Sec9p.
(Drees et 
aL, 2001) NO
SDC25 YLL017W Ras protein signal transduction NO
(Tong et aL, 
2002)
PIN3 LSB2YPR154W
Protein that induces appearance of [PIN+] prion when overproduced. Actin cytoskeleton 
organization and biogenesis.
YES?
ARC1 YGL105W
Protein that binds tRNA and methionyl- and glutamyl-tRNA synthetases (Mes1p and 
Gusip), delivering tRNA to them, stimulating catalysis, and ensuring their localization to 
the cytoplasm; also binds quadruplex nucleic 
acids.
Affinity
capture
-MS
(Krogan et 
oL, 2006) YES
Table 4.2: ScMCA potential protein partners and interacting pathways as 
predicted by various protein-protein interaction datasets
Data obtained from BioGRID (http://www.thebiogrid.org) and DIP (http://d1p.doe- 
mbi.ucla.edu), while browsing for the yeast metacaspase ScMCA (YOR197w). Only first- 
order interactions are represented here. Blast searches were performed using GeneDB 
(www.genedb.org).
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4.5. Predictions of structure, processing and post-translational 
modifications
Secondary structure predictions of the trypanosomatid metacaspases were 
performed with the PSiPRED software (McGuffin et al., 2000) (http:/ / bioinf.cs.ucl. 
ac. uk/psipred/psiform. htmU and schematic representations of the results are shown in 
figure 4.4. While sharing little  sequence identity at the primary amino acid level, 
similar secondary folds identified metacaspases as distant cousins of clan CD caspases 
(Uren et al., 2000). Using the predicted secondary structure of LmajMCA to screen a 
database of proteins with experimentally characterised secondary fold 
(mGenTHREADER, http://bioinf.cs.ucl.ac.uk/psipred/ psiform.html). the best matches 
obtained were, as expected, caspases and, more precisely, caspase-3 (PDB ID: IpauAO, 
score: 0.858, E value: 2e-04) and caspase-1 (PDB ID: IbmqAO, score: 0.850, E value 3e- 
04). The secondary structure of the human caspase-3 is shown, as an example, in figure 
4.4, to illustrate the similarities with the trypanosomatid metacaspases. At first glance, 
it  can be noted that, due to their proline-, glutamine- and tyrosine-rich C-terminal 
domains (figure 4.4, blue boxes), TbMCA5, LmajMCAS and TcMCAS are bigger than 
caspase-3. While the C-terminal extensions of LmajMCA and TbMCAS do not possess any 
a-helix or (3-strand and are predicted to be coil regions, TcMCAS C-terminus harbours 
two a-helixes and one p-strand. TbMCA4, which does not possess such C-terminal 
extension, has a size closer to caspase-3. Also, the trypanosomatid metacaspases all 
possess additional a-helixes in their N-terminus compared to the caspase-3 (figure 4.4, 
green cylinders). LmajMCA5, TbMCAS and TcMCA5 are predicted to possess a signal 
peptide cleavage site after these structures (figure 4.4, end of blue double arrows). 
TbMCA3, which possesses a 10 amino acids extension in its N-terminus compared to 
TbMCA2, harbours an additional a-helix and is predicted to possess a signal peptide 
cleavage site, while TbMCA2 does not. TbMCA4, which possesses 3 p-strands upstream of 
its short first a-helix, is not predicted to possess such signal. Consequently, it  is possible 
that the N-terminal a-helixes of the metacaspases might be involved in the targeting of 
these metacaspases to a specific compartment.
Nevertheless, as it  is known that many cysteine peptidases are activated by 
cleavage of an N-terminal domain, it  is also possible that this domain might act as a 
prodomain. Cysteine peptidases of the papain family (clan CA) undergo cleavage of N- 
terminal peptides of various lengths, which act as potent inhibitors of the full length 
enzyme, in order to enhance their enzymatic activity (Fox et al., 1992). Caspase 
maturation also involves proteolytic removal of a prodomain together with cleavage into
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LmajMCA (436 aa)
H147
D84
TbMCAS (500 aa) 
€81
D200
H147
D200
TcMCAS (442 aa)
080 H146
D83
TbMCA4 (3S3 aa)
098
D199
8219
D101
Hscaspase-3 (277 aa)
D217
H121 C163
p17 p12 50 aa
Q  a-helix □  P, Q, Y-rich motif or region 1 alternative active • • • site cysteine region recognised by anti-LmajMCA antibody
| )  p-strand 1  W W  binding domain 1 aspartate involved in substrate P I coordination
end of cloned fragment
signal peptide or proregion 1 active site residues ■
region recognised by | anti-TbMCA2/3 antibody '
start of cloned fragment
Figure 4.4: Comparison of the predicted secondary structures of some 
trypanosomatid metacaspases and the human caspase-3.
The schematics are based on the secondary structures predictions made with the 
PSIPRED software (McGuffin et aL, 2000) (http:/ / bioinf.cs.ucLac.uk/psipred / psiform 
.html). Amino acids (aa) of interest are labelled. Start or end of fragment used for the 
expression of Nterm-GFP (a), eNterm-GFP (b), GFP-eCterm (c) or Cterm-GFP (d) are 
indicated (refer to chapters 2 and 6).
two subunits; these subunits subsequently dimerise to form the active enzyme (Rotonda 
et aL, 1996). The procaspase-3 is first cleaved at DI 75-SI76 to remove the covalent 
connection between the large (17 kDa) and small (12 kDa) subunits (Nicholson et aL, 
1995) (figure 4.4, p i7 and pi 2). The prodomain (figure 4.4, blue double arrow) is 
then removed after cleavage at D9-S10 and then at D28-S29 (Fernandes-Alnemri et al., 
1994). Therefore, all cleavages involved in caspase maturation occur on the carboxyl 
side of aspartate residues. So far, the only characterised eukaryotic peptidases with this
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specificity are the caspases themselves and the cytotoxic T lymphocyte serine peptidase 
granzyme B (Earnshaw et aL, 1999). Also, activation of the caspases can occur either by 
auto-catalytic processing or by cleavage by an aspartate specific-peptidase.
Apart from in their N- and C-terminal regions, the secondary structures of the 
metacaspases are strikingly close to caspase-3. The active site region is particularly well 
conserved, with (3-strand structures in close proximity of the histidine and cysteine (or 
serine for TbMCA4) residues (figure 4.4, red bars). The sequence context of the 
catalytic histidine residue in trypanosomatid metacaspases is H(Y/F)SGHG, suggesting 
an intermediate stabilizing role for the adjacent glycine, as in mammalian caspases 
(Earnshaw et aL, 1999). In caspases, the catalytic cysteine is contained in a QAC(R/Q)G 
context, with the glutamine residue shown to coordinate the substrate PI aspartate. 
Interestingly, the trypanosomatid metacaspases have a DCCHSG signature, suggesting 
that this role is now played by an aspartate (D200 with LmajMCA numbering). This 
would imply that metacaspases are specific for a basic PI amino acid such as arginine or 
lysine (Szallies et aL, 2002). Supporting this hypothesis, several recombinant plant 
metacaspases were shown to harbor such substrate specificity (Vercammen et al., 2004; 
Watanabe and Lam, 2005) and lack caspase-like activity. It was postulated that D200 
and D84 might together specify the substrate PI scissile bond amino acid (for which 
Clan CD members appear to be highly specific) (figure 4.4, blue bars).
Interestingly, the 3D structure reconstruction of LmajMCA and TbMCA4 structure 
based on the tertiary structure of caspase-3, revealed that, while distant in the primary 
sequence, these two aspartate residues (D217 and D101 in TbMCA4) are in close 
association with the active site histidine and cysteine residues and contribute to the 
formation of the substrate pocket (the predicted 3D structure of LmajMCA is shown in 
figure 4.58). As discussed previously, the substrate pocket seems also to be lined with 
another cysteine (C81 and C84 for LmajMCA and TbMCA4, respectively), which might 
participate in the catalytic activity.
By analogy to caspases, but consistent with their arginine/lysine specificity, 
production of the type II A. thaliana metacaspase 9 in E. coli resulted in autoprocessing 
of the proform, after an arginine residue (ITSR/ALPFKAV), into large and small subunits 
(Vercammen et aL, 2004). An additional lysine-specific processing was also observed to 
occur in the N-terminus of AtMCA9, leading in the removal of an 8 kDa peptide 
(LYKK/AGSTM). Thus, the type II metacaspases, like the executioner caspases in 
animals, appear strongly dependent on (auto)processing in order to be active. Also 
these observations raise the possibility that the trypanosomatid metacaspases might 
indeed be matured, having an argine/lysine-specific processing instead of the caspase 
aspartate-specific cleavage. Nevertheless, it  has to be noted that, with their proline- 
rich domains, LmajMCA, TbMCA5 and TcMCAS are more closely related to the type I
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than the type II plant metacaspases. Indeed, the type I A. thaliano metacaspases 
possess large proline-rich N-terminal extensions that could represent prodomains 
analogous to those of the mammalian upstream initiator caspases. Also, bacterial 
overproduction of type I metacaspases failed to identified any processing pattern 
(Vercammen et al., 2004), suggesting that, like for the mammalian initiator caspases, 
they might need oligomerization to be activated.
8145*
Sequence used for 3D reconstruction
1 MADLFDIWGI 
61 RVRALFIGIN 
121 DNIIKHMLWL 
181 LFLMLVAPLP 
241 WMFSGCTDR 
301 VPQLTSSKPI 
361 PPQGYYPPPQ 
421 QPPPAQYTFS
GAVASLIPML
YTGMRNALRG
TGDVRPGDVL
SGVRMTCVFD
GTSADVQNGG
DLYKPFSLFG
SPGWGLGYPV
PLPPG
ANGLLLVDRP
CVNDVSSMLG
FFHFSGHGGQ
CCHSASMLDL
HANGAATLAF
MITVNASMMH
QGIPVQQATL
KRVDINAGRR
TLQQISFPIS
AKATRDSEEK
PFSYVAPRVG
TWSLLNTHGL
CVPQQYQQRP
GVSRCPPSQY
LIHTVRPIIP
ECCILVDDPS
YDQCLIPLDH
GGGACEYMQQ
SYLNILLKTR
QSLPPQVMPP
LPAPPPAVYA
YRAPVPYTGG
FPGFCGMPTR
VKNGSILDDD
VRRGNFSNGD
EELRKKGRVQ
ATGYPVHVPP
PPPPGQRGPP
M: residue not aligning on cii4oa sequence 
C : residue of the active site pocket 
Y : residue potentially phosphorylated 
s : residue potentially phosphorylated and glycosylated
Figure 4.5: Three dimensional structure prediction of LmajMCA based on 
caspase-3 tertiary fold.
Fold recognitions were obtained from the 3D-PSSM Web server V.2.6.0 
(http://www.sbg.bio.ic.ac.uk/-3dpssm/index2.html). Snapshots of the proteins viewed 
in RasMol V2.6 are represented here. The different colours identify the various 
structural features (a-helix in pink, p-sheet in yellow and coiled domain in blue). Amino 
acids of the active site pocket are represented. The predicted 3D structure of LmajMCA 
(panel A) as well as a zoom on its active site region (panel B) are shown. Below, the 
sequence used for the 3D prediction is shown in bold within the full LmajMCA sequence. 
A colour code was applied to important residues as detailed in the legend (please note 
that this code does not apply to the Snapshots).
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Another structural feature that might contribute to the differences in substrate 
specificity of the metacaspases is the predicted presence, in the tertiary fold, of a 
flaplike loop that projects over the active site (figure 4.5A). A similar flap is found in 
the caspase-3 and might explain their inability to cleave certain substrates even thought 
consensus cleavage sites are present (Rotonda et aL, 1996; Mitt I et aL, 1997). Indeed, 
because of steric hindrance by the flap, certain potential substrates might fail to dock 
in the catalytic site. This flap is, in caspase-3, also a potential site for post-translational 
modifications, for example phosphorylation (Martins et aL, 1998), which could 
conceivably cause it  to open or close further thereby providing a potential regulatory 
mechanism. LmajMCA is predicted to possess several potential serine, threonine and 
tyrosine phosphorylation sites (NetPhos 2.0, http: / / www. cbs. dtu. dk/services/ 
NetPhos/). some of which being in close proximity of the active site pocket (Y161, 5206, 
5253, T248, figure 4.5B). However, many glycosylation sites are also predicted and a 
few of them, present at potentially phosphorylatable serine or threonine residues, 
might actually prevent phosphorylation from occurring at these sites (YinOYang 1.2, 
http://www.cbs.dtu.dk/services /YinOYang/) and thus regulate the phosphorylation 
state of the metacaspase.
4.6. Discussion
The in silica analyses of the structural and biochemical properties of the 
trypanosomatid metacaspases reveals that although these proteins have a tertiary fold 
comparable to thoses of caspases, they are predicted to prefer susbtrates with, at their 
PI positions, basic (such as arginine or lysine) rather than the acid residues (such as 
aspartate) favoured by caspases. Nevertheless, because of the presence of protein- 
protein interaction modules in some of the metacaspases (with the WW binding domains 
or the proline-, glutamine- and tyrosine rich-regions), it  seems likely that the 
metacaspases might, as in the case for caspases, be involved in a cascade of events 
regulating a yet uncharacterised pathway. Whether these interactions are necessary for 
the regulation of the enzymatic activities of the metacaspases or of their bound 
partners remains to be determined. On the other hand, the role of these protein- 
protein interactions might be independent of any enzymatic activities. Indeed, the 
metacaspases might simply associate with other proteins to get trafficked throughout 
the cell. This idea is strengthened by the observation that some of the trypanosomatid 
metacaspases possess in their N-termini a predicted signal peptide, potentially 
targetting the protein to a special cellular compartment. One can thus assume that the 
metacaspases might play several roles in the cell, depending on their location and 
activation state. Metacaspases with differences in their active site dyad residues.
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although likely enzymatically inactive, might nevertheless play important roles in the 
cell by, for example, binding natural inhibitors or substrates for the functional 
metacaspases and thus indirectly modulating the activity of these latter enzymes. The 
regulation of metacaspase activity might also be mediated by proteolytic processing, 
either performed autocatalytically or by upstream peptidases and by the addition of 
post-translational modifications. In the present study, I attempted to produce 
experimental evidence that the metacaspases possess indeed such properties.
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5.1. Analysis of MCA expression in L. major
5.1.1. Antibodies
To elucidate the cellular function(s) of the metacaspase, its level of expression 
v/as assessed in the two life stages of L. major and at different time points of 
promastigote in vitro growth. In order to do so, antibodies were raised against a peptide 
covering the last 15 C-terminal amino acids of MCA. After affinity purification over the 
designed peptide, the rabbit antibody was used for Western blot analyses. In the first 
place, the experiment was performed on total protein lysates of wild type L. major 
promastigotes. The analysis allowed the detection of a protein with a molecular mass of 
about 50 kDa. This protein size was slightly higher than the one expected for MCA (-47 
kDa) (figure 5.1 A, left panel). Furthermore, at least two additional proteins, of about 
40 and 30 kDa, were visualised, showing that detected protein might either be 
processed or degraded within the cells. To evaluate its specificity, the anti-MCA 
antibody was absorbed against the MCA peptide prior to Western blot analysis. The 
presence of the peptide was able to completely block the detection of the 50 kDa 
protein (figure 5.1 A, middle panel). In addition, the anti-MCA antibody was tested with 
success on purified recombinant MCA and showed a protein profile similar to that 
observed in Leishmania (figure 5.1 A, right panel).
However, the low sensitivity of this antibody impeded its use for further 
analyses. Therefore, antibodies raised against the full length TbMCA5 or the active site 
region of TbMCA2 and TbMCA3 were assessed. Intriguingly, even thought LmajMCA is 
more closely related to TbMCAS than TbMCA2 and TbMCA3, only the antibody 
recognising these later two proteins was able to detect LmajMCA in promastigote cell 
extracts. The anti-TbMCA2/3 antibody was obtained by immunisation of rabbit with an 
80-mer peptide encompassing the catalytic site histidine and cysteine residues (from 
D144 to T224, with TbMCA2 numbering), a region that is identical at 60.5% in LmajMCA 
(refer to chapter 4, figures 4,3 and 4.5). This antibody detected in promastigote cell 
extracts a protein of - 50 kDa (figure 5.IB, left panel). Nevertheless, several additional 
proteins were also detected, of about 38-40 kDa and 30 kDa. These proteins possess 
molecular masses comparable to the ones detected with the anti-LmajMCA antibody. 
The specificity of the anti-TbMCA2/3 antibody for LmajMCA was confirmed by its ability 
to detect purified recombinant LmajMCA and several variants of LmajMCA expressed 
exogenously in L. major promastigotes (refer to chapter 6). Interestingly, the anti- 
TbMCA2/3 antibody was able to detect LmajMCA in lysates of 1x10  ^promastigotes, at a 
1:10,000 dilution, thus showing a much greater sensitivity than the anti-LmajMCA
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Figure 5.1: Antibodies specificity and expression profile of MCA
Western blot analyses performed on lysates of Leishmania promastigotes (L, L*) or 
amastigotes (Am) or on purified recombinant MCA-His (Rec). ). Cells were lysed with 2% 
SDS in the presence of a mix of anti-peptidases.Total lysates were loaded on a 12% 
acrylamide gel and separated by SDS-PAGE. The gels were then transferred to PVDF 
membranes and hybridised with rabbit anti-LmajMCA antibodies (A), anti-TbMCA2/3 
antibodies (B,C) or mouse anti-EFIa (C) at a 1:50, 1:10,000, and 1:20,000 dilutions, 
respectively. Revelation was performed using HRP-conjugated anti-rabbit or anti-mouse 
antibodies (Promega), at 1:5,000 dilutions, and the West Signal chemoluminescence 
detection system (Pierce). A,B) Peptide competition experiments carried out on 
promastigote extract (L). Anti-LmajMCA and anti-TbMCA2/3 were absorbed (+) or not (-) 
against 3 pg of the relevant peptide. L and L* promastigote extracts were done when 
cells were at a density of 1.5x10^ cells ml \The equivalent to 1x10  ^cells were loaded 
per lane except for L* where 1x10® cells were used. Molecular weight markers are shown 
on the sides.
antibody. Consequently, the anti-TbMCA2/3 antibody was subsequently used for further 
analysis of LmajMCA expression level.
5.1.2. In the two life stages
The Western blot analysis previously performed on promastigote cells was 
repeated with L. major amastigotes extracted from mice lesions (figure 5.1C). In both 
stages of the parasite, the anti-TbMCAZ/3 antibody was able to detect a major protein 
of - 50 kDa, thus suggesting that MCA was constitutively expressed. However, caution 
has to be exercised in the interpretation of the data collected on the amastigote cells. 
Indeed, while the amount of total protein from the promastigote and amastigote 
extracts was equalized by BCA quantification before loading on the SDS-PAGE gel, the 
subsequent Western blot analysis revealed that the protein used as a loading control, 
the elongation factor la  (EFIa), was most abundant in the amastigote lysate. It is 
known that EFIa is expressed at equal level in both life stages of the parasite. Although
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i t  should be possible to detect a size difference between the Leishmania and the 
macrophage EFIa (Nandan et al., 2003), the possibility that the amastigote preparation 
was contaminated with host EFIa could not be excluded. In that case, the protein 
detected with the anti-TbMCA2/3 antibody might be a cross-reacting protein from the 
mice macrophages. To exclude this hypothesis, an extract of non infected macrophages 
should have been probed, by Western blot, as a negative control.
5.1.3. During promastigote growth
Western blot analyses were performed on promastigotes at various stages during 
their in vitro growth (figure 5.2). Promastigote extracts were made when cells were at 
early (E) or late (L) time points of their logarithmic (L) or stationary (S) phases of 
growth (figure 5.2A). It was observed that a higher amount of MCA was detected in the 
early logarithmic phase of promastigote growth (figure 5.2B, EL) than in any of the 
subsequent phases (figure 5.2B, LL, ES, LS). Additional Western blot analyses 
performed on L. major metacyclic promastigotes, which were purified from a late 
stationary phase culture with peanut agglutinin (Da Silva and Sacks, 1987), revealed 
that the amount of MCA detectable in these cells was comparable to the one detected 
in late stationary phase promastigotes (data not shown). This decrease in the 
abundance of MCA within the cells could be the result of either a variation in the level 
of expression of the MCA during cell growth or a modification in the speed of its protein 
turn over.
In Leishmania, an approach combining proteomics and transcriptomics recently 
pointed out that there was little  correlation between the messenger RNA expression and 
the level of protein detected in the promastigote cell (McNicoll et al., 2006). Consistent 
with this observation, expression profiling experiments using shotgun DMA libraries 
established that only about one percent of the analysed RNAs harboured two fold or 
greater expression changes and were differentially transcribed (Akopyants et al., 2004). 
Therefore, in Leishmania, modification in the level of expression of a gene occurs 
mainly at the post-transcriptional, translational and post-translational levels (Clayton, 
2002; Ivens et al., 2005; McNicoll et al., 2006). Stabilisation and /or activation of 
protein products involve modification by phosphorylation, glycosylation, lipidation, GPI- 
anchor addition, acylation or prénylation ... (Ivens et al., 2005). On the other hand, 
protein degradation is mediated, in Leishmania, by proteasomes (Robertson, 1999), 
eubacterial HslVU complexes (Couvreur et al., 2002) and a specialised organelle termed 
the multivesicular tubule (MVT) /lysosome.
Interestingly, this lytic compartment undergoes major morphological and 
biochemical modifications during the promastigote growth and is particularly developed
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Figure 5.2: Anaiysis of MCA expression during promastigote in vitro growth
A) Schematic of the different phases of the promastigotes growth is shown. After a 
phase of exponential growth (dividing here in early and late logarithmic phases (EL,LL)), 
the cells enter a early stationary phase (ES) during which the cells progressively stop 
dividing, leading ultimately to a decline in the cell number as cells begin to die (late 
stationary, LS).
B) Promastigote extracts were made from cells at these various stages of growth (EL, 
5x10* cells ml ’ ; LL, 1.8x10  ^ cells ml*’ ; ES, 2.2x10^ cells ml ’ ; LS, 2x10  ^cells ml ’ ). The 
amount of total protein loaded per lane was equalised after BCA quantification. 
Western blot analysis was performed using rabbit anti-TbMCA2/3 antibody and rabbit 
anti-cysteine synthase (CS) antibody (Williams, R.A., unpublished data) as a loading 
control.
and active in late stationary phase (Mullin et al., 2001). Also, it  can be assumed that 
proteins involved in cell growth and division and particularly essential for the early 
stages of the promastigote development will be unnecessary to the non-replicative 
metacyclic promastigotes and therefore actively degraded. While it remains unclear 
whether the various protein bands detected in promastigote extracts with the anti- 
TbMCA2/3 antibody are the results of MCA maturation or degradation, the concomitancy 
of the decrease, within the cell, of the MCA level and the progressive promastigote 
differentiation into non-dividing form pinpoints a possible involvement of MCA in cell 
replication. Interestingly, proteomics approaches recently revealed that the yeast 
metacaspase was probably ubiquinated and subsequently targeted for the proteasomal 
degradation (Peng et al., 2003). Knowing the essential involvement of the proteasome 
in cell cycle control, this observation strengthens a potential role of the metacaspase in 
cell division (Robertson, 1999; Nakayama and Nakayama, 2006).
Leishmania development is non synchronous. At a given time point, cells at 
different phases of their division cycle can be observed within the same population. 
Nevertheless, cell cycle progression can be arrested by treatment with drugs such as 
hydroxyurea (Soto et al., 2004) or flavopiridol (Hassan et al., 2001). While hydroxyurea
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(HU) prevents DNA synthesis and blocks cell cycle progression at the boundary between 
the G1 and S phases, flavopiridol inhibits the mitotic kinase CRK3 and arrests the cells 
at the G2/M transition. However, the action of these two compounds is reversible and 
removal from the Leishmania culture medium results in a semi-synchronous release 
from the induced cell cycle block. Thus, with their ability to block and release cell 
cycle progression, HU or flavopiridol treatments enable the enrichment, within the 
population, of cells at a precise cell cycle phase. This method was used to analyse the 
potential variations in the amount of MCA present within the cell at precise time points 
of its division cycle.
Successful synchronisation of L. major promastigotes, as assessed by DNA 
content analyses performed by FACS, was achieved by treatment with either 5 mM HU 
(figure 5.3A, second FACS panel) or 2.5 pM flavopiridol for 12 hours. However, the 
synchronisation was only partial and even though cells in G1 or G2 phase were enriched, 
the rest of the population was composed of cells at various stages of their division cycle 
(figure 5.3A, second FACS panel, 46.4% cells in G1 phase, 15.6% in S phase and 17.9% 
in G2/M phase). The respective G1/S and G2/M blocks could be released after two 
successive washes of the cells and complete drug withdrawal. In the example of HU 
treatment shown in figure 5.3A, FACS analyses revealed that peaks in the number of 
cells in S or G2/M phases were reached at 1.5 hours or 4 hours after HU removal, 
respectively. Sample populations enriched in cells in G1, S and G2/M were thus 
collected and the cell lysates were analysed by Western blot to determine whether MCA 
protein level was cell cycle-regulated.
The Western blot membrane was probed with anti-TbMCA2/3 antibody and, in 
parallel, with anti-p-tubulin antibody as a loading control (figure 5.3B). After ECL 
revelation and relative quantification of the various proteins, it  was concluded that 
there was no detectable variation in the cellular amount of the full length MCA during 
cell cycle progression. However, the difference in the amount of the ~ 30 kDa MCA 
product suggests that MCA might be processed, or degraded, at different rates during 
cell cycle progression. It is tempting to speculate that the regulation of the cellular 
function of MCA does not mainly involve translational controls but rather post- 
translational processes modulating its activation state. Nevertheless, biochemical data 
is needed to strengthen this hypothesis, as the changes in the ~ 30 kDa protein 
abundance were not consistently observed.
In the absence of a method to assay MCA activity within the cell, the role of the 
metacaspase was further investigated using immunolocalisation.
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Figure 5.3: Anaiysis of MCA expression during ceii cycie progression
Promastigote cells at 0.5x10^ cells ml^ were partially synchronised at the G1/S phase 
boundary by treatment with 5 mM hydroxyurea (HU) for 12 hours and then released by 
drug removal.
A) Position within the cell cycle was determined by DNA content analysis using 
fluorescence activated cell sorting (FACS). The percentage of cells in G1, S and G2/M 
phase, respectively (numbers inside the FACS data frame) were determined before (not 
treated), during (0 h HU release) and after HU block (1.5 h and 4 h HU release). For 
each point, the most enriched cell population is indicated in bold.
B) Wild type population (NS) and HU treated populations enriched in cells in G1 phase, 
in S phase or G2/M phase were analysed by Western blot using rabbit anti-TbMCA2/3 
antibody and mouse anti-p-tubulin antibody (KMX) (Birkett et al., 1985) as loading 
control (both at a 1:10,000 dilution). The Western blot was then revealed using anti­
rabbit or anti-mouse HRP - conjugated secondary antibodies and the SuperSignal West 
Pico chemoluminescent system (Pierce).The equivalent of 10^  parasites were loaded per 
lane. Equal loading was confirmed by BCA quantification (Pierce) and Coomassie 
staining of the corresponding SDS-PAGE gel. Molecular masses are indicated, in kDa, on 
the right.
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5.2. Cellular localisation of MCA in promastigotes
5.2.1. Attempt to characterise MCA-positive compartment
The specific anti-TbMCA2/3 antibody was used to determine, by 
immunofluorescence, the subcellular localisation of MCA within the promastigote cells 
(figure 5.4).
The majority of the cells within a non synchronised Leishmania culture are found 
in the G1 phase (figure 5.3A, firs t FACS frame) and possess one nucleus, one 
kinetoplast, and one flagellum (1N1K1F). In those cells, MCA localised to punctate 
structures of heterogeneous size covering all of the cell body, with more of the 
structures in logarithmic phase promastigotes (figure 5.4Aa) than in stationary phase 
promastigotes (figure 5.4Ab). MCA-labelled structures did not co-localise with markers 
for known organelles such as the glycosome (glycosomal phosphofrutokinase 
(LdPFK,(Lopez et al., 2002)) or the acidocalcisome (vacuolar pyrophophatase (TbVP1, 
(Lemercier et al., 2002)) (data not shown). Nevertheless, it  was observed that the 
localisation of MCA changed during the cell cycle.
5.2.2. MCA relocates at various stages of the cell cycle
The temporal order of the events leading to division of Leishmania promastigote 
has been characterised and described in chapter 3. In summary, it  was established that 
the 1N1K1F cell first enters S phase and duplicates its DNA content (1N*1K*1F). Then the 
growth of the second flagella starts (1N*1K*2F) and initiate the segregation of the 
duplicated kinetoplast. The nuclear mitosis then begins (1N*^1K*2F) and terminates 
mainly after completion of kinetoplast segregation (1N*^2K*2F, 2N2K2F). Cytokinesis 
ultimately leads to the separation of the parent and daughter cells.
While in 1N1K1F cells, the MCA signal was distributed throughout the cell, upon 
the beginning of the segregation of the kinetoplast (as suggested, in 1N*1K*2F cells, by 
the growth of the second flagellum), MCA was found to be associated with the 
kinetoplast, suggesting an involvement in segregation of this organelle (figure 5.4Ac). 
In 1N*'^1K*2F cells MCA relocated to the nucleus (figure 5.4Ad, e). Immuno- 
colocalisation with anti-p-tubulin antibodies (figure 5.4B) revealed that MCA was 
associated with the mitotic spindle within the nucleus (Ersfeld and Gull, 1997; Ogbadoyi 
et ai., 2000). These studies also revealed that separation of the duplicated nuclei starts 
before and ends after kinetoplast segregation, as DAPI staining, coupled to anti-p- 
tubulin staining of the mitotic spindle, showed the presence of one (figure 5.4Ba) and
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Figure 5.4: Changes in MCA localisation during ceii cycie progression.
Fixed wild type cells were labelled with rabbit anti-TbMCA2/3 and Alexa Fluor 488 
(green) or 548 (red) - conjugated anti-rabbit antibodies. Anti-p-tubulin antibodies 
(KMX,(Birkett et al., 1985)) were used together with Alexa Fluor 488- conjugated anti­
mouse antibodies (green). DAPI staining of the nucleus (N) and kinetoplast (K) is shown 
in blue. Differential Interference Contrast (DIC) images are shown in the inset panels. 
Merged pictures are magnified. The scale bars apply to all pictures and equallO pm.
A) Immunolocalisation of MCA in logarithmic phase (a) and stationary phase (b) 
promastigotes. Examples of fluorescent staining observed for cells in G1 (a, b) and G2/M 
(c, d, e) phases as well as in late cytokinesis (f) are shown. The black arrow heads (in c, 
d and e) indicate the presence of a second growing flagellum. The white arrow heads 
point the regions where the MCA signal is the strongest. K: kinetoplast; N: nucleus; CF: 
cleavage furrow. B) MCA relocates to the mitotic spindle during mitosis. Co-localisation 
of MCA (red) with p-tubulin (p-tub, green) was observed by immunofluorescence (yellow
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in merged picture). The mitotic spindle starts to appear before (a) and disassembles 
after (b) kinetoplast segregation.
then two (figure 5.4Bb) kinetoplasts in cells undergoing nuclear division. MCA appears 
to associate with the mitotic spindle for the complete duration of this process. Upon the 
disassembly of the mitotic spindle and start of cytokinesis, MCA was found to be 
randomly distributed throughout the cell into the previously observed punctate 
structures. MCA accumulated near the cleavage furrow at a late stage of cytokinesis 
(figure 5.4Af).
The various changes in location of MCA during the L. major cell cycle, as well as 
its association with mitotic spindles, suggested that MCA might interact with 
microtubules.
5.2.3. MCA association with microtubules
Samples of semi-synchronised cells were fractionated following various 
extraction methods. First, the cells were lysed in 0.5% Triton X-100 for 15 mins at room 
temperature. The extracts were then centrifuged for 15 mins at 20,00Qg to separate the 
soluble protein fractions from the insoluble fractions. These latter protein pellets were 
then washed twice before resuspension in SDS-PAGE loading buffer. The various samples 
were then resolved by SDS-PAGE and processed for Western blot analyses using anti- 
TbMCA2/3 and anti-p-tubulin antibodies (figure 5.5A). It was observed that, 
independently of the various cell cycle phases, MCA was mainly present in the insoluble 
fraction together with the microtubule constituent, p-tubulin. This finding indicates 
that MCA is not a cytosolic protein and hinted that it  might be associated with the 
microtubular network. Nevertheless, this method of extraction enriches for all Triton 
XI 00-insoluble constituents of the cell, not just microtubules.
Therefore two additional extraction protocols were assessed. The first one was 
based on a microtubule-stabilising buffer used on mammalian cells and previously used 
in Ltropica (Kratzerova et al., 2001), while the second was derived from formerly 
published methods on the preparation of trypanosome cytoskeletons (Woods et al., 
1989; Robinson et al., 1991). Both protocols use non-ionic detergents to solubilise the 
plasma membrane and the internal membranous organelles while the intact microtubule 
cytoskeleton is stabilised by the presence of EGTA and magnesium ions in the buffers. 
The soluble and cytoskeletal fractions obtained were analysed by Western blot. While 
the anti-p-tubulin antibody confirmed that the microtubules were indeed in the 
insoluble fractions, the anti-TbMCA2/3 antibody revealed that these new extraction 
methods largely solubilised MCA (figure 5.5B and C). Nevertheless, a small proportion
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Figure 5.5: Cellular distribution of MCA along cell cycle progression
Non synchronised culture (NS) as well as promastigotes partially synchronised, by HU 
treatment, in G1, S or G2/M phase were analysed (blue labels). Cells were lysed in 0.5% 
Triton X-100 (v/v) in either water or microtubule-stabilising buffer (MSB, 20 mM Mes, pH
6.9, 2 mM EGTA, 2 mM MgClz, (Kratzerova et al., 2001)), in the presence of a cocktail of 
peptidase inhibitors for 15 mins at room temperature (panels A and B, respectively). 
Alternatively cells were lysed in 0.5% Nodinet P40 in PEME buffer (100 mM Pipes, pH
6.9, 2 mM EGTA, 1 mM MgSO^ , 0.1 mM EDTA), on ice for 5 mins (modified from (Woods 
et al., 1989; Robinson et al., 1991)) (panel C). The preparations were then centrifuged 
at 20,000g for 15 mins or at 250g for 30 mins, for the latter, at 4°C. The supernatants 
(S, soluble fractions) were collected for analysis. The pellets were washed twice in 
either water, MSB or PEME and then resuspended in T, TMSB or NP40-PEME (I, insoluble 
fraction). The S and I fractions were separated by SDS-PAGE in a 12% (w/v) acrylamide 
gel. The proteins were then transferred to a PVDF membrane and immunoblotted with 
rabbit anti-TbMCA2/3, anti-RABII and mouse anti- p-tubulin or anti-EFIa. The Western 
blots were then revealed using anti-rabbit or anti-mouse HRP-conjugated secondary 
antibodies and the SuperSignal West Pico chemoluminescent system (Pierce). Equal 
loading within the S fractions or P fractions group was confirmed by BCA quantification 
(Pierce) and Coomassie staining of the SDS-PAGE gels. Molecular masses are indicated, 
in kDa.
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of MCA co-fractionated with p-tubulin. Also it  can be said that depending of the method 
of extraction used, different amounts of MCA were detected in the microtubule 
fractions (figure 5.5A, B and C).
To determine more precisely the protein content of the detergent fractions, 
additional Western blot analyses were performed on cell extracts following 0.5% NP40 
lysis in PEME buffer (figure 5.5C). RAB11, a protein found on the membrane of 
endosomes (Jeffries et al., 2001), and thus not associated with the cytoskeleton, was 
absent from the cytoskeleton fraction, demonstrating the effectiveness of the detergent 
extraction. Interestingly, elongation faction 1 alpha (EF1a) was also detected in the 
cytoskeleton fraction (figure 5.5C). In mammalian cells, EFIa has been shown to 
stabilise microtubules in a calcium/calmodulin-dependent manner in vitro and is thus 
recognised as a microtubule-associated protein (MAP) (Moore et al., 1998). EFIa in T. 
brucei (TbEFIa) similarly binds to calmodulin in vitro (Kaur and Ruben, 1994). Little is 
known about the physical properties of Leishmania EF1a - although it has been reported 
to occur in a Triton-XI00 insoluble fraction (at 100,000g) (Nandan et al., 2003). These 
findings now suggest that LmajEFIa may also be a MAP. Surprisingly, LmajEFIa and MCA 
only partially associate with the cytoskeletal microtubules and most of the proteins are 
solubilised by the detergent extraction (figure 5.5C).
While most of the methods for identifying MAPs rely on their ability to bind 
microtubules in vitro, immunofluorescence analysis was important in demonstrating 
that these proteins were associated with microtubules in vivo (Olmsted, 1986). 
Interestingly, the immunolocalisation of MCA corroborates the detergent extraction 
findings. Indeed, the association of MCA with the mitotic spindle observed in vivo 
(figure 5.4B) confirms that a least a part of the MCA pool interacts with microtubules. 
Also, it  seems that a higher proportion of the MCA pool is associated with microtubules 
during the G2/M phase (figure 5.5C). It is tempting to speculate that this observation 
reflects the presence of MCA on the mitotic spindle during nuclear mitosis. However, it 
is unclear whether the method of extraction used in this experiment is conservative of 
this intranuclear structure and it  might have been solubilised. Furthermore, the cell 
fractionation protocol using 0.5% Triton X-100 in microtubule-stabilising buffer failed to 
confirm this transitory increased association between MCA and the cytoskeletal 
microtubules (figure 5.5B).
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5.3. Genetic manipulation of the MCA chromosomal locus
The studies of MCA expression and localisation suggested that the metacaspase 
might play an essential role during Leishmania division. To gain further insights into 
MCA function, gene knock-out was attempted.
5.3.1. In wild type cells
5.3.1.1. By gene replacement
In order to obtain MCA null mutants, targeted gene replacement was 
undertaken. pGL842 and pGL849, two plasmids containing the 5’ flanking region (FR) 
and the 3' FR of MCA were designed to replace MCA by homologous recombination with 
an antibiotic resistance marker (blasticidin or hygromycin, respectively) (figure 5.6A). 
Multiple attempts to knock-out the first MCA allele were made, with each construct, 
but no transfectant was obtained. Consequently, the transfection protocol was adapted, 
in the following ways, to try to optimise its efficiency. First, two different batches of L. 
major wild type cells were used, one coming from stabilates (WUMP 1815) and the other 
freshly isolated from mouse lesions (WUMP 3888). Then, various different amount of 
plasmid DNA were used for the transfection. The conditions of electroporation were 
modified, e.g. the 0.2 cm electroporation cuvettes were replaced by 0.4cm ones 
(Robinson and Beverley, 2003). And finally, different antibiotics concentrations were 
assessed to favour the selection of the transfectant cells. Unfortunately, all these 
adaptations had no effect on the outcome of the MCA knock-out attempts.
In trypanosomatids, it  is well documented that even though the 5’ and 3’ FRs of 
a given gene are untranslated regions (UTRs), they contain essential information for the 
polyadenylation and the trans-splicing of the genes in 5' and 3’ of the gene of interest, 
respectively (LeBowitz et al., 1993). Any interference with these processes would 
impede the maturation of the transcribed messenger RNA and subsequently their 
translation into protein. While the identity on the gene in 3' of MCA remains unknown, 
the gene in 5' of MCA, LmjF35.1570, encodes a putative methyltransferase 
(www.genedb.org). In case the 5’ and 3’ UTRs used in the MCA knock-out constructs 
disrupted somehow the regulation of the transcription of these genes and affected the 
cell survival, a new approach was tackled.
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Figure 5.6: Schematics of MCA knock-out strategies
ORFs are shown as arrows, intergenic and flanking DNA sequences are shown as boxes.
A) Gene replacement approach. The 5' and 3’ untranslated flanking regions (5'UTR and 
3’UTR) of MCA were amplified by PCR using the primer pairs OL1190-OL1191 and 
OL1192-OL1193, respectively. The 582 bp and 566 bp fragment were cloned, using the 
Hind\\\/Sal\ and Xmal/6g/ll restriction sites, respectively, into pGL896 to generate 
pGL842. The blasticidin cassette (BSD) was then removed by Spel/BamHI digestion and 
replaced by either a hygromycin {HYG) or a phleomycin (BLE) resistance genes, to give 
pGL849 and pGL1033, respectively.
B) Gene disruption approach. The regions used for the homologous recombination are 
parts of MCA gene itself. The fragment covering the 262 first base pairs of MCA was 
obtained by PCR amplification of MCA with OL1397-OL1216, subcloning into the pPCR- 
Script and digestion by Hind\\\/Sal\ (Note that the H/ndlll site comes from the pPCR- 
Script backbone). The last 255 bp were obtained by flstEII/BamHI digestion of OL1188- 
OL1189 amplified MCA. The two fragments were cloned into the pGL842 using its 
Hind\\\/Sal\ and 8stEII/6g/ll restriction sites, respectively (Note that the Bg/ll site being 
lost, the SapI site was consequently used for the linearization of the recombination 
cassette). DHFR, dihydrofolate reductase gene.
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5.3.1.2. By gene disruption
New gene knock-out constructions were designed. Instead of using the 5' and 3’ 
UTRs of MCA for the double cross-over recombination, the first 262 bp and last 255 bp 
of the MCA gene were used (figure 5.6B). This new strategy therefore allowed gene 
knock-out by gene disruption thus ensuring that the genomic environment of MCA was 
not modified and that the expression of genes upstream and downstream of MCA was 
not affected.
Unfortunately, this new strategy did not yield to successful gene knock-out 
either. Again, the removal of the first allele of MCA was impossible. No report of 
incapacity to delete the first allele of a gene in Leishmania has been reported. 
Generally, the first allele of an essential gene can be successfully deleted (e.g. CRK3 
(Hassan et al., 2001)), only the disruption of the second allele induces lethal 
phenotypes or genome rearrangements (triploid chromosomes, tetraploidy, aneuploidy 
(Cruz et al., 1993; Mottram et al., 1996a; Dumas et al., 1997; Tandon and Fraser, 
2002)). One possible explanation could be that MCA locus is present at only one copy 
per genome. However, locus-specific haploidy has never been observed in Leishmania so 
far. Therefore, it  seems likely that the incapacity to delete MCA first allele underlines a 
tight control of the level of expression of this gene and pinpoints its essential role in 
cell survival (Cruz et al., 1993).
5.3.2. In cell lines containing an additional copy of MCA
To confirm that recombination was possible in the MCA locus but also establish 
the primary function of MCA for Leishmania growth, the gene knock-out experiments 
were repeated in cell lines expressing an extra copy of MCA.
5.3.2.I. PptubMCA-TAP
A cell line allowing the expression of tandem affinity purification (TAP) tagged- 
MCA was previously created in the laboratory, by integration of a linearised MCA-TAP 
construct (pGL958) into the L. major p-tubulin locus (Besteiro, S. unpublished data). 
These parasites were transfected with the knock-out cassettes excised from pGL842 
{BSD) and pGL1033 {BLE). The replacement of both chromosomal copies of MCA was 
surprisingly straightforward. Double resistant parasites were obtained and correct 
integration of the knock-out constructs was confirmed by PCR. A Southern blot analysis 
using a part of the MCA open reading frame as a probe and performed on the genomic 
DNA of the mutant parasites corroborated the PCR data and proved that the targeted 
replacement of MCA chromosomal copies had indeed been successful. Indeed, no copy
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of the chromosomal MCA was detected (1.2kb DNA fragment) in the PpjuB MCA-TAP 
Amca::BSD/Amca::BLE cell line (figure 5.7, light green arrow head, line 4).
Surprisingly, the number of copies of the MCA-TAP appeared to be fluctuating 
between the parental, heterozygote and chromosomal null cell lines (figure 5.7, dark 
green arrow head, lanes 2, 3 and 4, respectively). This variable amount of MCA-TAP 
between cell lines could be explained by a possible maintenance of non-linearised MCA- 
TAP construct within the cell. In this case, the level of expression of MCA-TAP would not 
solely be regulated by the p-tubulin promoter, as desired, but mainly by modulation of 
the cellular number of MCA-TAP episome. The decrease of MCA-TAP copy number in 
PpTUB MCA-TAP Amca::BSD/Amca::BLE compared to the parental cell lines could thus 
indicate a physiological need to tightly regulate MCA-TAP expression. Indeed, as 
detailed previously, the level of expression of the wild type MCA seems to be securely 
adjusted during cell growth. It is then possible that, upon removal of both wild type 
copy of MCA, this stringent control was assigned to MCA-TAP expression.
5.3.2.2. MCA-His
To assess whether MCA was essential for L. major survival and infectivity in 
mice, attempts to remove both chromosomal copies of MCA were made in a cell line 
expressing a His- tagged variant of MCA, from an episomal construct. Indeed, once in 
the animal and upon removal of antibiotic pressure, Leishmania tend to lose their 
episomes unless the exogenously expressed protein is essential to the parasite 
persistence within the mammalian host (Vergnes et al., 2005a). If a successful infection 
occurred, the amastigotes would then be extracted from the lesion and the number of 
episomes per cell determined.
Wild type L  major cells were transfected with pGL981 to allow the episomal 
expression of MCA-His (from the pNUS-HcN vector (Tetaud et al., 2002)). While 
populations of drug resistant mutants grew fine, clones were impaired in their growth 
and were tetraploid (see chapter 6). As the populations were expressing detectable 
amount of MCA-His, one of them was chosen to attempt the deletion of MCA 
chromosomal copies. The insert from pGL842 was transfected into this selected cell 
line, to replace one allele of MCA with a blasticidin selectable marker. Mutants 
resistant to blasticidin were obtained. While successful integration of the gene 
replacement cassette was confirmed by PCR, at least one additional MCA locus was 
detected and DNA content analyses revealed that the obtained transfectants were 
actually tetraploid. Therefore, removal of the chromosomal copies of MCA could not be 
achieved.
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Figure 5.7: Removal of MCA locus in a cell line expressing a TAP-tagged 
copy of MCA under the control of the p-tubulin promoter.
A) Southern blot analysis and schematic representation of the wild type MCA locus and 
the plasmid constructs used for expression of MCA-TAP (pGL958) or for MCA gene 
replacement (pGL842, pGL1033). ORFs are shown as arrows, intergenic and flanking DNA 
sequences are shown as boxes. Genomic DNA was digested with PstI, separated on a 
0.8% agarose gel, blotted on a nylon membrane and hybridised with ^^P-labelled PstI 
digested MCA ORF as a probe. The sizes of the DNA fragments labelled are indicated. 
Restriction enzymes of particular interest are shown. BSD, blasticidin resistance gene; 
DHFR, dihydrofolate reductase gene; HYG, hygromycin resistance gene; BLE: phleomycin 
resistance gene. B) Western blot analysis. Lysates corresponding to 10^  promastigotes 
were, after transfer onto a PVDF membrane, hybridised with rabbit anti-TbMCA2/3 
antibody at a 1:10,000 dilution. Revelation was performed using an anti-rabbit-HRP 
conjugated secondary antibody (Promega) and West Signal chemoluminescence 
detection system (Pierce). Lane 1: wild type L. major; Lane 2: Ppxue MCA-TAP; Lane 3: 
PpTUB MCA-TAP Amca:: BSD / MCA ; Lane 4: Ppjue MCA-TAP Amca:: BSD / Amcar.BLE. The 
molecular mass size markers are shown on the left.
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Whether the tetraploidy results from the cloning of the transfected cell line, or 
from the attempt to delete the genomic MCA, remains uncertain. Possible ways to solve 
this issue would involve an improvement of the transfection efficiency to avoid the 
selection of clonal transfectants and a removal of the antibiotic pressure to reduce the 
episome copy number. Indeed, if  the episomally-drived expression of MCA-His is 
essential to the removal of the chromosomal MCA, then it  is very likely that the cells 
would conserve their episomes even in the absence of antibiotic selection. Furthermore, 
in such conditions, the level of expression of MCA-His would be minimal and would 
potentially tightly match the cellular requirements for the metacaspase. Consequently, 
the tetraploidy phenotype associated with the overexpression of MCA-His might be 
abrogated and new MCA knock-out attempts would be possible.
5.3 2.3. PrRNA MCA and P^rna MCA”’‘‘"
MCA and an MCA""'* active site mutant were integrated independently into the 
18S rRNA locus of wild type L. major. Integration was confirmed by PCR (figure 5.8Aa, 
b). A single MCA allele could be removed successfully from both cell lines (figure 
5.8Ac, d, e, f), but i t  was not possible to remove both MCA alleles; in all cases an 
additional copy of the MCA locus was detected (figure 5.8Ag, h).
DNA content analyses were performed on the various cell lines (figure 5.88). It 
is established that cells in G1 phase of the cell cycle are diploid (2C) while those in 
G2/M are tetraploid (4C) and the ones in S phase are between both. Within a given 
culture, Leishmania cells can be at different phases of the cell cycle. Nevertheless, 
even during the early periods of Leishmania promastigotes growth, when the growth 
rate is at its highest, cells in the G1 phase represent about 65% of the population. While 
the ploidy of the PrRNA MCA and the single MCA allele deletion cell line PrRNA MCA 
Amcar.BSD was found to be normal, the removal of the second allele of the 
chromosomal MCA resulted in the duplication of the cellular DNA content (figure 5.882, 
3 and 4, respectively). These cells also exhibited a slower growth rate than wild type 
(figure 5.8C, compare 4 with 1), and had similar defects in cell cycle progression as 
observed with WT[MCA] type 2 transfectants (refer to chapter 6).
Surprisingly, the PrRNA MCA Amca::BLA/Amca::HYG/MCA cell line showed a 
growth defect whereas the PpTUB MCA-TAP Amcar.BSD/Amcar.BLE cell line did not. One 
possible explanation, which could also account for the tetraploidy phenotype, is that 
the expression of the exogenous MCA is in PrRNA MCA Amcar.BLA/Amca::HYG/MCA 
controlled by the 18S rRNA promoter while in PpiuB MCA-TAP Amca:: BSD/Amca:: BLE is 
episomal and thus potentially reaching higher levels and producing an overexpression 
phenotype (refer to chapter 6).
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Figure 5.8: Removal of MCA locus In cell lines expressing an additional copy 
of MCA or MCA^^^^ ,^ under the control of the 18S rRNA promoter.
A) Upper panel. Schematic representation of the 18S rRNA locus, the wild type MCA 
locus and the plasmid constructs used for integrative ectopic expression of MCA 
(PGL1399), (pGL1400) or MCA gene replacement (pGL849, pGL842). ORFs are
shown as arrows, intergenic and flanking DNA sequences are shown as boxes. BLA, 
blasticidin resistance gene; DHFR, dihydrofolate reductase gene; HYG, hygromycin 
resistance gene; PAC: puromycin resistance gene. The pairs of oligonucleotides used for 
PCR amplifications, as well as the sizes of the fragments generated are indicated. Lower 
panel. The PCR reactions were performed to assess the integration of pGLI 399 or 
pGL1400 inserts into the 18S rRNA locus (a, b), the integration of pGL849 insert (c, d) 
and pGL842 insert (e, f) in the wild type MCA locus, and the integrity of the wild type 
MCA locus (g, h). Integration or integrity in the 5’ (a, c, e, g) and the 3’ (b, d, f, h) of 
the loci were tested.
B) DNA content analysis performed by FACS. The peaks representative of the cell count 
per arbitrary fluorescence units (AFU) indicates diploid (2C), tetraploid (4C) or octaploid 
(8C) cells.
C) Representative growth curves performed on the wild type (1), PrRNA MCA 
Amcar.BLA/Amcar.HYG/MCA (4) and PrRNA MCA"^ ^^  ^ Amca::HYG/Amcar.BLA/MCA (7) 
cells.
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Attempts to remove the second MCA allele in the PrRNA Amcar.HYG cell
line lead to a duplication of MCA locus, but not of the entire DNA content, as the cell 
line was still diploid (figure 5.8B7). This finding suggests that firstly, MCA"^ "*^ * might 
indeed be a catalytically inactive mutant, and secondly that MCA exhibits an essential 
enzymatic activity that is indispensable for cell survival.
5.4. Phenotype analysis of the P r^na Amca::HYG/Amca:
:BSD/MCA mutant
Less pronounced than during MCA overexpression, a slow growth phenotype was 
nevertheless observed for Pprna MCA"^ "^ *^ Amcar.HYG/Amcor.BLA/MCA (figure 5.8C, 
compare 7 to 1). The slow growth rate could be explained by observation of the 
nucleus and kinetoplast configurations (figure 5.9A). A build up of cells in 2N2K2F 
(12.9% compared to 4.6% in the WT) and a decrease of cells in G1 phase (1N1K1F and 
1N*1K*1F, “ 1N^ *^ 1K^ *hF” from 63.1% to 52.1%) was observed suggesting a defect in 
cytokinesis (figure 5.9A, left panel). The increase in 2N2K2F cells was due to an 
accumulation of cells engaged in cytokinesis (11.9% compared to only 3.8% in the WT). 
Similarly, a detailed analysis of the additional cells with other configurations (16.5% 
against 10.0% for the WT) revealed the presence of aberrant cells in which cytokinesis 
was impaired (figure 5.9A, right panel). Most of those cells had started cytokinesis but 
were delayed in its completion by improper organelle segregation, inaccurate organelle 
positioning or aberrant axis of progression of the cleavage furrow (figure 5.9B). In 
parallel, the reduction in the number of cells in 1N*^2K2F (from 12.3% to 6.7%) 
underscored a potential delay in the onset of mitosis, which might subsequently account 
for impaired nuclear partitioning.
5.5. Discussion
In the present chapter. Western blot analyses performed on L. major extracts 
firstly showed that MCA was slightly bigger than the predicted molecular weight. This 
size difference might be due to post-translational modifications such as glycosylation, 
phosphorylation, ubiquitination, ... (ivens et al., 2005) and therefore underpins that the 
stability/degradation of MCA might be stringently adjusted. Furthermore, the presence 
of additional proteins of mainly -38-40 kDa and - 30 kDa suggest that MCA might be 
processed and that its biological function might be regulated by this mechanism. For 
caspases, processing leads to the formation of large and small sub-units which remain 
tightly associated through covalent interactions and to the subsequent dimérisation and 
catalytic activation of the protein complex. Also, active caspases being involved in
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Figure 5.9: The PrRNA Amca:: HYG /  Amca::BSD /  MCA mutant
shows a delay in kinetoplast segregation, nuclear division and cytokinesis.
A) Classification of the various cell configurations observed in the wild type (white bars) 
and mutant (blue bars) based on DAPI staining and cell morphology. Sub-groups of the 
cells classified in “others” are shown on the right panel. N: nucleus; K: kinetoplast; F: 
flagellum. Impaired cytokinesis refers to a group of cells having an ingressing cleavage 
furrow. F<K and F>K correspond to the cells with a number of nuclei different from the
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number of flagella and where the number of flagella was either smaller or bigger than 
the number of kinetoplasts.
B) Immunolocalisation of MCA and /or MCA^ "^*^ i^n various types of aberrant cells.
Fixed cells were labelled with rabbit anti-TbMCA2/3 and anti-rabbit Alexa Fluor 488- 
con jugated antibodies (green). DAPI staining of the nuclear and kinetoplast DNA is 
shown in blue. An example of a 2F2K2F is shown in (a). Pictures of cells classified in the 
“ impaired cytokinesis” or “ unclassified” groups are presented in b-f and g-h, 
respectively. The white arrows highlight structures at the base of the flagellum that 
were labelled by the antibodies. The white arrow heads point the kinetoplasts.
apoptotic cell death, their processing is closely controlled by mammalian cells 
(Earnshaw et o/., 1999). Interestingly, it  was observed that, to gain their full enzymatic 
activity and exert their biological functions, caspases undergo (auto)processing and 
intracellular translocation (Kamada et a/., 2005). Indeed, nuclear degradation, one of 
the main features of apoptosis, is triggered by the translocation of several cytoplasmic 
caspases into the nucleus and the subsequent cleavage of nuclear proteins such as the 
lamins, the poly (ADP-ribose) polymerase (PARP), DNA-dependant protein kinase, DNA 
topoisomerase I, DNA replication factor RFC-140, RAD51 and members of the cohesion 
complex (e.g.RAD21) (Earnshaw et al., 1999; Porter, 1999; Fuentes-Prior and Salvesen, 
2004).
In L. major, immunofluorescence analyses revealed that MCA was transiently 
present in the nucleus. However, this nuclear “ translocation” occurred upon mitosis 
onset rather than, like in mammalian cells, after initiation of apoptosis. Also, MCA was 
not randomly distributed in the nucleus but was mainly associated with the mitotic 
spindle. Interestingly, some of the substrates cleaved by caspase during apoptosis play, 
in mammalian cells, crucial roles in cell division. Indeed, some of the PARP family 
members localise to the mitotic apparatus (Schreiber et al., 2006).While PARP-1 and 
PARP-2 are mainly associated with the chromosome centromeres, vPARP bind to the 
kinetochore microtubules of the mitotic spindle. Thus, the presence of MCA on the 
mitotic spindle might underscore an interaction with its potential substrate. Although 
no gene encoding for vPARP was identified in L. major, other members of the PARP 
family are present. Thus it  can not be excluded that some of these proteins might 
resume vPARP functions and that MCA might mediate its processing. However as the 
intracellular targets of MCA remain unknown, these remarks are highly speculative and 
the exact function of MCA on the mitotic spindle still awaits elucidation.
The restricted intranuclear localisation of MCA argues against an involvement in 
programmed cell death and rather suggests functions in cell proliferation. Also, while 
programmed cell death occurs principally in aging cells (Lee et al., 2002; Herker et al., 
2004), MCA is present at a higher level in actively dividing logarithmic phase cells than 
in quiescent stationary phase cells, providing evidence for a role for the metacaspase in
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cell division. Consistent with this observation was the finding that MCA intracellular 
localisation changes at different time points during cell cycle progression. Indeed, 
immunofluorescence experiments showed that initially distributed throughout the cell 
in punctuate structures of unknown nature, some MCA relocates to the kinetoplast at 
the onset of kinetoplast segregation, then later to the mitotic spindle during mitosis 
and, finally, close to the cleavage furrow at a late stage of cytokinesis. Therefore, MCA 
might not only be involved in mitosis but also in kinetoplast segregation and cytokinesis 
as strengthened by the phenotypical analyses of the PrRNA MCA"^ ^^  ^ Amca:: HYG / 
Amco::BLA / MCA mutant. Indeed, in this cell line, the reduction in the amount of 
active MCA in the cell led to an impairment of kinetoplast and nucleus division and a 
delay in cytokinesis. Moreover, all the failed attempts to produce a MCA chromosomal 
null mutant underscore the essential role played by MCA in the cell.
Also, as we were unable to remove the first allele of MCA from L. major genome 
without expression of an MCA transgene, it  suggests that the level of expression of MCA 
is very tightly regulated. Indeed, we observed that L. major adapted so as to keep at 
least one active copy of MCA. Removal of the two chromosomal copies of MCA was 
achieved successfully in a cell line containing episomal copies of the gene, but was 
accompanied by modulation of the number of MCA-bearing plasmids within the cell. 
When an extra copy of MCA was integrated in the genome, the first allele of MCA locus 
could be disrupted, but attempts to replace the second allele led to tetraploidy. This 
duplication of the genome could be explained by the fact that in this cell line the extra 
copy of MCA was integrated into the 18S rRNA locus and the regulation of the level of 
expression of the protein was perturbed and ultimately led to an accumulation of MCA 
in the cell and a phenotype previously observed during MCA overexpression. While 
tetraploidy has previously been reported to occur when attempting to knock-out an 
essential gene (Cruz et al., 1993), it  was unlikely that the genome duplication observed 
during MCA overexpression and in the present case resulted from such process. Indeed, 
attempts to remove the two chromosomal alleles of MCA from a cell line containing a 
catalytically inactive extra copy of MCA (AICA"^ ^^ )^ led to duplication of the MCA wild 
type locus, but not of the entire genome. This provides evidence that MCA function is 
linked to genome replication and that the cysteine peptidase catalytic activity of MCA is 
essential for cell survival.
In eukaryotic cells the cytoskeleton is involved in multiple vital processes such as 
cell growth and division, motility, intracellular organelle trafficking and morphogenesis. 
Intimately linked together, three main types of filaments form the backbone of the 
cytoskeleton. First, the actin filaments (microfilaments) give the cell its surface shape, 
its polarity, its ability to move and mediate cytokinesis. Second, the intermediate 
filaments confer mechanical strength to the cell and mediate crosstalk between
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cytoskeletal proteins. And last but not least, the microtubules regulate intracellular 
traffic of proteins, vesicles and organelles as well as their positioning and are required 
for execution of mitosis (e.g. mitotic spindle formation) (Goode et al., 2000; Rodriguez 
et al., 2003; Chang and Goldman, 2004). The observation that MCA co-localise at least 
transiently with p-tubulin and its partial association with the cytoskeleton underpins the 
potential interaction of MCA with various types of cytoskeletal filaments.
Microfilaments are poorly characterised in Leishmania, but genes encoding actin 
and myosin are present in this parasite. In L. donovani, actin was shown to be present in 
the nucleus, kinetoplast and in a plasma-membrane associated network that co­
localised with the sub-pellicular microtubules (Sahasrabuddhe et oL, 2004). While L. 
major apparently lacks genes coding for the intermediate filament proteins vimentin 
and desmin, epitopes common to the mammalian proteins can be detected in 
Leishmania promastigotes with anti-vimentin antibodies (Draberova et al., 1986; 
Kratzerova et al., 2001 ). The detected 57 kDa protein was located only on cell poles and 
was most marked during cell division. A 210 kDa microtubule-associated protein (MAP) 
was found to co-distribute with the vimentin/desmin-like 57 kDa protein at the anterior 
and posterior poles of cells, in a cell-cycle-dependent manner (Kratzerova et al., 2001). 
Direct fluorescence observation of MCA"^ ^^ *-GFP revealed that, similarly, this protein 
accumulated at the posterior end of L. major suggesting that MCA might, like the 
previously reported 210 kDa L. donovani MAP, interact with intermediate filament-like 
proteins. In mammalian cells intermediate filaments such as the nuclear lamins, 
keratins and vimentin were found to be substrates of caspase-3 (Prasad et a i,  1999), so 
we can postulate that MCA might act on intermediate filament-like proteins and 
participate in cellular remodelling during the cell cycle. Most importantly, in addition to 
its association vrith the mitotic spindle, we were able, after detergent extraction, to 
demonstrate by Western blot that MCA partially associates with cytoskeletal 
microtubules. Therefore, through its association with the sub-pellicular microtubules of 
the cytoskeleton, MCA may play a crucial role in cell division.
indeed, overexpression of MCA led to a rapid growth arrest due to defect in 
kinetoplast segregation, mitotis and cytokinesis. In T. brucei kinetoplast segregation 
and cytokinesis are mediated by sub-pellicular microtubules (Robinson et aL, 1995). T. 
brucei procyclic cells overexpressing the sub-pellicular proteins CAP15 and CAP17 
duplicate but fail to segregate their kinetoplast and lose their kinetoplast 
duplication/cytokinesis coordination (Vedrenne et al., 2002). An association of MCA 
with filaments of the cytoskeleton provides an explanation of the phenotype when MCA 
is overexpressed, such as a severe impairment of cell division.
Remarkably, while caspases have mainly been reported to mediate cell death, 
recent findings suggest that they also possess fundamental apoptosis-independent
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functions, their crucial tasks paradoxically also favouring cell survival, differentiation, 
proliferation, receptor internalisation, cytokine maturation and cell spreading 
(Algeciras-Schimnich et aL, 2002). In the present work, we showed that MCA plays an 
essential role in the Leishmanio cell cycle but no role for MCA in L. major programmed 
cell death has been identified. Yet MCA has recently been shown to complement the 
programmed cell death-inducing function of the yeast metacaspase (Gonzalez et al., 
2006). In mammals, cell proliferation and cell death are essential yet opposing cellular 
processes, but an essential function for programmed cell death in parasitic protozoa 
remains controversial. Nevertheless, we can postulate that MCA might mediate crosstalk 
between these processes and promote a balance between proliferation and death. Also, 
knowing the crucial role played by the microtubules and other cytoskeletal filaments on 
the spatial organisation of signal transduction, then maybe, MCA, which associate with 
this network, also plays a role in transmission of signals to downstream targets 
(Gundersen and Cook, 1999). The biochemical characterisation of the L. major 
metacaspase and the identification of its in vivo substrates should provide new insights 
into its function.
145
Chapter 6:
Expression of MCA in L. major, E. coH 
and P. pastoris
Chapter 6: Expression of MCA in L  major, E. coli and P. pastoris 146
6.1. Expression in Leishmania major
6.1.1. Constructs generated
Previous experiments had showed that the removal of the chromosomal copies of 
MCA could not be achieved in wild type L  major, so the possible functions of MCA 
within the cell were assessed by episomal expression of several variants of the protein. 
Alignments between metacaspases and caspases were performed (chapter 4) and 
protein residues or domains for which functional analyses would be most revealing were 
chosen.
Within the MCA active site region, the catalytic cysteine was predicted to be 
C202. A mutant of the L  major metacaspase was created by changing C202 into a 
glycine, a residue lacking the sulfhydryl group predicted to be involved in MCA catalytic 
mechanism. The generated MCA^ °^^ ° was thus theoretically catalytically inactive.
Furthermore, MCA is predicted to possess either a signal peptide cleavage site or 
a proregion processing site between residue 28 and 29 (refer to chapter 4). To analyse 
the putative role of this particular domain, a 35 amino acid long N-terminal region was 
removed from the potentially catalytically active and inactive variants of MCA (to give 
AproMCA and AproMCA*'^ ®^ )^. In addition, to allow the visualisation by fluorescence and 
immuno-detection of these proteins. Green Fluorescent Protein (GFP) or polyhistidine 
(His) tags were fused to their C-terminus. Two expression vectors were used for this 
purpose, the pNUS-GFPcN and the pNUS-HcN (Tetaud et al., 2002), both using a 
neomycin (G418) resistance gene as the selection marker.
The plasmid constructs encoding the various proteins of interest were then transfected 
and expressed in L  major promastigotes. Surprisingly, while generally 50 p.g ml^ of 
G418 is used for the selection of L  major transfectants, in this case no transfectant was 
obtained until the G418 concentration was lowered to 15 jig ml \  Even so, most of the 
transfectants obtained had a severe growth phenotype and an abnormal shape (table 
6.1). The presence and expression of the plasmid constructs within the transfectants 
was confirmed by PCR and Western blot analyses (figure 6.1.), respectively. The 
exogenous expression of the full length active MCA, the potentially catalytically 
inactive, as well as the N-terminally truncated MCA all seemed to be toxic for the cells. 
As all the MCA variants had GFP or histidine tags at their C-terminus (table 6.1), it  was 
thought that the tags might be interfering with the function(s) of the episomally 
expressed proteins and thus leading to the prevalence of the phenotype observed. 
Indeed, the steric hindrance created by the tags might induce the expressed proteins to 
misfold or might inhibit/promote physical interactions with other proteins. So, new
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Cell lines His-tag GFP fusion No tag
pGL P/T (P%) pGL P/T (P%) pGL P/T (P%)
WT [MCA] 981 4/6 (67%) 985 5/6 (83%) 1128 1/4 (25%)
WT [MCA“ “ ®] 982 2/4 (50%) 986 5/6 (83%) 1/15* (7%) 1129 2/4 (50%)
WT [AproMCA] 983 1/6 (17%) 987 5/6 (83%) 1130 0/1
WT [AproMCA''^^®] 984 2/5 (40%) 988 5/6 (83%) 1131 1/4 (25%)
WT [MCA^^°^°] - 1293 0/16 1294 0/3
WT [MCA^^°^^°^ ]^ - 1295 0/16 1296 0/0
WT [MCA^^^^ ]^ 1401 3/9 (33%) 1402 2/8 (25%) (1406) -
WT [Nterm-GFP] - 1109 0/2 “
WT [Cterm-GFP] - 1108 0/3 -
WT [MCAACterm] - 1110 3/8** (37%) -
WT [AproMCAACterm] - 1111 0/10 -
WT [eNterm-GFP] 1403 1-4***/5 (20-80%) -
WT [GFP-eCterm] - 1404 0/10 -
WT [eNterm-GFP-Cterm] - 1405 1/7 (14%) -
Table 6.1; Summary of the MCA variants expressed in L. major and the 
proportion of cells showing a phenotype
The constructs generated as well as their matching pGL numbers are show. For each 
construct, the total number of transfectants is indicated (T, second number) as well as 
the number of cells showing a phenotype (P, first number). The percentage of 
transfectants with a phenotope over the total number of transfectants is indicated (P%). 
(-) indicates variants that were not created or transfected into L  major. (*) Western 
blot analysis revealed that of the 15 transfectants, only the one with a phenotype was 
expressing detectable amount of the MCA variant. (**) Note that the transfectants with a 
phenotype expressed the expected size MCA variant while the others have a N- 
terminally truncated variant (see text). (***) While initially growing well immediately 
after selection, 3 transfectants showed a phenotype after less than two weeks in 
culture.
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constructions were generated to allow the expression of the multiple MCA variants 
without any tags.
However, transfectants expressing the non-tagged MCA variants were also 
difficult to obtain. Only by decreasing the antibiotic pressure could plasmid-bearing 
cells be isolated. And still many of the created cell lines experienced difficulties in 
multiplying and developing properly (table 6.1); a phenotype strikingly comparable to 
the one observed upon expression of the C-terminally tagged MCA variants. Therefore, 
the growth phenotype could not be attributed to the presence of the C-terminal tags, 
but rather suggested the involvement of the metacaspase itself. However, as the WT 
[MCA^ °^^ ] cell line had a similar phenotype as the WT [MCA] cell line (table 6.1), it 
seemed that the phenotype was not due to the metacaspase enzymatic activity. 
Nevertheless, as an additional cysteine residue is immediately adjacent to the predicted 
active site cysteine, we could not rule out that this neighbouring residue, C201, might 
be involved in the catalytic activity of the metacaspase. In that case, what was thought 
to be a catalytically inactive mutant might instead still be functional.
Thus, to establish whether the observed growth phenotype was linked with the 
proteolytic function of the metacaspase, additional active site mutants were generated. 
C201 alone or together with C202 was mutated to a glycine residue (MCA^ °^^  ^ and 
Mca^^ o^i-zoig) jç previously postulated that C81, or even several other cysteines, 
might be involved in catalysis (see chapter 4), so instead of mutating all these 
potentially important residues, the inactivation strategy was shifted toward the active 
site histidine (HI47). Indeed, by replacing H147 with an alanine residue (MCA"^^ *^), the 
de-protonation and estérification of the active site cysteine will be prevented and the 
catalytic mechanism will subsequently be ineffective. Surprisingly, while WT [MCA‘' °^^^ ] 
and WT [MCA^ °^^ '^ °^ ]^ cell lines grew at a rate comparable to the wild type cells, some 
cell lines carrying the MCA"^ "^ *^ construct had impaired growth (table 6.1). Thus whether 
the enzymatic activity of the metacaspase is involved in the observed growth phenotype 
remains an open question.
The WT [AproMCA] and transfectants expressing N-terminally truncated MCA 
variants were slightly less affected in their survival ability than the ones expressing the 
full length MCA variants. A potential involvement of the N-terminal domain in the 
correct targeting of the metacaspase was therefore suspected. To confirm this 
hypothesis, the first 21 amino acids of MCA were fused to GFP (to give Nterm-GFP). At 
the same time, I evaluated the possible role of the C-terminal domain in MCA trafficking 
by generating a GFP fusion of the last 108 amino acids (Cterm-GFP). Upon transfection 
into the parasite, the expression of Nterm-GFP or Cterm-GFP was confirmed and their 
respective intracellular localisations were determined. Like the GFP within the control 
cell line, Nterm-GFP and Cterm-GFP were found to be present in the cytosol of the cell.
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Therefore it  was deduced that these domains were unlikely to mediate the targeting or 
trafficking of MCA to a special compartment or organelle. Nevertheless, Western blot 
analysis of these overexpressing cell lines revealed that Cterm-GFP was extensively 
processed in the cell (figure 6.1G), suggesting it  was degraded. Also, it  was impossible 
to determine whether the observed fluorescent signal was due to Cterm-GFP or some of 
its cleavage products. However, even if  no growth phenotype were associated with the 
expression of Cterm-GFP, its intensive degradation within the cells suggested that this 
domain of MCA might be somehow not properly folded or detrimental to the cells. 
Interestingly, this observation overlapped with the previous finding that transfectants 
expressing C-terminally GFP-fused MCA variants were more susceptible to growth 
impairment then the ones expressing non-tagged variants. Both sets of data suggested 
that the C-terminal domain of MCA might possess a defined function and that any 
interference with it  was detrimental for the cell. The MCA C-terminal domain is rich in 
proline, glutamine and tyrosine residues that potentially could be involved in protein- 
protein interactions (refer to chapter 4), so it  is conceivable that the contiguous 
presence of a bulky 25 kDa GFP protein might impede this function.
To investigate the role of the C-terminal extension several variants of MCA 
lacking their last 108 amino acids were created (constructs MCAACterm-GFP and 
AproMCAACterm-GFP) and expressed in L, major. Interestingly most of the transfectants 
grew normally, suggesting that the previously observed slow growth phenotype was 
probably linked to the presence of the MCA C-terminal domain within the cells. 
Nevertheless, a few WT[MCAACterm-GFP] transfectants had a growth defect. Western 
blot analysis with anti-GFP antibodies revealed that one of these slow growing 
transfectants was expressing the expected size MCAACterm-GFP, while the 
transfectants which grew normally contained a shorter protein that was most likely N- 
terminally truncated (figure 6.1H). Also, the WT[AproMCAACterm-GFP] transfectants 
were all found to express the expected size protein. However, the anti-GFP antibodies 
also detected a -30 kDa protein (figure 6.1H), suggesting that AproMCAACterm-GFP was 
processed near its C-terminus. Taken together, these data indicate that the 
metacaspase is processed in both its N- and C-termini and that the N-terminal domain of 
MCA might be associated with the growth phenotype. Furthermore, it  seemed that the 
cleaved domains, and the C-terminal one in particular, might be slightly larger that the 
ones predicted initially (chapter 4). To assess i f  the previously generated Nterm-GFP 
and Cterm-GFP constructs were too short to be able to target the protein properly or 
allow its interaction with other proteins, new constructions encoding extended N- and 
C-terminal domains of MCA (101 and 179 amino acids, respectively) were generated ( to 
give eNterm-GFP and GFP-eCterm). In addition, in case both the N- and C-terminal
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Figure 6.1: Analyses of L. /nayor transfectants expressing MCA variants
Transfectants showing (Type 2, T2) or not (Type 1, T1) an impaired growth phenotype 
and a tetraploid DNA content were analysed. A) Representative growth curves. B-l) 
Western blot data. For each blot, a colour code indicates the antibodies that were used 
(legend in the yellow box). TK refers to L  mexicana transketolase (70kDa). Molecular 
masses are indicated on the left and show, from top to bottom: 83, 62 (thicker band), 
47.5, 32.5 and 25 kDa control proteins. Proteins of interest are indicated with a black 
arrow head, those of unknown identity are shown with a grey arrow head. (*): cross­
reacting band of -83 kDa seen with the anti-GFP antibodies.
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domains of MCA are needed for the protein’s proper targeting, an additional construct 
with both domains was produced (eNterm-GFP-eCterm). The plasmids encoding these 
MCA variants were then transfected and expressed in Leishmania. Surprisingly, while 
initially growing at a rate comparable to the wild type, the cell lines expressing the 
construct with the extended N-terminal domain of MCA started to be impaired in their 
growth after about two weeks in culture (table 6.1.). Thus, this domain of MCA seems 
to be able to mediate the appearance of the overexpression growth phenotype. Western 
blot analyses were performed (figure 6.11.) and are detailed in the section below. In 
addition, the cellular localisation of these last MCA variants was assessed and 
unexpectedly gave new insights into the potential functions of MCA (section 6.1.3).
6.1.2. Phenotype analyses
6.1.2.1. Altered growth rate
In the previous section, I described the different constructs that were generated 
for the study of MCA function as well as the rationale behind their design. Also, to make 
the analysis of the results easier, I only referred to the primary screen of the 
transfectants isolated, which was based on their growth rate compared to the wild 
type. Many growth experiments were performed, but again, to simplify, I decided to 
present a single example (expressors of non-tagged MCA, WT[MCA], figure 6.1 A). Also it 
should be noted that the expression of the different variants of MCA being based on 
episomal systems (Kelly et al., 1992; Tetaud et al., 2002), thus the plasmid copy 
numbers and subsequently the levels of protein expression could vary from one cell to 
the another. Therefore, it  was impossible to compare the growth rate of the 
developmentally-affected transfectants between one MCA variant and another, as there 
were already some growth rate variations within groups of transfectant expressing the 
same MCA variant. Accordingly, transfectants expressing the same MCA variant were 
classified in two groups. Type 1 refers to the transfectants that were growing at a rate 
comparable to the wild type cells while type 2 included all those that had an impaired 
growth rate (figure 6.1 A). It was observed that while the transfectants coming from 
populations were generally growing like the wild type cells, most of those that were 
clonal were classified as type 2. Whether this finding results from the prolonged 
selection time of the clone compared to the population or reflects MCA involvement in 
growth from a single cell remains unclear.
Also, Western blot analyses were performed to detect any possible correlation 
between the level of expression of the MCA variants and the severity of the growth 
phenotype observed.
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6.1.2.2. Western blot analysis
For most cell lines obtained there was a relationship between the level of 
expression of the MCA variants and the occurrence of a type 2 phenotype. Indeed, type 
2 transfectants in the main expressed more MCA variant than the type 1 cell lines 
(figure 6 .IB, C, D). Thus the evidence suggested that the observed phenotype was not 
due to the presence of the shuttle vectors within the cell or to the transfection 
procedure but truly to the expression of the protein of interest.
However, in some particular cases it  was impossible to establish such a 
correlation. Indeed, for MCA^ ®^^ *^ , AproMCA^ ^®^  ^ (figure 6 ,IB), MCA"^ "*^  ^ (figure 6.1D, E) 
and eNterm-GFP-eCterm (figure 6.11), there was no obvious difference in the level of 
expression of either the variant MCA and the wild type MCA between the type 1 (T1 ) 
and type 2 (T2) transfectants. While the type 2 phenotype remains unexplained for cells 
expressing MCA"^ ^^ *, the detection of additional protein products (figure 6.IB, grey 
arrow head) in type 2 transfectants expressing MCA^ °^^ ° and AproMCA^ ^®^  ^compared to 
the type 1 transfectant expressing the same MCA variants suggest that alternative 
processing/degradation might be occurring in those former cells. Nevertheless, it  was 
also observed that the expression of particular MCA variants was somehow affecting the 
expression of the wild type MCA. For example, expression of the GFP-fused extended N- 
terminal domain of MCA (eNterm-GFP), resulted in a considerable augmentation of the 
expression level of the wild type MCA (figure 6.11).
The expression of various truncated forms of MCA allowed us to unravel some 
aspect of the processing of the protein in vivo. Indeed, removal of - 5 kDa and - 15 kDa 
peptides in the N- and C-terminal region of most of the MCA variants was observed. This 
was particularly distinguishable when performing Western blot using anti-GFP antibodies 
on the cell lines expressing MCAACterm-GFP and AproMCAACterm-GFP (figure 6.1H). 
Interestingly, the wild type MCA seems indeed to be processed as a consistent pattern 
of protein products was observed (chapter 5). Furthermore, expression of non-tagged 
variants of MCA confirmed that the full length protein as well as the observed 
processing products, detected in the wild type with the anti-TbMCA2/3 antibodies, was 
indeed the L  major metacaspase (figure 6.IB). Nevertheless, it  was impossible to 
clearly identify the positions within the peptide sequences where the cleavages occur.
Meanwhile, some MCA variants, MCA“ °^ *^  and MCA^ °^^ '^ °^  ^ for example, showed 
alternative processing with the appearance of additional protein band(s) on Western 
blots (figure 6.IF , grey arrow head). Whether this was due to break down products or 
an impairment of their autoprocessing ability is still obscure. However, i t  is tempting to 
speculate that this alternative processing might impede the function of these MCA
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variants, as none of the corresponding transfectants were found to be impaired in their 
growth and all were expressing a detectable amount of the protein of interest.
6.1.2.3. Tetraploidy
In my attempt to identify the cause of the lowered growth rate, a FACS analysis 
of the cellular DNA content was performed. While the type 1 transfectants had a diploid 
2C-4C DNA content comparable to the wild type cells, all the type 2 transfectants had a 
tetraploid 4C-8C content (figure 6.2A). In several cases, an increase in the antibiotic 
pressure induced the appearance of a type 2 phenotype in transfectant previously 
classified as type 1. Therefore, concomitant with the growth impairment, the level of 
expression of the MCA variants is also linked with the tetraploidy phenotype. DAP I 
staining of representative type 2 cells showed that they had normal nuclear and 
kinetoplast configurations, but with twice the DNA content (figure 6.2Cb), indicating 
that the synchronisation between DNA duplication and its subsequent segregation is 
somehow impaired.
6.1.2.4. Defect in kinetoplast and nuclear division and cytokinesis 
impairment
In order to explain the tetraploidy phenotype, 1 decided to investigate whether 
cell cycle progression was somehow affected in the type 2 transfectants. To do so, a 
particular cell line was selected, in the present case, a type 2 transfectant expressing 
MCA without any tag (WT [MCA] type 2) was used, and a DAP I staining -based analysis of 
its nuclear and kinetoplast configurations was undertaken.
Comparison of the various cell configurations in WT [MCA] type 2 transfectant 
and wild type cells, revealed a reduction in cells in early mitosis (1N*^1K*2F, from 12.3% 
in WT to 0.9% in WT [MCA]), a moderate reduction of cells with two nuclei, two 
kinetoplasts and two flagella (2N2K2F, from 4.6% to 1.9%) and a doubling of cells with 
other configurations (from 10.0% to 20.6%) (figure 6.26, left panel). Consistent with 
the decrease in the number of cells undergoing mitosis, an accumulation of aberrant 
cells with one or several mitotic nuclei (as indicated be the presence of a mitotic 
spindle, figure 6.2Cd) and multiple kinetoplasts and flagella were observed, indicating 
that mitosis was delayed in the WT[MCA] type 2 transfectants (“ impaired mitosis", 
figure 6.26, right panel). Additionally, most of the 2N2K2F cells had an aberrant 
positioning of the nuclei and kinetoplasts (figure 6.2Cc) and only very few were found 
to be undergoing cytokinesis (figure 6.26, left panel). In WT [MCA] type 2 transfectants 
a high number of aberrant cells with differing configurations of nucleus.
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Figure 6.2: Phenotypes associated with the overexpression of MCA in 
Leishmania
A) FACS analysis of the cellular DNA content. Cell lines expressing MCA variants were 
classified as type 1 when growing at the same rate as wild type cells or as type II when 
showing an impaired growth rate. A representative example of the DNA content analysis 
performed on each of these groups is showed.
B) Classification of the various cell configurations observed in the wild type (yellow 
bars) and WT[MCA] type 2 (purple bars) cells, based on DAP I staining and cell 
morphology. Sub-groups of the cells classified in “others” are shown on the right panel.
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N: nucleus; K: kinetoplast; F; flagellum; N* :^ nucleus in mitosis; F<K and F>K correspond 
to the cells with a number of nuclei different from the number of flagella and where 
the number of flagella was either smaller or bigger than the number of kinetoplasts.
C) Immunofluorescence performed on L.major wild type (a) and WT[MCA] type 2 cells 
(b-f). Fixed cells were labelled with rabbit anti-TbMCA 2/3 antibodies and Alexa Fluor 
488-conjugated anti-rabbit antibodies (green). DAP! staining of the nuclear and 
kinetoplast DNA is shown in blue. Examples of a wild type and a WT[MCA] type 2 cells 
with one nucleus, one kinetoplast, and one flagellum (1F1K1F) are shown in a and b, 
respectively. Note the cell in b has a larger nucleus and kinetoplast than the wild type 
cell, due to its tetraploidy. Picture (c) shows a 2N2K2F cell In which the kinetoplasts 
and nuclei are not properly positioned within the cell. Aberrant cells v/ith mitotic 
nucleus (ms, mitotic spindle in d), and fewer (F<K, e) or more (F>K, f) flagella than 
kinetoplasts are shown. White arrow heads identify kinetoplasts.
kinetoplast and flagellum were observed (figure 6.2B, left panel and Cd-f), suggesting 
a severe defect that caused de-regulation of cell cycle control.
6.1.3. Direct fluorescence localisation
Traditional immunolocalisation methods necessitate the fixation of the cells, 
which can alter the sub-cellular compartments and compromise the observation of the 
localisation of the protein of interest. Indeed, organelles such as the multivesicular 
tubule (MVT)/lysosomes in Leishmania are known to be particularly sensitive to fixation 
and tend to disintegrate under such conditions (Mullin et al., 2001; Besteiro et al., 
2004). These restrictions were overcome by the use of the Aequorea victoria green 
fluorescent protein (GFP) as a localisation marker. The advantages of the GFP are that, 
once fused to the protein of interest, it  allows the following of its movement within live 
cells and also the monitoring of dynamic cellular events (Gerdes and Kaether, 1996). 
Thus, data collected with GFP fusions are very likely to closely relate to the 
physiological behaviour of the corresponding wild type proteins.
GFP fusions of multiple MCA variants were designed to visualise the localisation 
of these proteins within the cell and establish whether differently processed proteins 
were trafficked to different intracellular compartment. I also wanted to assess whether 
the catalytic activity of MCA was necessary for its correct targeting and whether active 
and inactive MCA were present in distinct compartments. Furthermore, the existence 
within the MCA sequence of a predicted signal peptide suggested that this particular 
domain of MCA might play an important role in the localisation of the metacaspase. 
Also, as the proline-, glutamine- and proline- rich C-terminal extension of MCA might 
mediate protein-protein interactions, I wished to determine the intracellular 
localisation(s) of the MCA with this domain.
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6.1.3.1. Full length protein and N-terminally truncated mutants
Theoretically a powerful tool, the use of the GFP as a fluorescent marker for the 
localisation of MCA rapidly showed its limitations. Indeed, as previously detailed, the 
expression of MCA-GFP and AproMCA-GFP was toxic for most of the transfectants and 
they had abnormalities such as an aberrant shape and DNA content and an impaired 
growth rate. For both protein variants, the only transfectant that was still behaving 
similarly to the wild type cells was actually expressing a barely detectable level of the 
protein of interest. Therefore, the intensity of the GFP signals, in those transfectants, 
was too low to be able to visualise the localisation of MCA-GFP and AproMCA-GFP.
6.1.3.2. N-terminal domain
Secondary structure software predictions suggested that MCA might contain a 
signal peptide in its N-terminus. A part of MCA N-terminus was fused to GFP (Nterm- 
GFP) to see if  this region of the protein was targeting the protein to a specialised 
compartment/organelle within the cell. Nterm-GFP was found to be present in the 
cytoplasm of the transfectant cells. However, in vivo removal of a N-terminal fragment 
of MCA was confirmed by Western blot (see section 6.1.2.2) although there were 
doubts about the nature and the length of removed domain. Indeed, it  was unclear 
whether this domain was acting as predicted as a target signal or if  i t  was acting as a 
proregion. Experiments performed with plant type I metacaspases revealed that they 
were autocatalytically-processed after arginine/lysine residues, both in their N- and C- 
termini (Vercammen et al., 2004). Also, these metacaspases were found to possess a 
preference for GRR substrates. Thus, the MCA peptide sequence was analysed for the 
presence of similar residues. Three GR motifs were identified, two present in the MCA 
N-terminus, at positions 38 and 60, and one in MCA C-terminus (G297). The sizes of the 
potentially removed fragments based on these cleavage sites could f it  with the 
molecular mass of the MCA processing products identified by Western blot. 
Furthermore, MCAACterm-GFP and AproMCAACterm-GFP, which still contained these GR 
motifs, were also processed in their N- and C-termini (refer to section 6.1.2.2.). 
Therefore it  was probable that these motifs were genuine processing sites.
To determine where these cleavage events were occurring in the cell, extended 
regions of MCA N- and C-termini, of 101 and 179 amino acids respectively, were fused to 
the GFP (eNterm-GFP, GFP-eCterm and eNterm-GFP-eCterm) and expressed in 
Leishmania. Fluorescence observations performed on the live transfectants revealed 
that eNterm-GFP and eNterm-GFP-eCterm were located in a reticulated structure 
extending throughout the cell body. Co-localisation experiments with MitoTracker Red
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CAAXRos (Molecular Probes) indicated that both MCA variants were located in the 
mitochondrion (figure 6.3Aa). However, the wild type MCA does not seem to be present 
within the mitochondrial matrix (figure 6.3Ab). The data collected with GFP-eCterm 
are detailed below.
6.1.3.3. Catalytic mutants and C-terminal domain
Even though the expression of various catalytic mutants of MCA was inducing 
type 2 phenotypes in clonal transfectants, viable cell lines expressing lower level of 
those protein variants were obtained. Thus the localisations of MCA^ °^^ -^GFP, 
AproMCA^ ^®^ -^GFP and MCA^ '^*^ '^ -GFP could be assessed. The fluorescent signals observed 
for the three protein variants were strikingly similar to each other and those detected 
for GFP-eCterm. An example of these observations is shown in figure 6.3B. While the 
majority of the detected GFP signal was cytosolic, various discrete localisations within 
the cell were also labelled. Fluorescent punctate structures were seen mainly at the tip 
of the cell (white arrow heads) but also moving along the cell body and the flagellum 
(white arrow). A tubular structure was also visualised in some cases (grey arrow). 
However, the use of various dyes such as the FM4-64 and the MitoTracker Red CMXRos 
(Molecular Probes), respective markers of the MVT-lysosome and the mitochondrion, 
failed to identify the nature of these compartments. The dynamics of the GFP labellings 
lead us to postulate a potential association of these MCA variants with the microtubular 
network.
Interestingly, the extended C-terminal domain of MCA fused to GFP (GFP- 
eCterm) showed similar localisations within the cells. It could be argued that the 
punctate signals might actually reflect the trafficking of GFP degradation products. 
However such labelling was not visible in cell lines expressing the GFP only or Cterm- 
GFP, a MCA protein variant that was extensively processed as determined by Western 
blot (figure 6.1G). This finding raises the possibility that MCA interacts with 
microtubules trough its C-terminal proline-, glutamine- and tyrosine-rich domain.
MCA^ °^^ -^GFP and MCA^ °^^ '^ °^ -^GFP were found to be present in the cytosol of the 
overexpressing cells. No motile punctate structures could be detected.
6.1.4. Association with the cytoskeleton
Consistent with these observations, I previously characterised the wild type MCA 
as a protein partially associated with cytoskeletal microtubules (see chapter 5). 
However, basic proteins (such as MCA is predicted to be) have been reported to bind to 
tubulin in a non-specific manner (Robinson et a i,  1991). Nevertheless, the fact that 
several GFP-fused MCA variants, which possessed lower predicted pis, were present
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Figure 6.3: Localisation of several MCA variants within the cells.
Panel A. (a) Live fluorescence observation of eNterm-GFP (green). The mitochondrion 
was labelled in red with the MitoTracker Red CMXRos (Molecular Probes). Co-localisation 
is shown in yellow, (b) Immunolocalisation of MCA in wild type cells. The mitochondrion 
was labelled in green (MitoTracker Green, Molecular Probes) before fixation.
Panel B. Examples of the fluorescent signals observed in cells expressing MCA^ °^^ -^GFP, 
AproMCA^ °^^ -^GFP, MC A " GF P  and eCterm-GFP (green). The kinetoplast and nuclear 
DNA were stained with DAP I (blue). Scale bar =10 pm. C) Association of MCA and other 
variants with the cytoskeleton microtubules. Promastigotes were extracted with 0.5% 
Nodi net P40 in PEME buffer. The total (T), soluble (S) and insoluble (I) fractions were 
analysed by SDS-PAGE, transferred to a PVDF membrane and immunoblotted with rabbit 
anti-TbMCA2/3 (panel 1) or mouse anti-GFP (Clontech) antibodies. (*) and (**) indicate 
soluble and insoluble cross reacting protein bands, respectively, on panels 2,3 and 4.
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within motile sub-cellular structures, suggested that MCA interaction with microtubules 
was real. To confirm this finding, experiments previously performed with the wild type 
MCA were repeated with diverse MCA variants.
6.1.4.1. Overexpressors of
After extraction in PEME buffer with 0.5 % NP-40, while most of MCA^ '^^ ^^ -GFP 
processing products were present in the soluble fraction, a large part of the full length 
protein variant remained associated with the cytoskeletal microtubules (figure 6.3C, 
panel 2, arrow 2). It was previously observed that the wild type MCA was also able to 
associate with the cytoskeleton (chapter 5 and figure 6.3C, panel 1). However, the 
proportion of protein interacting with these microtubules seems to be lower for the wild 
type MCA than for MCA"^ "^ *^-GFP. It is still unclear whether this accumulation of 
MCA"^ ^^ *-GFP with the cytoskeletal network results from the overexpression of the 
protein or the fact that it  is potentially catalytically inactive. This experiment will have 
to be repeated with overexpressors of active MCA variants.
6.1.4.2. Overexpressors of eNterm-GFP
To exclude the possibility that the association of MCA"^ "‘^^ -GFP with the 
cytoskeleton might be an artefact due to the presence of the GFP, the experiment was 
repeated with a cell line expressing eNterm-GFP. Consistent with its presence in the 
mitochondrial matrix, eNterm-GFP was found to be present mainly in the soluble 
fraction of the detergent-treated cell extracts (figure 6.3C, panel 3, arrow 3). 
Therefore, the GFP does not seem able to mediate interactions with the microtubular 
network.
6.1.4.3. Overexpressors of eCterm-GFP
Direct fluorescence observations revealed that the localisation within the cell of 
eCterm-GFP was comparable to that of MCA"^ "‘^ -^GFP. Therefore, detergent extractions 
were performed on cells expressing eCterm-GFP to assess whether the C-terminal 
domain of MCA was promoting interaction with the cytoskeleton. While most of the 
protein was processed, only a very small portion of eCterm-GFP remained associated 
with the sub-pellicular microtubules (figure 6.3C panel 4, arrow 4). Therefore, it  
seems unlikely that this C-terminal region of MCA would, by itself, be able to mediate 
the binding of MCA to the cytoskeleton.
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As observed for the wild type MCA (chapter 5), the proportion of MCA"^ "^ ^^ -GFP, 
eNterm-GFP or eCterm-GFP associated with the cytoskeleton does not seem to change 
with cell cycle progression (data not shown).
6.2. Expression in Escherichia coli
I initially attempted to produce recombinant MCA for two reasons. First, to 
immunise rabbits and induce the production of anti-MCA polyclonal antibodies. 
Secondly, to assess the potential in vitro enzymatic activity of MCA toward a range of 
substrates and its sensitivity to inhibitors.
The pET28a (+) vector was used to generate N- and/or C-terminally polyhistidine 
tagged variants of MCA. Constructs allowing the expression of MCA-His, His-AproMCA, 
and MCA^ '^^ ^^ -His were produced and transformed into E. coli BL21(DE3) cells. Initial 
expression trials and the subsequent sample analyses revealed that these protein 
variants were expressed at a low level and were mainly present in inclusion bodies. We 
tried to optimise the expression conditions by increasing the induction time, lowering 
the induction temperature or using a different bacterial host (BL21 (DE3)pLys), but none 
yielded satisfactory expression. Therefore, we were unable to achieve either of the two 
initial aims of this part of the project. However, even when expressed at a low level, 
processing of the different MCA variants was observed. Like in L  major cells. Western 
blot using antibodies against MCA or against the histidine tag revealed a pattern of 
multiple protein bands and suggested proteolytic cleavage was occurring in both the N- 
and C-termini of MCA (data not shown).
6.3. Expression in Pichia pastoris
The low level of expression and the extreme insolubility of different MCA 
variants in E. coli suggested the proteins were toxic for the bacteria. Therefore, a 
different expression host, Pichia pastoris, was evaluated.
As a yeast, P. pastoris has many of the advantages of higher eukaryotic 
expression systems such as protein processing, protein folding, and post-translational 
modifications but is easier and less expensive to use than other eukaryotic expression 
systems such as baculovirus or mammalian tissue culture, and generally gives higher 
expression levels. Furthermore, in association with the pPiC9 vector, this system allows 
the secretion of the expressed recombinant protein in the culture medium, thus limiting 
the potential toxicity of the protein for the cell and facilitating its purification process.
As a methylotrophic yeast, P. pastoris is capable of metabolizing methanol as its 
sole carbon source. The methanol metabolism initiates with the oxidation of methanol 
into formaldehyde and hydrogen peroxide, a process mediated by alcohol oxidase (AO).
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Also, to avoid hydrogen peroxide toxicity, methanol metabolism takes place within the 
peroxisome, a specialized organelle that sequesters toxic by-products from the rest of 
the cell. Furthermore, as the alcohol oxidase has a poor affinity for oxygen it  is 
expressed at a high level by the cell. Thus, the Pichia system uses the promoter of the 
AO to drive the expression of heterologous protein. After integration of the gene of 
interest into the alcohol oxidase (AO) locus, the expression of the recombinant protein 
starts upon addition of methanol into the yeast culture medium and activation of the 
methanol-inducible AO promoter. For more detail about the Pichia system, please refer 
to the Material and Methods section (chapter 2).
The principal aim of this approach being the production of active MCA to 
facilitate biochemical characterization of its enzymatic properties, constructs allowing 
the expression of the full length active MCA, but also truncated variants AproMCA, 
MCAACterm, AproMCAACterm, were generated. All of them were fused in their N- 
termini with the a-factor secretion signal. The linearised plasmids were then 
transfected into Pichia. After verification by PCR of the correct integration of the 
expression cassette into the Pichia genome, expression trials were performed. In 
parallel, a control cell line expressing and secreting bovine albumin was used. After 
about 10 days of methanol induction, 24 hours time point samples were analysed by 
SDS-PAGE, Coomassie staining and Western blot.
While in the control cell line the production of albumin was easily detectable, 
expression of the various MCA variants could not be visualized. Western blot analysis 
revealed that the MCA variants were probably expressed, but at a very low level and 
within the cell. This finding was most unexpected and suggested both that the multiple 
MCA variants were not efficiently translated and that they were somehow not properly 
secreted and so retained within the cell. The weak expression of the MCA variants could 
be explained by the poor codon bias for Pichia (Sinclair and Choy, 2002). As for the 
absence of recombinant protein secretion, one possible explanation was that the N- 
terminal signal sequence of MCA was interfering with the a-factor secretion factor, 
thwarting its correct trafficking and liberation into the culture medium. However, 
AproMCA and AproMCAACterm constructs, which lacked the first 21 N-terminal residues 
of MCA, also lacked significant expression and were not secreted. Thus, the secretion 
problem was either not due to the N-terminal domain of MCA or the domain removed 
was too short and there was still, in AproMCA, a conflicting region. Therefore a new 
expression construct was generated where a bigger part of the N-terminus of MCA was 
removed (the first 73 amino acids, AeproMCA and AeproMCAACterm). Attempts to 
produce these MCA variants were made and the results are presented in figure 6.4. A 
cell line previously created, AproMCAACterm, was used as a negative expression
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Figure 6.4: Expression of several MCA variants in P. pastoris.
A) Schematic representations of the MCA variants expressed.
B) SDS-PAGE analyses of culture medium samples after induction with methanol for 217 
hours. Secreted proteins were visualised by Coomassie staining. The red arrow head 
indicates the presence of an additional protein. On the right panel, culture medium 
samples were concentrated 5 times.
C) Western blot analysis performed using anti-TbMCA2/3 rabbit antibodies. The 
experiment was performed on concentrated culture medium samples.
control. Culture media of the different Pichia transfectants, concentrated (figure 6.4B, 
right panel) or not (figure 6.4B, left panel) were analyzed, by SDS-PAGE and/or 
Western blot, for the presence of the secreted MCA variants. As indicated in figure 6.4B 
by a red arrow head there was, in the culture medium of one (lane 3) of the 
transfectants expressing AeproMCAACterm, an additional protein compared to the 
secretion pattern of the other transfectants. However the size of the protein detected 
(-50 kDa) was much bigger than the expected size of AeproMCAACterm (37.5 kDa) 
(figure 6.4A). Therefore, a Western blot was carried out and probed with anti- 
TbMCA2/3 antibodies to check the identity of the additional secreted protein (figure 
6.4C). The additional protein was thus recognized as the metacaspase variant. One 
possible explanation for the increased molecular weight of AeproMCAACterm is the
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addition of bulky glycans to the protein by Pichia. Indeed, the Pichia expression system 
was initially chosen because it allows eukaryotic post-transcriptional modifications, and 
glycosylation is one of them. Also, Pichia is known to add N-linked oligosaccharides that 
are larger than the ones used by Leishmania for its post-translational modifications 
(Grinna and Tschopp, 1989; Parodi, 1993; Montesino et al., 1998). There are 7 
glycosylation sites predicted in MCA (chapter 4) and so it  is reasonable to expect that 
the MCA variant would be glycosylated in Pichia. It is still unknown whether such 
modifications occur in Leishmania.
6.4. In vitro translation
I previously reported the advantages of the Pichia expression system and 
although it proved to be relatively efficient, many aspects of this method of production 
render its utilisation unaccommodating. The need to check for the integration of the 
expression constructs, the long induction periods and the heavy glycosylation that might 
compromise the functionality of the expressed protein are many of the factors that 
restrict its use. We tried to overcome these limitations by using a cell-free protein 
biosynthesis system (or in vitro translation system). The method chosen (EasyExpress, 
Qiagen) generates proteins by coupled or successive transcription and translation, in 
cell-free extract of prokaryotic cells. It possesses many advantages, among which are its 
rapidity (as it  is theoretically possible to use PCR product templates for protein 
synthesis), the possibility to produce toxic protein and the simplification of the 
purification process.
Having already generated constructs for the expression of various MCA variants 
in f .  coli, the in vitro  translation was performed using one of these plasmid DNAs as a 
template (pET28a(+)-MCA (pGL1421)), in order to express a C-terminal His-tagged full 
length MCA (MCA-His). In parallel, the reaction was performed with a control DNA that 
encodes the elongation factor EF-Ts with a C-terminal His-tag (32 kDa). After a 1 hour 
incubation at 37“C, the protein production was stopped and the His-tagged proteins 
were purified by Nickel-affinity. The samples were then further analysed by SDS-PAGE 
(figure 6.5, left panels). While the positive control protein was easily detectable on a 
Coomassie stained gel (figure 6.5B, black arrow head), it  was difficult to determine 
whether MCA-His was expressed (figure 6.5A). Therefore, a Western blot using anti- 
TbMCA2/3 antibodies was performed (figure 6.5, right panels). The production of the 
protein of interest was thus confirmed and the efficiency of its purification validated.
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Figure 6.5: Purification of His-tagged proteins expressed using an in vitro 
translation kit.
His-tagged MCA (A) or elongation factor-Ts (B) were affinity purified by Nickel chelate 
affinity chromatography under native conditions, from 50 pi of an Easy Express Protein 
Synthesis Mini Kit (Qiagen) in vitro translation reaction. Protein samples were then 
analysed by SDS-PAGE and visualised by Coomassie staining (left panels) or by Western 
bot, using anti-polyhistidine mouse antibodies (Qiagen) (right panels). I :  total fraction; 
FT: flow through; W: wash; El and E2: first and second elution fractions.
6.5. Discussion
6.5.1. Metacaspases locatisations and functions
In the yeast S. cerevisiae, heterologous expression of TbMCA4 resulted in a 
petite phenotype. In these cells, mitochondria had a reduced thiol content compared to 
mitochondria from wild type cells. Thus, TbMCA4 expression seems, in yeast, to be 
acting on the metabolic state of the mitochondrion (Szallies et al., 2002). TbMCAl, 
TbMCA3, TbMCAS and LmajMCA, but not TbMCA2 and TbMCA4, are predicted to possess 
a signal peptide at their N-terminus, indicative of a possible specific intracellular 
targeting (chapter 4). While little  is known of the nature of the predicted signal 
peptide at the N-terminus of the T. brucei metacaspases, we observed here that this 
region of LmajMCA was targeting the GFP to the mitochondrion (figure 6.3Aa). The fact 
that a short region of the LmajMCA N-terminal sequence was not able to target the GFP 
(Nterm-GFP) to the mitochondrion, while a longer domain (eNterm-GFP) could, shows 
that at least 21 amino acids of the domain are required for targeting. In the absence of 
the complete signal peptide sequence, interaction with the translocon apparently did 
not occur and Nterm-GFP was left in the cytoplasm.
Chapter 6: Expression of MCA in L  major, E. coli and P. pastoris 165
In mammalian cells, a consensus sequence of a few amino acids is enough to 
target a protein to the mitochondrion. No such signal was predicted to be present in 
LmajMCA using algorithms based on mammalian mitochondrial targeting sequences, 
such as MITOPROT (http://ihg.gsf.de/ihg/mitoprot.html). Also, it  was possible that the 
observed mitochondrial targeting of eNterm-GFP was an artefact and did not reflect the 
behaviour of the wild type LmajMCA. However, another construct, much larger and 
likely to possess a different tertiary fold, eNterm-GFP-eCterm, was also found in the 
mitochondrion. Furthermore, phylogenetic analyses indicate that metacaspases might 
have been introduced into eukaryotes by their mitochondrial endosymbiont (Koonin and 
Aravind, 2002), thus the metacaspases might still possess a physiological function within 
the mitochondrion, as suggested by TbMCA4 expression in yeast and the localisation of 
the extended N-terminal domain of LmajMCA. Consistent with these observations, 
immunolocalisation of the wild type LmajMCA, revealed that it  temporally associates 
with the mitochondrial DNA during kinetoplast segregation (chapter 5). It is likely that, 
to be able to access this organelle, the metacaspase will need to be translocated into 
the mitochondrion first. In T. brucei, a kinetoplast protein overexpressed as a GFP 
fusion was shown to be present throughout the mitochondrion and not only its DNA 
(Klingbeil et al., 2002). Therefore, it  is possible that the fluorescence detected 
throughout the mitochondrion for eNterm-GFP and eNterm-GFP-eCterm are some 
overexpression artefacts and that the N-terminal domain of LmajMCA actually targets 
the protein to the kinetoplast. Nevertheless, other yet uncharacterised regions of 
LmajMCA might also target LmajMCA to the kinetoplast after its entry into the 
mitochondrion via its N-terminal domain.
The N-termini of caspases and plant metacaspases were shown to contain 
prodomains whose removal was required for acquisition of full enzymatic activity 
(Earnshaw et al., 1999; Vercammen et al., 2004). The plant metacaspase AtMCA9 is able 
to process its small N-terminal prodomain through its R/K substrate specificity 
(Vercammen et al., 2004). Substrate profiling experiments revealed that this enzyme 
preferred GRR (Vercammen et al., 2004) but also VRPR/I (Vercammen et al., 2006) 
peptide substrates. Interestingly, GRR and VRPI motifs were found in MCA N-terminus at 
positions 38-40 and 45-48, respectively, thus namely between the regions used for the 
construction of Nterm-GFP (residues 1-21) and eNterm-GFP (residues 1-101). Thus, 
although data are missing to confirm this hypothesis, either of these motifs could be 
sites for autocatalytic processing of MCA. Therefore, LmajMCA might contain in its N- 
terminus not only a targeting signal but also a prodomain and consequently might 
possess a preprodomain. This LmajMCA N-terminal preprodomain would present the 
advantages of not only controlling the intracellular localisation of the metacaspase but 
also of regulating its activity. After targeting into the mitochondrion, the pre-domain
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would be removed by signal peptidase and the pro-domain autoprocessed to ultimately 
obtain a fully functional LmajMCA, The protein AeproMCAACterm, which starts at 
residue 74, lacks this predicted preprodomain. Interestingly, i t  was the only LmajMCA 
variant that was successfully expressed by Pichia and secreted in the culture medium. 
Unfortunately, we were unable at the time to determine the substrate specificity of 
LmajMCA and thus determine if  it  was capable of autoprocessing. Consequently, it  is 
still unclear whether the processing of the N-terminal prodomain of LmajMCA can be 
done autocatalytically.
For caspases, interacting peptidases such as Granzyme B have been shown to be 
necessary for their processing and activation (Stennicke and Salvesen, 2000). If such a 
process applies to LmajMCA then the compartment in which the metacaspase will 
become active would depend on the location of the activating enzyme(s). Thus, a 
LmajMCA protein activated in the cytoplasm would not translocate to the 
mitochondrion, whereas a non-processed protein would enter the mitochondrion and 
become active after removal of the N-terminal preprodomain. Both of these situations 
might be occurring in the cell as LmajMCA was found to be present in different 
compartments. Constitutively present in punctate structures throughout the cell, 
LmajMCA transiently relocates to the kinetoplast and then to the mitotic spindle during 
nuclear division (see chapter 5). Also, in the event where LmajMCA becomes active in 
the cytoplasm, the removal of the N-terminal preprodomain might expose a second 
targeting signal and thus promote LmajMCA translocation into the nucleus. The 
presence of LmajMCA in this organelle can also be achieved by either direct or indirect 
(thought motor protein) association of the active metacaspase with microtubules. These 
different intracellular locations suggest that metacaspases play several roles in the cell, 
some in the kinetoplast and others in the nucleus, and that these functions might be 
interconnected. Indeed, analysis of the phenotypes associated with the overexpression 
of LmajMCA variants showed that LmajMCA was likely involved in kinetoplast and 
nuclear segregation and cell cycle progression.
In T. brucei, it  is well established that kinetoplast division and cytokinesis are 
cytoskeletal microtubule-mediated events (Robinson et al., 1995; Vedrenne et al., 
2002). We showed previously that LmajMCA associates partially with the cytoskeleton. 
Here we found that several MCA variants (mostly GFP-fusions) associated with 
subpellicular microtubules. Live fluorescence observations suggested that the MCA C- 
terminal domain (eCterm-GFP) might be involved in these interactions, although 
fractionation experiments failed to confirm this hypothesis. Although many aspects of 
LmajMCA processing remain obscure, it  seems that the N- and C-terminal domains of 
this protein are likely to be important for its function.
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6.5.2. Expression of MCA variants in different systems
One initial aims of my thesis project was to determine whether MCA functions as 
a peptidase and to identify the residues involved in its catalytic activity. Unfortunately, 
expression of various MCA variants, in both bacterial and eukaryotic systems, failed to 
provide sufficient amount of recombinant protein to perform biochemical studies. 
However, one promising lead remains. Although it needs scaling up, the in vitro 
translation method proved to be moderately efficient and easy to perform. Thus 
additional constructs were created to allow the expression of potentially catalytically 
inactive MCA variants (MCA^ ^®^ ,^ MCA^ °^^ '^ °^ ,^ MCA*"^ ®^  ^ and MCA"^ '*^ * with C-terminal His 
tags). Hopefully, future work using these constructs together with in vitro translation 
will lead to a better understanding of MCA catalytic processes.
Meanwhile, the various phenotypes observed, in Leishmania, upon expression of 
Mca^202g_gpp and MCA"^ '*^ -^GFP might be explained by: i) these MCA variants being still 
catalytically active and their expression being toxic for the cell when above a certain 
threshold; ii) the fact that MCA function is conferred by its structural properties but not 
by any enzymatic activity; iii) the possibility that if  MCA is present in the cell as homo­
oligomers or within a complex then the overexpressed MCA^ °^^ -^GFP and MCA"^ ^^ "^ -GFP 
would take part to these complexes and therefore cause the same phenotype as when 
overexpressing MCA-GFP (via a dominant negative effect). However, several 
observations suggest that the latter two hypotheses are more likely to be true. First, we 
have so far no evidence that the enzymatic activity of MCA is directly responsible of the 
observed overexpression phenotypes. While WT [MCA^^ °^ -^GFP] and WT [MCA"^ ^^ -^GFP] 
overexpressors had a growth defect, most of the WT [MCA^ °^^ -^GFP] and WT [MCA“ °^ ' 
202G-GFP] overexpressors lacked such phenotype. Also, it  was observed that MCA^ °^^ -^GFP 
and MCA^ "^^ '^ °^ -^GFP were processed differently than MCA^ °^^ -^GFP and MCA"^ ^^ *^-GFP, 
with the appearance of an additional protein (figure 6 .IF, grey arrow). Thus i t  seems 
likely that the absence of phenotype in the WT [MCA^ ^^ ^^ -^GFP] and WT [MCA^ °^^ '^ ^^ -^GFP] 
overexpressors was not likely to be linked with an alteration of the catalytic activity of 
the proteins, but rather due to their alternative processing and a modification of some 
of their properties. In addition, i t  appeared that overexpression of MCA variants lacking 
the 102 C-terminal amino-acids gave, in most cases, no particular phenotype. Although 
it is tempting to postulate that the MCA C-terminal extension might be involved in the 
observed overexpression phenotype, it  was impossible to establish whether the 
disappearance of such phenotype in WT [MCAACterm-GFP] and WT [AproMCAACterm- 
GFP] transfectants was due to the removal of the C-terminal interaction module or to 
the expression of severely shortened and therefore incomplete and non functional
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proteins. However, evidence that the function of MCA within the cell relies on its 
structural properties rather than solely on its enzymatic activity were given by the 
observation that the expression of eNterm-GFP was in itself able to reproduce a 
phenotype induced by the expression of full length MCA.
Indeed, although eNterm-GFP lacks the catalytic domain of MCA, it  seems able 
to influence the level of expression of the wild type MCA therefore suggesting a 
potential interaction between these two proteins. Also it  is possible that in complex 
with MCA, eNterm-GFP might facilitate the translocation of this protein into the 
mitochondrion. The possibility that the growth phenotypes observed upon expression of 
various MCA variants resulted from their aberrant accumulation within the 
mitochondrion was considered. However, cell fractionation experiments revealed that 
while eNterm-GFP was mainly soluble, most of the MCA variants were associated with 
the sub-pellicular microtubules fraction, thus excluding their possible gathering in the 
mitochondrion. Nevertheless, it  was shown previously that the accumulation of eNterm- 
GFP in the matrix of the mitochondrion was probably an overexpression artefact and 
that MCA was likely associated with the mitochondrial DNA. Therefore, the MCA variants 
being expressed at a lower level than eNterm-GFP might also be associated with the 
kinetoplast. Thus, the growth defect observed during the expression of these multiple 
MCA variants could be the result of the accumulation of MCA in the kinetoplast. 
However, direct fluorescence observations failed to confirm this hypothesis. On the 
other hand, the N-terminal domain of MCA might be able to mediate protein-protein 
interactions and association with MCA partners. In that case, expression of eNterm-GFP 
but also all the MCA variants carrying this domain would induce a dominant negative 
effect and the appearance of the type 2 phenotype.
To understand the mechanisms by which MCA generates this defined 
overexpression phenotype, it  is essential to characterize the proteins interacting with 
MCA within the cell. Indeed, the identification of protein partners might give some clue 
about not only the substrate specificity of the metacaspase but also about its function 
within the cell.
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I also attempted to determine the biological function(s) of metacaspases in 
trypanosomatids by investigating the role of three metacaspases of T. brucei, TbMCA2, 
TbMCA3 and TbMCAS. Also, before presenting the data produced by Matthew J. Helms in 
the context of his PhD thesis (2004) as well as the new set of findings concerning these 
proteins, I would like to introduce some relevant aspects of T. brucei biology.
7.1. Trypanosoma brucei and Trypanosomiasis
Although Leishmania spp. and the African trypanosome Trypanosoma brucei are 
both parasitic protozoa from the Kinetoplastidae order and Trypanosomatidae family, 
there is a vast genetic distance between them (Vickerman, 1994). While both possess a 
diphasic life cycle, alternating between an insect and a mammalian host, the nature 
and the spectrum of the diseases they cause differ profoundly.
In contrast to Leishmania, which spends most of its mammalian stage as an 
intracellular form, T. brucei procyclic forms (PCF), transmitted during the bloodmeal of 
an infected tsetse fly (Glossina spp.), will remain as free living forms within the 
mammalian host blood, rapidly adapting and differentiating into the bloodstream forms 
(BSF). BSFs will divide and spread up to the point where their number will overtake the 
number of red blood cells, leading to severe anemia, one symptom of the sleeping 
sickness in human (for Trypanosoma brucei rhodesiense and T. b. gombiense infections) 
or Nagana in livestock (for T. b. brucei). After developing in the blood, lymph and 
peripheral organs, the parasites cross the blood-brain barrier and enter the central 
nervous system, where they cause serious neurological disorders, leading to coma and, 
if  left untreated, death. It is estimated that sleeping sickness (or Human African 
Trypanosomiasis, HAT) causes 66,000 deaths each year, with 300,000 to 500,000 new 
cases reported annually. HAT is known to occur in 36 countries in sub-saharan Africa. T. 
b. gambiense, which causes chronic form of HAT, is found in central, west and some 
parts of Eastern Africa while T. b. rhodesiense, responsible of acute HAT, is present in 
Southern and Eastern Africa. Treatment has always been difficult, especially when the 
disease has reached an advanced stage with central nervous system involvement, as few 
effective drugs are available. Pentamidine is not effective against late-stage disease 
and some parasite strains are resistant to it. Suramin has to be administered 
intravenously and can have adverse side-effects, Melarsoprol, an arsenical drug 
developed over 50 years ago, is used against late-stage disease, but often induces 
serious - sometimes fatal side-effects. Eflornithine, originally developed as an 
anticancer agent, has shown promising results against the gambiense form but 
treatment is expensive and most of the time unaffordable for the affected patients.
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After over 100 years of research in the field, trypanosomiasis is still highly prevalent, 
(www.who.int/tdr)
7.2. Introduction to T. brucei metacaspases
Antibodies raised against TbMCA2/3 or TbMCAS were used to determine the 
expression profiles of these proteins in T. brucei. It was observed that TbMCA2 and 
TbMCAS are exclusive to the mammalian bloodstream form (BSF) parasites, while 
TbMCAS is expressed in both BSF and procyclic trypomastigote forms (PCF) at 
approximately equal levels. In addition, proteomic analyses (Mascot score: 126, 
peptides matched: 8) suggested that TbMCA4 is expressed in bloodstream form parasites 
(personal communication to genedb, M.A.J. Ferguson, D. Martin and I. Nett, 
http://www.genedb.org/genedb/FreeTextSearch?searchText=Full+Content+Search&q=M 
CA4&org=trvp). Finally, messenger RNA transcripts of TbMCAl to TbMCAS have 
successfully been amplified by reverse transcription-based PCR from T. brucei 
bloodstream forms (Szallies et al., 2002).
Gene knock-out experiments demonstrated that TbMCAl and TbMCA3 genes are 
non-essential in vitro within BSF parasites. Gene deletion of TbMCAS was done on wild 
type and ATbmca2f3 bloodstream forms. ATbmca2/3ATbmcaS cells showed a reduced 
growth rate compared to the wild type and while their morphology appeared normal, 
their movement was sluggish. This reduction in growth rate was not permanent 
however, as after several passages the growth rate returned to wild-type levels. This 
suggests that the ATbmca2/3ATbmcaS mutants might be undergoing some form of 
adaptation to the loss of TbMCAS in the ATbmca2/3 background. The fact that this 
phenomenon was not observed during TbMCAS knockout into BSF wild-type background 
does suggest that there is redundancy within the metacaspase gene family. TbMCAS was 
also shown to be non-essential for PCF. Nevertheless, as the expression patterns and 
functions of TbMCAl and TbMCA4 remain uncharacterised, we can not rule out that 
these metacaspases could compensate for the loss of the others.
Cells lines allowing the silencing, by RNA interference (RNAi), of TbMCA2, 
TbMCA3 and/or TbMCAS were also generated. RNAi is a mechanism of gene silencing 
which, after introduction of specific double stranded RNA (dsRNA) within the cell, leads 
to the selective down-regulation of the expression of the targeted gene. In T. brucei, 
production of dsRNA can be achieved by insertion of the chosen nucleic sequence 
between the two opposing T7 RNA polymerase promoters of the p2T7 ’^ vector (LaCount 
et a i,  2000). Present downstream of the T7 promoters, a tetracycline operator allows 
the expression of dsRNA to be tetracycline-inducible. Meanwhile, T7 polymerase 
terminators ensure that only the inserted gene sequence is transcribed into dsRNA.
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After linearization, the RNAi cassette integrates into the transcriptionally silent 
ribosomal DNA (rDNA) spacer regions of the T. brucei genome. A bleomycin resistance 
gene allows the selection of the vector within the transfected cells. For the system to 
work, transgenic BSF and PSF cell lines expressing the bacterial T7 RNA polymerase and 
the tetracycline repressor protein (TetR) were engineered (427 pLew13pLew90-6 and 
427 pLew13pLew29, respectively) (Wirtz et al., 1999). The produced TetR protein binds 
to the tetracycline operator and blocks T7 RNA polymerase transcription of the targeted 
gene, until addition of tetracycline to the parasite culture medium (Wirtz et al., 1994). 
Indeed, TetR possesses a higher affinity for tetracycline than for the tetracycline 
operator, so it  preferentially binds to the tetracycline and undergoes conformational 
changes that ultimately prevent its DNA binding affinity. This removal of repression
;
allows the T7 RNA polymerase to begin the transcription of the RNAi DNA cassette and 
production of the specific dsRNA. A complex cellular machinery then process the 
synthesized dsRNA into 20-26 base-pair fragments (siRNA) and unwinds them, allowing 
specific recognition of and degradation of the target mRNA (LaCount and Donelson,
2001). In the case of TbMCA2, TbMCA3 and/or TbMCAS silencing, the RNAi data 
suggested that TbMCA2 and TbMCA3 in the BSF and TbMCAS in both BSF and PCF are 
non essential to general parasite health or survival in vitro. Nevertheless, triple RNAi of 
TbMCA2, TbMCA3 and TbMCAS led, in BSF, to a rapid growth arrest and a mutant 
morphology (enlarged, misshaped parasites with multiple flagella).
Localisation of TbMCA2 and TbMCA3 proteins was performed by immuno­
fluorescence (IF), on BSF parasites, using a system of HA-tag and anti-HA antibodies.
The IF images showed that the HA-tagged TbMCA2 and TbMCA3 proteins are located 
within several organelles found primarily between the nucleus and kinetoplast. How the 
trypanosome MCAs are directed to the compartments in which they reside is unclear. As 
seen in chapter 4, TbMCA3 and TbMCAS have predicted signal peptides, whereas 
TbMCA2 does not. TbMCA3 and TbMCAS are therefore likely to be sorted through the 
classic secretory pathway, whilst TbMCA2 might either be trafficked in association with 
TbMCAS, TbMCA3 or another ER-directed protein or via an unconventional secretory 
pathway. Double labelling with TbMCAS, using polyclonal anti-TbMCAS sheep antibodies, 
showed that both TbMCA2HA and TbMCA3HA were mainly located within the same 
structures as TbMCAS. Co-localisations with various characterised protein markers were 
performed to identify the nature of these structures. TbMCAS was found to be mainly 
present in a RAB11-positive compartment. RAB11 has been shown to be associated with 
the recycling endosomes in T. brucei (Grunfelder et al., 2003), and most notably to be 
involved in the VSG recycling pathway and anti-VSG antibodies degradation (Jeffries et 
al., 2001). In mammalian cells, RAB11 has also been localized in the Golgi complex 
(Wilcke et al., 2000). Recently, RAB11- and FIP3-containing recycling endosomes were
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shown to accumulate near the cleavage furrow and be required for successful 
completion of cytokinesis (Wilson et al., 2005).
7.3. New results
In 7. brucei B5F there was a major difference between the consequences of 
knocking down TbMCA2, TbMCA3 and TbMCAS expression in the RNAi cell lines, which 
was lethal, and sequential deletion of TbMCAI, TbMCA3 and TbMCA5, which was not 
lethal.
So far, prostaglandin Drinduced cell death is the best characterised form of 
programmed cell death in 7. brucei BSF (Figarella et al., 2005; Figarella et al., 2006). In 
order to test i f  the metacaspases are involved in prostaglandin Dz-induced cell death in 
BSF, wild type BSF parasites and ATbmcaZ/SATbmcaS mutants were treated with 
prostaglandin Dz and their growth characteristics assessed. However, as the growth 
phenotype of the ATbmca2/3ATbmca5 mutants was lost after several weeks in culture, 
suggesting an adaptation (section 7.2.2), the experiments were carried out on freshly 
selected transfectants.
TbMCA2, TbMCAS and TbMCAS were found, in BSF, to partially co-localise with 
RAB11-positive vesicles. The RAB11 compartment in 7. brucei BSF has been shown to 
contain recycling receptors and their cargo, such as transferrin receptor/transferrin and 
VSG/anti-VSG antibody (Jeffries et al., 2001). A significant level of co-localisation 
between internalised anti-VSG 221 antibodies and TbMCAS was previously reported by 
Matthew John Helms. These data provide evidence that a proportion of metacaspases of 
7. brucei are in close association with RAB 11-positive recycling endosomes and their 
cargo. Therefore the efficiency of VSG recycling and anti-VSG antibodies degradation 
were assessed in wild type, ATbmca2/3ATbmca5 and triple RNAi cell lines.
Finally, as the growth rates of triple RNAi-induced BSF cells and to a lesser 
extent ATbmcaZ/3ATbmca5 cells were significantly slower than wild type, analysis of 
kinetoplasts and nuclei configuration was performed to follow the progression of the 
parasites through their cell cycle. The potential modification of the metacaspases 
localisation during cell division was also investigated.
7.3.1. Prostaglandin D2 treatment
Wild type and non adapted ATbmca2/3ATbmca5 BSF cells were treated with 
either 0, 2.5, 5 or 7.5 pM of prostaglandin Dz (PGDz) (figure 7.1). In the absence of 
treatment, the non adapted ATbmcaZ/3ATbmca5 cells have a slower growth rate than 
the wild type cells (refer to 7.2.2).
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Figure 7.1: Prostaglandin Da-induced cell death in wild type and 
ATbmca2/3ATbmca5 T. brucei bloodstream forms.
Wild type (upper panel) and non adapted ATbmca2/3ATbmca5 cells (lower panel) were 
treated with either 0 (open diamond), 2.5 (triangle), 5 (round) or 7.5 pM (square) of 
prostaglandin 0% (PGD2) and the growth rates were compared to the non-treated cells 
(close diamond).
Prostaglandin 0% caused death as previously reported (Figarella et ol., 2005; 
Figarella et al., 2006). Nevertheless, no obvious difference in the kinetics of cell death 
was noted between the wild type and ATbmcal/3ATbmco5 (figure 7.1), demonstrating 
that TbMCA2, TbMCAS and TbMCA5 are not required as effectors of prostaglandin D2- 
induced cell death in BSF T. brucei.
7.3.2. Assessment of VSG recycling in vivo
To establish if  the metacaspases are involved in the VSG recycling process in 
bloodstream form trypanosomes, wild type parasites were compared with 
ATbmcal/3ATbmcaS and triple RNAi-induced cells. Surface VSG was biotinylated at 4°C 
prior to 5 minutes of endocytosis at 37°C. Non-internalised biotin was cleaved from the
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Figure 7.2: Recycling of VSG.
Wild type, ATbmcal/3ATbmcaS and triple RNAi lines (+/- induction with tetracycline for 
8 hours) parasites were biotinylated at 4°C prior to incubation at 37°C for 5 minutes in 
HMI-9 medium. Remaining surface label was then cleaved by incubation with 50 mM 
glutathione at 4°C. Cells were then prepared for I FA both immediately after the 
glutathione incubation and following a 5 or 10 minutes chase period in HMI-9 medium at 
37°C. Parasites were stained with streptavidin-Texas Red conjugate (red). DNA was 
visualised with DAP! (blue). DIC images of the parasite are shown. Scale bar = 10 pm.
parasite surface and cells resuspended in medium for 0 to 10 minutes to allow time for 
recycling to occur.
Immuno fluorescence analysis of parasites showed that internalised biotin-VSG 
co-localised with RAB11-positive structures (Helms et al., 2006) and that, following 5 
minutes and 10 minutes chase periods, wild type, ATbmca2/3ATbmca5 and induced 
triple RNAi parasites were able to recycle this internalised VSG and return it to the cell
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surface (figure 7.2). Therefore, i t  appears that the loss of TbMCAZ, TbMCAS and 
TbMCAS does not prevent endocytosis of VSG, the trafficking through RAB11-positive 
vesicles, or its subsequent return to the cell surface.
7.3.3. Assessment of the degradation of anti-VSG antibodies
It has been documented previously that IgG-VSG immune complexes are internalised by 
T. brucei and that whilst the VSG is recycled to the surface, the IgG is degraded 
intracellularly (O'Beirne et al., 1998; Jeffries et al., 2001; Pal et al., 2003). Anti-VSG 
IgG has been localised to RAB11-positive vesicles, but the peptidases involved in the 
degradation of IgG and their location within the cell have not been identified. The 
finding that the metacaspases are present within recycling endosomes, which traffic 
anti-VSG IgG, raised the possibility that they might be involved in the degradation of the 
internalised IgG. To investigate this hypothesis, parasites were labelled with a 
polyclonal rabbit anti-VSG221 IgG at 4°C for 30 minutes, washed extensively and 
incubated at 37°C for a further 5 or 10 minutes. Following this period, parasites were 
examined by I FA. The ability to internalise and degrade antibody was unimpaired in 
ATbmcal/3ATbmcaS and the triple RNAi mutant 8 hours after induction (figure 7.3). 
Whole cell lysates from wild type and ATbmcal/3ATbmcaS and TCA precipitations of the 
culture medium were then subjected to SDS-PAGE, transferred to PVDF membrane and 
probed with an anti-rabbit HRP conjugate to determine the fate of the internalised 
antibodies (Helms et al., 2006). Examination of cell-associated anti-VSG221 IgG 
illustrated that there was no build up of it  within ATbmca2/3ATbmca5 parasites 
compared with wild type parasites. A single protein, corresponding to rabbit heavy 
chain IgG, was detected at equivalent levels in both cell lines (Helms et al., 2006). 
Analysis of the secreted products illustrated that the degradation of the anti-VSG IgG 
was very similar in ATbmcal/3ATbmcaS parasites as in wild type parasites (Helms et al., 
2006). These data show that the ATbmca2/3ATbmcaS parasites are still functional with 
regard to anti-VSG antibody internalisation, degradation and secretion and show that 
the absence of TbMCA2, TbMCA3 and TbMCAS from recycling endosomes does not affect 
this process.
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Figure 7.3: Degradation of anti-VSG IgG.
BSF wild type, ATbmcal/3ATbmcaS and triple RNAi lines (+/- induction with tetracycline 
for 8 hours) were labelled with anti-VSG221 rabbit IgG at 4°C in HMI-9 prior to 
incubation at 37°C for 10 and 30 minutes in HMI-9. Parasites were fixed and stained 
with anti-rabbit-FITC conjugate (green) and DARI (blue). Scale bar = 10 pm.
7.3.4. Growth curves and cell cycle analysis
While a proportion of metacaspases of T. brucei are in close association with 
RAB11-positive recycling endosomes and their cargo, we demonstrated that TbMCA2, 
TbMCA3 and TbMCAS are not required for efficient recycling of VSG or the degradation 
of anti-VSG antibodies. To pursue our attempts in elucidating the function(s) of these 
metacaspases in the cell, we decided to analyse in more detail the phenotypes 
associated with the simultaneous gene silencing of TbMCAZ, TbMCA3 and TbMCAS by 
RNA interference.
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As described previously, triple RNAi of TbMCA2, TbMCA3 and TbMCAS resulted in 
a rapid growth arrest (figure 7.4A, left panel). Western blot analysis confirmed almost 
total down-regulation of TbMCAZ, TbMCAS and TbMCAS after induction with tetracycline 
for 24 hours (figure 7.4A, right panels), whilst the level of the cross-reacting protein of 
48 kDa (marked *) remained constant. Analysis of kinetoplast and nuclei configuration in 
induced cells was performed in order to analyse the progression of the parasites through 
the cell cycle in comparison to wild type (figure 7.4B). At 4 hours post-induction, a 
significant increase was observed in the number of cells with one nucleus and one 
kinetoplast (1N1K) (figure 7.4B, lower panel). This increase was attributed to an 
accumulation of cells with a bone-shaped kinetoplast (41% of the 1N1K cells vs 27% in 
the non-induced, figure 7.4C, upper panel) indicating that kinetoplast segregation was 
impaired. The concomitant appearance of aberrant cells with two nuclei and a single 
big kinetoplast (2N1K, figure 7.4B), not normally found in wild type cells as kinetoplast 
division typically occurs before mitosis, confirmed the delay in kinetoplast segregation. 
By 8 hours post-induction, many 1N1K cells had belatedly managed to divide their 
kinetoplast leading to a slight increase of 1N2K cells (figure 7.4B). Most marked, 
however, was an accumulation of 2N2K cells, suggesting a post-mitotic block prior to 
the start of furrow ingression at cytokinesis. Cells appeared to be unable to escape this 
pre-cytokinesis block, as by 12 hours post-induction the number of cells with multiple 
nuclei and kinetoplasts was almost four times higher than in the non-induced control, 
showing that DNA replication and mitosis still occurred but cell division invariably failed 
(figure 7.4B). These data suggest that TbMCAZ, TbMCAS and TbMCAS expression is 
required for multiplication of BSF T. brucei, but i t  is known that these proteins can 
individually compensate for the loss of each other (Helms, 2004),
Furthermore, progressive gene knock-out of these three metacaspases, in BSF, 
suggests that alternative biochemical pathways could balance for the lack of TbMCAZ, 
TbMCAS and TbMCAS. Indeed, while shortly after selection, ATbmcal/3ATbmcaS 
parasites were impaired in their growth compared to the wild type cells, after several 
weeks in culture, the growth rate of the mutants was back to wild type level, suggesting 
that adaptation had taken place. Interestingly, it  has to be noted that, at early stages 
of selection, the ATbmcal/3ATbmcaS parasites showed a higher number of cells at the 
pre-cytokinesis stage of the cell cycle than wild type parasites (wild type: 71% 1N1K, 
18% 1N2K, 9% 2N2K; ATbmcal/3ATbmcaS: 54% 1N1K, 24% 1N2K, 17% 2N2K) suggesting a 
pre-cytokinesis cell cycle block. This phenotype mirrors, at a lesser extend, the one
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Figure 7.4: RNAi of metacaspases in bloodstream form T. brucei.
(A) Left panel: growth curve of a TbMCA2/3 and TbMCAS triple RNAi clone + or - 
induction with tetracycline (tet). Right panels: Western blot of cell extracts from a 
TbMCA2/3 and TbMCAS clone, + or - tet, probed with anti-TbMCAZ/3 (left) or anti- 
TbMCAS antibodies (right). * cross-reacting 48 kDa protein. (B) Upper panel: normal cell 
cycle progression in BSF. The kinetoplast division occurs before nuclear division, 
ultimately followed by cytokinesis. Pictures illustrating various cell stages are shown 
(DARI, stained nucleus (N) and kinetoplast(K), in white) In the bottom right corner of 
the INIK pictures an enlargement of the kinetoplast is shown (blue). Lower panel: N 
and K configurations determined by DAP! staining post-induction with tet. “ Others”
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indicates cells with an abnormal configuration excluding 2N1K cells. For each time 
point, 200 cells were analysed. (C) Upper panel: analysis of kinetoplast configuration in 
INIK cells after tet induction. Images of representative triple RNAi induced BSF are 
shown below. The Western blots in Panel A were performed by Matthew J. Helms.
observed rapidly after triple RNAi induction. Also it can be postulated that it  is the 
rapid removal of all three metacaspase genes at once that resulted in the RNAi lethal 
effect, the parasite could not adapt to overcome this.
7.3.5. Metacaspase localisation during cytokinesis of bloodstream 
forms
In T. brucei bloodstream forms, TbMCAS was previously shown to co-localise 
partially with RAB11-positive endosomes. Also, in view of the finding that RNAi of 
TbMCAI, TbMCAS and TbMCAS induces a pre-cytokinesis block, we decided to 
investigate further the role of these metacaspases during cell division. To do so, we 
followed, during the process of cytokinesis, the localisation of TbMCAS and RAB11. As 
cells undergoing cytokinesis represent only a small percentage of the total cell 
population (about S%), we used a cell line that, upon RNAi induction, accumulate at a 
post-mitotic state (2N2K) and harbour a defect in cytokinesis progression (Hammarton 
et a i,  200S). 8 hours after RNAi induction of the kinase activator M0B1, 60% of the 
2N2K bloodstream form cells displayed a visible cleavage furrow, indicating that furrow 
ingression was somehow impaired by the downregulation of this protein. This phenotype 
was used to investigate whether TbMCAS and RAB11 were associated with the cleavage 
furrow during cytokinesis. In 2N2K cells with a visible furrow, these two proteins were 
found to mainly co-localise in a compartment close to the kinetoplast (data not shown), 
comparable to the one observed in 1N1K cells (figure 7.5, left panel).
In mammalian cells, RAB-11 recycling endosomes are known to accumulate at 
the cleavage furrow during the ultimate stage of cytokinesis, when the cells undergoes 
abscission (Wilson et al., 2005; Fielding et al., 2005). Therefore, the observation of 
TbMCA5 and RAB11 localization was then focused on cell-cell scission. However, upon 
completion of daughter cells separation, TbMCAS and RAB11 were not present at the 
cleavage furrow and instead maintained their peri-kinetoplast localization (figure 7.5, 
right panel). Thus, it  seems that TbMCAS is not directly involved in cleavage furrow 
ingression and cytokinesis completion.
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Figure 7.5: TbMCA5 localisation during cytokinesis of bloodstream forms
Bloodstream form parasites were fixed and stained using sheep anti-TbMCAS (green) and 
rabbit anti-TbRAB11 (red). Nuclear and kinetoplast DNA were visualised by DAP I staining 
(blue). Co-localisation of the signals appears in yellow. The panel on the left shows a 
1N1K cell, while the one on the right shows a 2N2K cell at a late stage of cytokinesis 
(abscission). Scale bar = 10 pm
7.4. Discussion
7.4.1. Features of 7. brucei metacaspases
This study concentrated on TbMCA2, TbMCAS and TbMCAS of T. brucei. The 
parasite’s genome encodes two other metacaspases, TbMCAI and TbMCA4, although 
they lack the predicted active site cysteine and so presumably are not active as 
cysteine peptidases. TbMCAI and TbMCA4 have extensive sequence identity with 
TbMCA2, TbMCAS and TbMCAS, including within the catalytic centres (figure 4.2), even 
though both proteins have substitutions at the predicted essential catalytic positions 
(Szallies et al., 2002; Mottram et al., 2003). Recent analysis has shown that inactive 
enzyme homologues are abundant in a variety of enzyme families, including peptidases 
(PiIs and Schultz, 2004). It has been proposed that some of these “dead” peptidases, by 
adapting existing protein modules, have evolved new regulatory functions. This could be 
the case for TbMCAI and TbMCA4 of T. brucei. However, it can not be excluded that 
these proteins might possess an enzymatic activity (see chapter 4). Active or not, the 
fact that TbMCAI and TbMCA4 possess different active site residues from the one 
present in TbMCA2, TbMCA3 and TbMCAS strongly suggests that the two sets of proteins
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have different functions within the cell. Furthermore, the fact that TbMCA4 is 
expressed in bloodstream forms (see section 7.2.1), and that simultaneous RNAi of 
TbMCA2, TbMCA3 and TbMCAS affects the growth rate of those parasites, this could be 
taken as evidence that TbMCA4 is not able to compensate for the loss of these three 
metacaspases and that they have separate functions within the cell. At the same time it 
seems that there is some level of functional redundancy between TbMCA2, TbMCA3 and 
TbMCAS as sequential deletion of these genes led to no obvious phenotype, while 
deletion of all three genes induced a reduction of the growth rate of the mutant 
bloodstream forms compared to the wild type cells. However, the apparent adaptation 
of the ATbmca2/3ATbmca5 parasites is intriguing. Indeed, while initially growing more 
slowly than the wild type, the growth rate of the triple null mutant gradually increased, 
with the time spent in culture, to finally match the wild type level. Selection of faster 
growing parasites might explain this adaptation. However, the mechanism behind this 
recovery is uncertain. The most obvious explanation would be for TbMCAI and TbMCA4 
to be able to complement the loss of TbMCA2, TbMCA3 and TbMCAS. Indeed it  will be 
interesting to determine if  TbMCAI or TbMCA4 are up-regulated in the 
ATbmca2/3ATbmcaS line but no antibodies are available at present to investigate this 
possibility. It would also be interesting to determine whether these metacaspases co- 
localise with TbMCA2, TbMCA3 and TbMCAS within the cell.
7.4.2. TbMCA2, TbMCAS and TbMCAS localisation in the cell
Immunofluorescence observations, performed in bloodstream forms, revealed 
that TbMCA2 and TbMCA3 are co-localising almost completely in a compartment that 
was identified as RAB11-positive (Helms et al., 2006). As previously discussed (chapter 
4), TbMCA2 and TbMCA3 have significant divergence only in their N-terminal domain, a 
region that in TbMCA3 is predicted to contain a putative signal peptide. Also, it  was 
initially believed that the small extension present on TbMCA3 might have been involved 
in differential targeting of TbMCA2 and TbMCAS. However, this does not seem to be the 
case, as these two proteins are found in the same compartment. Furthermore, TbMCAS, 
which is also predicted to possess a signal peptide at its N-terminus but does not show 
any homology with TbMCAS in this region, is also found in the RAB11-positive 
compartment that contains TbMCA2 and TbMCAS. Therefore, the N-terminal domain 
may not be involved in the targeting of TbMCAS and TbMCAS to the RAB11-positive 
compartment. However, we can not exclude the possibility that this domain might, 
through some secondary structure peculiarities, be able to target these metacaspases to 
another cellular compartment. Indeed, immunofluorescence observations revealed that
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the CO-localisation between TbMCAS and RAB11 was not total, and that at least a small 
part of the TbMCAS protein pool is distinct from RAB11 (Helms et al., 2006).
Secondary structure predictions suggest that the extension at the N-terminus of 
TbMCAS contains an a-helix domain. Also this additional structural feature might 
participate in the shielding of the nearby WW binding domain and might therefore 
modulate the ability of the protein to associate with its partners. However, as TbMCA2 
possesses a similar WW binding domain, but no additional N-terminal helix structure to 
modulate its interaction capacity, then the benefit of TbMCAS adopting such a 
regulatory strategy is unclear. We could also say that, by modifying the structural 
environment of the WW binding domain, the N-terminal region of TbMCAS might confer 
some binding specificity to this interaction module. Thus, although both proteins 
possess a WW binding domain, TbMCA2 and TbMCAS might have two distinct sets of 
protein partners. On balance it  is unlikely that the N-terminal domain of TbMCAS 
modulates protein-protein interactions, however, it  can not be excluded that this 
domain might contain, like in LmajMCA, an atypical mitochondrial targeting signal. In 
the L  major metacaspase, this region was postulated to enable the entry into the 
mitochondrion and the subsequent interaction with the mitochondrial DNA, the 
kinetoplast. In 7. brucei, immunofluorescence observations seem to indicate that 
TbMCA2, TbMCAS and TbMCAS do not associate with the kinetoplast. Nevertheless, the 
N-terminal domains of TbMCAS and TbMCAS might mediate a transient relocation to this 
organelle during the cell-cycle. This might correlate with the observation that LmajMCA 
relocates to the kinetoplast upon the start of the mitochondrial DNA segregation 
(chapter 5). Thus the premature entry or exit of the metacaspases from the 
mitochondrion would then presumably interfere with the kinetoplast division. And 
indeed, overexpression in L. major and RNAi in 7. brucei bloodstream forms of the 
metacaspase(s) induce a defect in kinetoplast segregation. Consequently it  is possible 
that the N-terminal domain of LmajMCA, TbMCAS and TbMCAS mediate the transient 
relocalisation of these metacaspases to the mitochondrion and more precisely the 
kinetoplast DNA. We might then postulate that metacaspases trafficking to this 
alternative location might represent a part of the metacaspase pool not co-localising 
with RAB11.
Meanwhile, it  is still unclear how TbMCA2, TbMCAS and TbMCAS are targeted to 
the RAB11-positive recycling endosomes. In eukaryotic cells, the secretory and 
endocytic pathways consist of multiple compartments, each with a unique set of 
proteins and lipids. Also, to ensure their identities and functions, these various 
compartments are required to direct molecules to defined locations. Various signals 
responsible for targeting proteins to different intracellular locations have been 
described (van Vliet et al., 200S). One of the main platforms where protein targeting is
__
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performed is the trans-Golgi network (TGN). At this site, cytosol-oriented sorting signals 
direct protein cargo to the appropriate export compartment (Traub and Kornfeld, 
1997). However, it  is difficult to predict if  there are any such sorting signals in the 
metacaspases. It is probable that a yet uncharacterised conserved motif within TbMCAZ, 
TbMCAS and TbMCAS is responsible for their targeting to the same compartment.
7.4.3. T. brucei metacaspases putative functions
The reasons why these three metacaspases accumulate in a RAB11- positive 
compartment remain obscure. Rab proteins are small GTPases belonging to a sub-group 
of the Ras superfamilly which are involved in the spéciation and regulation of vesicular 
traffic (Novick and Brennwald, 199S; Nuoffer and Balch, 1994). In T. brucei, RAB11 is 
highly expressed in bloodstream form and mediates recycling of glycosylphosphatidyl- 
inositol-anchored proteins, including the variant surface glycoprotein (VSG) and the 
transferrin receptor, plus trafficking of internalized anti-VSG antibody and transferrin. 
T. brucei expresses around 10^  copies of the VSG on the external surface of the plasma 
membrane (Jackson et a i,  1985). This surface coat molecule is proposed to act 
primarily as a steric barrier preventing antibody and complement binding to invariant 
surface determinants. VSG is highly immunogenic, and a robust anti-VSG immune 
response can eliminate parasites from the bloodstream with high efficiency. However, a 
process of antigenic variation, consisting in a rapid switching of the expressed VSG gene 
to an immunologically non-cross reactive VSG (Cross et a i,  1980) ensure that host anti- 
VSG antibodies do not reach levels sufficient to clear the infection (Pays et a i,  1994). 
Nevertheless, host antibodies may be generated faster than the switching of VSGs. Also, 
it  is believed that the rapid trafficking and recycling of the VSGs plays an important role 
for the defence against the immune system (O’Beirne et a i,  1998). Indeed, in the 
bloodstream forms, it  has been demonstrated that the total surface pool is being, in 
vitro, turned over in 12 minutes (Engstler et a i,  2004). Also, it  is very likely that this 
rapid membrane turn over could allow the removal of anti-VSG antibodies, thus ensuring 
the parasite’s escape from the host immune response. In trypanosomatids, the endo- 
and exocytosis are highly polarised processes occurring exclusively at the site of the 
flagellar pocket (McConville et a i,  2002). Upon their endocytosis, the VSGs enter the 
endosomal system. Also, as VSGs are very stable molecules, the majority of the 
internalised VSGs are being recycled back to the surface (Seyfang et al., 1990), while in 
contrast, the anti-VSG antibodies are extensively degraded (O'Beirne et a i,  1998). It 
has been established that the internalisation of the VSG and the anti-VSG antibodies is 
mediated by the RabS-positive early endosomes while their recycling occurs through the 
RAB11-positive recycling endosomes (Jeffries et a i,  2001; Pal et a i,  2003). However,
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immunofluorescence experiments failed to establish the lasting presence of TbMCAZ, 
TbMCA3 and TbMCAS in early endosomes while revealing their co-localisation with the 
RABII-posivite recycling endosomes.
To assess whether the metacaspases were involved in recycling processes in T. 
brucei bloodstream forms, we followed, by immunofluorescence analyses, the 
trafficking of internalised biotinylated VSGs through the endocytic pathway and their 
subsequent return to the cell surface via RAB11-positive recycling endosomes in 
ATbmca2/3ATbmcaS and triple RNAi induced parasites and compared it  with the wild 
type cells. As expected, in the wild type BSF, a rapid turn over of the surface VSG pool 
was observed and within 15 minutes, most of the internalised biotinylated VSGs were 
back on the cell surface. However, even in the absence of TbMCAZ, TbMCA3 and 
TbMCAS, the rate of the VSG recycling was comparable to the wild type, indicating that 
these proteins are unlikely involved in this process. The analysis then shifted to the 
pathway of the removal and degradation of the host anti-VSG antibodies. It is still 
unclear whether the dissociation of the antibodies from the VSGs occurs via a 
proteolytic clipping event or via a pH reduction, during their shifting from one 
endosomal compartment to the next. Additionally, the peptidases involved in the 
degradation of these antibodies and the compartment(s) where this occurs are still 
elusive. However, it  was observed that TbMCAS is partially co-localising with anti-VSG 
antibodies (Helms et al., 2006). Also it  was initially thought that the metacaspases 
might play a role in the degradation of these IgGs. However, our analysis revealed that 
the ATbmca2/3ATbmcaS and triple RNAi- induced parasites were not displaying any 
marked build up of internalised anti-VSG antibodies, thus suggesting that the 
metacaspases were not responsible for anti-VSG antibodies processing. Furthermore, it  
has recently been established that the A. thaiiana metacaspases possess a strict 
substrate specificity, with a preference for arginine or lysine residues at the PI position 
of their substrates (Vercammen et al., 2004; Watanabe and Lam, 2005). Also, if  the 
same is true for the T. brucei metacaspases, it  is very unlikely that they would be 
effective general degradative enzymes. Rather, the metacaspase would be predicted to 
specifically cleave and process protein substrates to allow their activation. Also, even 
though the metacaspases are present in RAB11-positive recycling endosomes, we failed 
to establish any involvement of TbMCAZ, TbMCA3 and TbMCAS in the recycling processes 
themselves.
In Drosophila cells, the endocytic and secretory pathways are postulated to 
converge in Rab-11 positive recycling endosomes (Pelissier et al., 2003; Strickland and 
Burgess, 2004). Also, even if  this has not been experimentally established yet, i t  is 
possible that, in trypasomatids, the RAB11-positive recycling endosomes are also a 
constitutive part of the traditional secretory pathway. In that case, the metacaspases
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might be involved in the activation of a secreted protein. The comparison of the 
secretion profiles of wild type, ATbmcal/SATbmcaS and triple RNAi-induced 
bloodstream form parasites may be able to address this possibility. However, the very 
rapid cell cycle arrest induced, in bloodstream forms, upon RNAi of TbMCAZ, TbMCAS 
and TbMCAS, suggest that the metacaspases are more likely involved in the control of 
cell division.
It has recently been shown that, in mammalian cells, RAB11-positive recycling 
endosomes recruit, during cytokinesis, various proteins and membrane constituents on 
the site of cleavage furrow ingression (Wilson et al,, 2005; Fielding et al., 2005). In 
most eukaryotic cells, mitosis ends with the start of cytokinesis, a process by which the 
plasma membrane is dramatically constricted and ultimately leading to the production 
of two daughter cells. Cytokinesis is mediated by the contraction of an actin/myosin 
ring that forms perpendicular to and midway between the nuclear mitotic spindle and 
creates an ingressing cleavage furrow (Fishkind and Wang, 1995; Glotzer, 1997a; 
Glotzer, 1997b; Field et al., 1999; Robinson and Spudich, 2000; Glotzer, 2001; Robinson 
and Spudich, 2004; Glotzer, 2005) (figure 3.2e, f). In mammalian cells, it  has recently 
been suggested that the increased surface area necessary for the production of two 
daughter cells is supplied, during cytokinesis, by insertion of additional membrane at 
the cleavage furrow (Finger and White, 2002). Interestingly, at this site, the plasma 
membrane seems to possess a distinct lipidid and protein content (Emoto et al., 1996; 
Umeda and Emoto, 1999; Emoto and Umeda, 2000). This unique composition might 
explain the malleability of cleavage furrow plasma membrane during ingression and its 
ability to be pinched in two, but might also mediate the creation of transduction signals 
necessary for progression through cytokinesis. Thus, membrane traffic during 
cytokinesis not only promotes the expansion of the plasma membrane surface but also 
mediates the delivery of key proteins involved in cleavage furrow ingression and 
abscission. Also, work in Xenopus indicates that the additional membrane does not come 
from the expansion of the preexisting surface membrane but from the insertion of 
internally-stored membrane (Bluemink and de Laat, 1973; Byers and Armstrong, 1986; 
Bieliavsky et al., 1992). In plant cells, it  is well established that, during cytokinesis, 
membrane expansion is induced by delivery of Golgi-derived exocytic vesicles (Bednarek 
and Falbel, 2002). Also, it  has been suggested that the endocytic machinery and more 
precisely the endosomes are likely to be a source of membrane during cytokinesis. 
Indeed, dynamin, a protein involved in clathrin coat-dependent endocytosis, and a- 
adaptin, a component of coat proteins involved in receptor-mediated endocytosis, are 
both known to be present in the cleavage furrow and to be required for cell division 
(Swanson and Poodry, 1980; Dornan et a i,  1997). Even if  the dynamics of endosomes 
during cell division are still elusive, it  was proposed that RAB11 may regulate the
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delivery of endocytic vesicles to the cleavage furrow (Riggs et al., 2003, Strickland and 
Burgess, 2004). While playing a key role in the regulation of plasma membrane receptor 
trafficking, RAB11 -positive recycling endosomes were indeed found to accumulate near 
the cleavage furrow and implicated in regulating membrane delivery to the cleavage 
furrow, an essential requirement for successful completion of cytokinesis in mammalian 
cells. In Caenorhabditis elegans ovaries, RNAi of RAB11 causes cytokinesis defects 
including furrow regression and scission (Skop et a i,  2001) indicating that vesicular 
transport through the RAB11-recycling endosomes is indeed required for supplying the 
extra membrane necessary for furrow ingression. In mammalian cells, RAB11 interacts, 
between others, with at least six RAB11- Family Interacting Proteins (RAB11-FIPs) 
(Hobdy-Henderson et a i,  2003). Also, in those cells, the complex of RAB11 and RAB11- 
FIP3 has been shown to be essential for cytokinesis completion, but not cytoplasm 
furrowing and mid body formation, and is suggested to play a role in the last stage of 
cytokinesis, abscission (Wilson et al., 2005; Fielding et al., 2005). Therefore, RAB11- 
recycling endosomes deliver not only membrane but also essential proteins that control 
the ingression of the cleavage furrow and completion of cytokinesis.
Cytokinesis in trypanosomatids remains an obscure process. Particularly, it  is still 
unknown whether additional membranes are being recruited to the cleavage furrow. 
Furthermore, no proteins localising to the cleavage furrow have been characterised yet. 
We therefore decided to determine the localisation of RAB11 and the associated 
metacaspases during cytokinesis and more precisely during the abscission process 
(figure 7.5). Immunofluorescence observations performed on dividing T. brucei 
bloodstream forms revealed that RAB11 and TbMCAS were not directly associated with 
the cleavage furrow. Nevertheless, while data for the other four T. brucei metacaspases 
are lacking, the same experiment performed in L. major suggested that LmajMCA, 
might be present at that site upon the cell-cell scission (figure 5.4f). In T. brucei 
bloodstream forms, RNAi of RAB11 leads to a immediate and complete growth arrest 
(Hall et al., 2005), suggesting that somehow, RAB11 might play a role in cell cycle 
progression. However, as genome database searches failed to identify any homologue of 
the RAB11-FIP family in T. brucei and L. major, it  is still unclear if  RAB11 might be 
involved in the control of cytokinesis. However it  is tempting to postulate that it  might 
be the case and that the metacaspases might be somehow linked to this process. 
Nevertheless, as the TbMCAZ, TbMCA3 and TbMCA5 RNAi lead to a complete pre­
cytokinesis block, then it  is more likely that these metacaspases would be involved in 
the early cytokinesis events. In addition, as the phenotypes observed during the triple 
RNAi induction, namely the delay in kinetoplast segregation and the complete block in 
cytokinesis, are known to be microtubule-mediated events (Robinson et a i,  1995), then 
TbMCAZ, TbMCA3 and TbMCA5 might be involved in the control of microtubules
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dynamics. Recently, in Drosophila embryos, RAB 11-containing recycling endosomes were 
characterised as mediators of actin cytoskeleton remodelling during the early stages of 
furrow formation (Riggs et aL, 2003). Even if  actin is still poorly characterised in 
trypanosomatids, but knowing how intrinsically the microtubular and actin networks are 
connected in mammalian cells (Rodriguez et a i,  2003), it  will then be tempting to 
speculate that the metacaspases might be involved in cytoskeleton remodelling during 
cell cycle progression.
Clearly, further analysis of the metacaspases in T. brucei is necessary to 
elucidate their roles and to provide insights into the networks to which they contribute. 
Whether these might involve PCD-like phenomena is an open question. Whilst i t  has 
been proposed that metacaspases of yeast (Madeo et al., 2002b; Herker et al., 2004; 
Wadskog et al., 2004), plants (Hoeberichts et al., 2003; Watanabe and Lam, 2005; 
Bozhkov et al., 2005), and L. major (Gonzalez et al., 2006) have functions associated 
with PCD, we have not been able to find any evidence for similar functions in BSF T. 
brucei. Indeed, the observations that TbMCAZ and TbMCA3 are stage-regulated, and, 
with TbMCAS, do not undergo any caspase-like processing, that the absence of the 
metacaspases does not prevent prostaglandin D^-induced programmed cell death, and 
that these three metacaspases are co-located mainly in RAB11-positive vesicles, argue 
against a caspase-like involvement in PCD. Although it  cannot yet be ruled out that 
metacaspases are involved in apoptotic-like cell death in BSF T. brucei, the data 
presented here suggest that metacaspases may have PCD-independent functions that 
could be associated with RAB11 -positive endosomes and play crucial roles for the cell.
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At the beginning of this study nothing was known about the role of the 
metacaspase in Leishmania. During these three years, I have managed to answer some 
of our initial questions. First I demonstrated that the metacaspase is expressed in both 
the insect and the mammalian forms of the parasite. Surprisingly, I identified a role for 
LmajMCA in DNA segregation during mitosis and kinetoplast division and an involvement 
in cytokinesis. These finding were most unexpected as to date metacaspases had 
principally been found to be involved in the induction of defined forms of programmed 
cell death in yeast and plants (Madeo et al., 2002b; Suarez et al., 2004; Bettiga et al., 
2004; Watanabe and Lam, 2005; Weinberger et al., 2005; Mazzoni et al., 2005; Bozhkov 
et al., 2005). Recently, Gonzalez et a i showed that the L  major metacaspase was able 
to complement the programmed cell death-inducing function of the yeast metacaspase 
(Gonzalez et al., 2006). Therefore, many aspects of the multiple functions of this 
metacaspase still remain to be investigated.
In this study I tried to produce recombinant LmajMCA, in order to establish the 
biochemical properties of this enzyme. Unfortunately, many problems were 
encountered and success was achieved only towards the end of the project. The Pkhia 
system seemed to be the most promising expression system. Unfortunately the yields of 
the recombinant protein were not reproducible and impeded any biochemical 
characterisation. In the meantime, our collaborators managed to establish optimised 
conditions for the expression of LmajMCA in yeast and solved in part the mystery of 
LmajMCA substrate specificity (Gonzalez et al., 2006), They found that, like its plant 
counterparts, LmajMCA cleaves substrate after arginine residues and possesses an 
affinity for peptide substrates of GGR composition. An N- and C-terminally truncated 
version of LmajMCA, mainly containing its catalytic domain (termed cd-LmajMCA), 
showed a higher activity toward this substrate than the full length LmajMCA, indicating 
that, like caspases, LmajMCA needs to be processed to become active. Cleavage that 
seems to occur in a caspase-like fashion, between large and small sub-units, apparently 
depends on the catalytic dyad C202 and HI47, indicating that LmajMCA is likely subject 
to auto-processing (Gonzalez et al., 2006). Although the exact location of the cleavage 
site remains to be determined, it  seems that LmajMCA is processed in both its N-and C- 
terminus, with the removal of an N-terminal domain and the C-terminal proline-, 
glutamine- and tyrosine-rich extension. In addition, the N-terminal signal peptide is 
apparently removed independently of LmajMCA auto-cleavage (Gonzalez et al., 2006). 
Interestingly, the present study showed that similar processing was occurring in L  
major promastigotes for LmajMCA and also most of the other LmajMCA variants 
expressed. It is possible that LmajMCA possesses a preprodomain in its N-terminus 
involved in both the targeting of the peptidase and the regulation of its catalytic 
activity. Recently, a cysteine residue conserved in all metacaspases (C29 in AtMCA9,
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C98 in TbMCA4 or C81 in LmajMCA), present apparently in close proximity to the 
catalytic dyad in the tertiary fold, and previously identified as playing a role in the 
toxicity of TbMCA4 when expressed in yeast (Szallies et al., 2002), was found to be, in 
the plant metacaspase AtMCA9, involved in the processing of an N-terminal peptide 
(Belenghi et al., 2006). The removal of the N-terminus appears to be essential for the 
production of a fully functional AtMCA9, as mutation of C29 to an alanine residue 
resulted in 90% reduction of the enzyme activity toward its favoured substrate Ac-VRPR- 
AMC. Nevertheless, it  was observed that in this mutant processing between the large 
and small sub-units of the enzyme still occurred and that this process was dependent on 
the active site cysteine C147 (Belenghi et al., 2006). Taken together these data suggest 
that LmajMCA, like AtMCA9, might need two steps of activation. First the protein is 
cleaved between large and small sub-units by removal of N-and C-terminal fragments 
and then the enzyme is further processed at its N-terminus to gain optimal activity.
Interestingly, it  was established that the full length AtMCA9 is S-nitrosylated on 
C147 (Belenghi et al., 2006). S-nitrosylation, which consists of the covalent attachment 
of a nitrogen monoxide group to the thiol side chain of a cysteine, is a post-translational 
modification mediating nitric oxide (NO) signalling (Hess et al., 2005). As for caspases 
(e.g. caspase-3), S-nitrosylation of the AtMCA9 zymogen resulted in inhibition of the 
enzyme activity, thus providing a mechanism by which caspase/metacaspase activity 
could be regulated (Mannick et al., 2001). However, once processed between its large 
and small sub-units, the S-nitrosylation of AtMCA9 resulted in an increased proteolytic 
activity of this enzyme toward its favoured substrate. Therefore it  seems that S- 
nitrosylation can control both steps of the activation process of the metacaspase, first 
by blocking the initiation of the protein auto-processing and then later by activating the 
second step and favouring the action of the S- nitrosylation-i nsensitive C29 and the 
removal of the N-terminal peptide, which would result in the production of a fully 
functional enzyme. It w ill be interesting, therefore, to test whether LmajMCA is 
subjected to S-nitrosylation and whether this post-translational modification regulates 
the catalytic activity of LmajMCA. This finding could be of physiological significance as, 
within the mammalian host, Leishmania promastigotes and amastigotes are subject to 
high level of NO, one of the main antimicrobial agents produced by the infected 
macrophages (Basu and Ray, 2005).
The potential involvement of C81 in the enzymatic activity of LmajMCA needs to 
be investigated further. If this cysteine residue can, as suggested for AtMCA9, replace in 
part the function of the active site cysteine (C202) in the catalytic centre, then this 
might provide a possible explanation for the phenotype observed during the 
overexpression of LmajMCA^^^^  ^in L. major, LmajMCA^ -^ *^^  being still active. By analogy, 
C81 would only be involved in the final step of the metacaspase activation process, a
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step that would take place after the C202-mediated auto-processing. Therefore, the 
only possible mechanism by which LmajMCA^ ^®^  ^ could become active would involve 
other peptidases carrying out the first processing step. Belenghi et al. showed that the 
active site mutated metacaspase variants AtMCA9^ '^*^  ^ and AtMCA^ ’^  ^ possessed a 
VRPRase activity that was more than twice that of the wild type enzyme when 
processed correctly by in vitro incubation with the wild type AtMCA9 (Belenghi et al., 
2006). Also, in the context of the LmajMCA^ °^ °^ overexpressors, the wild type LmajMCA 
is still present in the cell and thus would be able to process LmajMCA^ °^^ .^ The second 
step of activation could then be mediated by either the additional cysteine residue C81 
or maybe again by the wild type LmajMCA. This would mean that mutations in crucial 
residues in LmajMCA active site would not interfere with the processing of the mutant 
protein during its overexpression in cells with a wild type background. Therefore, 
LmajMCA^^^^, LmajMCA^ ^®^ ,^ LmajMCA^ ^®^ '^ *^ ^^  and LmajMCA"^ "^ *^ are all likely to be 
processed by the wild type LmajMCA in their respective overexpressors. However, only 
enzymes with available alternative active site residues would be able to become 
catalytically active. If the cysteine C81 is indeed involved in the catalytic centre, 
LmajMCA^ '^ ®^ '^ , LmajMCA^^^^  ^ and LmajMCA^ °^^^°^  ^ could theoretically become active 
enzymes. However, while the overexpression of LmajMCA^ ^®^  ^ induced in L. major a 
phenotype comparable to the one induced by overexpression of the wild type LmajMCA, 
suggesting that LmajMCA*"^ ®^  ^ is indeed still active, no such phenotype was detected in 
the LmajMCA^ ^®^  ^ and LmajMCA^ ^®’’ ®^^  ^ overexpressors. With the current state of 
knowledge available, I cannot explain why the overexpression of LmajMCA^ *^^ ^^  and 
LmajMCA^ ”^ '^^ “  ^ are not toxic for the cell when the overexpression of LmajMCA'^ ^®^  ^ is. 
One could predict that the C201G active site mutation might interfere with the catalytic 
centre configuration and thus modify somehow the catalytic mechanism of LmajMCA^ ^®^  ^
and LmajMCA"-^ °^ '^ °^ .^ Alternative processing/degradation of these proteins might also 
occur. As for LmajMCA^ '^*^  ^ only the existence of an additional histidine residue able to 
substitute for the active site histidine would explain the phenotype associated with the 
overexpression of this variant. Surprisingly, even though the recombinant cd- 
LmajMCA"^ '*^ '^  lacked catalytic activity toward GGR substrate in vitro, LmajMCA" '^* *^ was 
found to still be able to partially complement the PCD-inducing function of the yeast 
metacaspase (Gonzalez et al., 2006), suggesting that this mutant enzyme might possess 
some residual activity. This might account for the reduced number of transfectants 
possessing a type 2 phenotype in the LmajMCA"^^^* overexpressors compared to the 
WT[MCA] or WT[MCA“ °^ ]^ cells. However it  can not be excluded that some of the 
phenotypes observed during overexpression of LmajMCA and its several variants, in 
Leishmania promastigotes, might be independent from the metacaspase activity. 
Therefore it  can be concluded that the identity of the active site residues essential for
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LmajMCA function remain to some extent cryptic and need to be fully elucidated. 
Hopefully, further biochemical studies on the recombinant LmajMCA and several of its 
active site variants will clarify this point. In addition, the positions of LmajMCA 
processing sites need to be determined. Based on the latest findings on the substrate 
specificity of the plant and L. major metacaspases (Vercammen et al., 2006; Gonzalez 
et al., 2006), the processing of LmajMCA N-terminus might occur at any of positions 38- 
40, 45-48, or 59-61, where GRR, VRPI and GGR sites are respectively present. Also it  will 
be interesting to determine whether the removal of this peptide actually affects 
LmajMCA activity and whether C81 plays a role in this process.
Interestingly, applying the AtMCA9 findings to the T. brucei metacaspases 
suggests that even though TbMCA4 might be unable to auto-process because of a 
substitution of its active site cysteine by a serine residue, it  could theoretically acquire 
enzymatic activity through processing mediated by the successive action of an upstream 
peptidase and of the alternative active site cysteine C98. Processing of TbMCA2, 
TbMCA3 or TbMCA5 has so far not been observed in vivo (Helms et al., 2006), but we 
can not rule out that autocatalytic cleavage or activation by an upstream peptidases 
might occur under special circumstances. The potential for an active TbMCA4 might thus 
explain the progressive recovery from the initial slow growth phenotype of the 
ATbMCA2/3ATbMCA5 bloodstream forms, with the active TbMCA4 compensating for the 
loss of the other metacaspases activities. Also, as sequential RNAi of TbMCA2, TbMCA3 
or TbMCA5 in T. brucei bloodstream forms (Helms et al,, 2006) revealed that these 
three metacaspases possess overlapping functions, the same might occur for TbMCA4, 
which is also apparently expressed in this stage of the parasite (see section 7.2.1). 
Futures investigations should now focus on the functional characterisation of the 
remaining two metacaspases of the T. brucei family, TbMCAI and, most importantly, 
TbMCA4. Determination of their expression pattern, intracellular localisation, possible 
processing and substrate specificity should complete the previous (Helms, 2004) and 
present studies and will hopefully provide new insights into the roles of these proteins 
in the parasites.
TbMCA2 has recently been expressed and purified from E. coli and a sufficient 
amount of active enzyme has been obtained to start a biochemical characterisation of 
its properties (Gareth Westrop and Cathy Moss, unpublished data). Interestingly, 
induction of TbMCA2 expression resulted in an endogenous protein from E, coli being 
cleaved. This processing was specific to TbMCA2 enzymatic activity, as a catalytic 
mutant (C213G) of this protein failed to produce a comparable cleavage. Mass 
spectrometry analysis identified the f .  coli protein cleaved by TbMCA2 as being the 
elongation factor Tu (EF-Tu). Since then, in vitro assays confirmed that EF-Tu but not 
EF-G was cleaved by TbMCA2. N-terminal peptide sequencing revealed that TbMCA2
Chapter 8: General discussion 194
cleaved EF-Tu at two different sites, distant by only 5 amino acids, after an arginine 
and then a lysine residue (VR/GSALK/ALEG). Therefore, TbMCAZ seems to possess a 
substrate specificity comparable to the plant metacaspases AtMCA9 and AtMCA4 and the 
L  major metacaspase (Vercammen et al., 2004; Watanabe and Lam, 2005; Gonzalez et 
al., 2006). Also, EF-Tu might represent an in vivo substrate of the metacaspases as 
homologues of this protein are found in both T. brucei (Tb10.389.0070) and L  major 
(LmjF18.0740). It is assumed that EF-Tu and EF-G diverged from a common ancestral 
GTPase and then gave rise to the eukaryotic elongation (EF1a, EF2) and release (eRF1, 
eRF3) factors (Inge-Vechtomov et aL, 2003). These proteins were initially characterised 
for their role in protein translation. Except for eRF1 (which is derived from EF-G), all of 
them possess potential orthologues in trypanosomatids. More recently, EFIawas found 
to interact with the cellular actin network (Izawa et al., 2000) and to stabilise 
microtubules (Moore et al., 1998) and thus seem to be involved in cytoskeleton 
organisation. This protein was found to be up-regulated during the early stages of serum 
deprivation- and hydrogen peroxide-induced apoptosis (Duttaroy et al., 1998; Chen et 
al., 2000; Talapatra et al., 2002). In T. cruzi, EFIa relocates to the nucleus upon 
programmed cell death-induction (Billaut-Mulot et al-, 1996). In L  donovani EF1a was 
identified as a virulence factor essential for the parasite survival in the mammalian host 
through its modulation of host cell apoptosis (Nandan et al., 2003; Olivier et al., 2005). 
In sea urchin embryos, EF1a appears to associate with the mitotic apparatus (Ohta et 
al., 1990). Therefore, with these multiple functions, EFIa acts on processes associated 
with both the survival and the death of the cell. Assuming that EFIa possesses such 
varied roles in trypanosomatids, then any possible modulation of EFIa activity by 
metacaspase cleavage will have dramatic consequences for the cell. The same might be 
said of EF2 which, in mammalian cells, is indirectly controlled by the extracellular 
signal-regulated kinase (ERK) pathway promoting entry and progression through mitosis 
(Roberts et al., 2006) and is involved in cytokinesis and initiation of differentiation in 
Dictyostelium (Watanabe et aL, 2003). Possessing C-termini comparable to that of 
EFIa, two yeast orthologues of the mammalian release factor eRF1 and eRF3 (encoded 
by SUP45 and SUP35, respectively), initially characterised for their involvement in the 
termination of protein translation, were found to participate not only to cytoskeleton 
organisation but also in cell cycle regulation (Valouev et aL, 2002). Deletion of the 
SUP35 gene in S. cerevisiae resulted in cells with aberrant morphology in which the 
actin cytoskeletal structures had disappeared and where mitosis was impeded by an 
impairment in mitotic spindle formation. The EF1a-like C-terminal domain of eRF3 was 
found to be responsible of these phenotypes. Cells lacking eRFI accumulated with 2C 
and more DNA content, indicating that DNA replication was somehow uncoupled from
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cell division. Strikingly, the phenotypes observed in yeast upon deletion of eRF3 and 
eRF1 were similar to the ones observed during the overexpression of LmajMCA in L  
major (impairment in kinetoplast segregation, mitosis and cytokinesis, aberrant shape 
and tetraploidy). Although no homologue of eRFI has been identified in the L  major 
genome, a putative orthologue of eRF3 is present (LmjFII.1170). Interestingly, this 
protein possesses, in its EF1 a like C-terminal, a VRGIDENDIH sequence that could 
potentially work as a cleavage site for LmajMCA (in case it  has a substrate specificity 
similar to TbMCAZ). Therefore it  is tempting to speculate that eRF3 might be an in vivo 
target for LmajMCA. To gain further insights into this exciting finding, a determination 
of LmajMCA in vivo partners in now needed. This could be achieved by either 
expressing, in L  major cells, LmajMCA at a low level, or in an inactive form, with a tag 
optimised for protein purification (see section 6,5.2) or by doing a two-hybrid screen in 
yeast. Such an approach has recently been successfully followed with a catalytically 
inactive variant of the plant metacaspase AtMCA9 (Vercammen et aL, 2006). initially 
found to bind to AtMCA9 in vitro, a serine peptidase inhibitor termed AtSerpinI was 
subsequently identified as a suicide inhibitor of AtMCA9 (Vercammen et aL, 2006). No 
orthologue of AtSerpinI is present in trypanosomatids, but such a strategy of 
investigation if  performed with the parasite metacaspases could lead to a better 
understanding of the functions of these proteins. Indeed, the identification of 
metacaspase specific inhibitors might provide leads for the development of much 
needed new anti - try panosomatid drugs.
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